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ABSTRACT 
 
Porcine epidemic diarrhea (PED) is a highly contagious and acute enteric disease of 
swine featured by vomiting, watery diarrhea, and severe dehydration causing high mortality in 
piglets. In the U.S., PED emerged for the first time in 2013 and severely affected most pig-
producing states. The causative agent is PED virus (PEDV), which is an enveloped, positive-
sense, single-strand RNA virus in the genus Alphacoronavirus of the family Coronaviridae in 
the order Nidovirales. The innate immune system is the first line of host defense in response to 
viral infections. Type I interferons (IFN-α/β) are the major components of the innate immune 
system, and in turn many viruses have evolved to modulate the host interferon responses.   
In the present study, the PEDV IFN antagonism was investigated. We found that IFN-β 
production was significantly suppressed during PEDV infection, and of 16 PEDV nonstructural 
proteins (nsps), nsp1, nsp3, nsp7, nsp14, nsp15, and nsp16 were found to inhibit the IFN-β and 
IRF3 promoter activities. The sole accessory protein ORF3 and the envelope (E), membrane (M), 
and nucleocapsid (N) proteins were also determined to inhibit such activities. Since nsp1 is the 
first viral protein synthesized during PEDV infection and appears to be the most potent IFN 
antagonist, nsp1 was further investigated for its action. PEDV nsp1 did not interfere the IRF3 
phosphorylation and nuclear translocation upon stimulation but interrupted the enhanceosome 
assembly of IRF3 and CREB-binding protein (CBP) by degrading CBP. The CBP degradation by 
nsp1 was proteasome-dependent.  
We further showed that PEDV inhibited both NF-κB and proinflammatory cytokine 
production in porcine epithelial cells. PEDV blocked the p65 activation in infected cells and 
suppressed the PRD II-mediated NF-κB activity. Nine proteins were identified as NF-κB 
antagonists, and nsp1 was the most potent suppressor of proinflammatory cytokines. Nsp1 
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interfered the phosphorylation and degradation of IκBα, and thus blocked the p65 activation. 
Mutational studies demonstrated the essential requirements of the conserved residues of nsp1 for 
NF-κB suppression.  
Recent reports showed that type III interferons (IFN-λs) play a vital role to maintain the 
antiviral state of the mucosal epithelial surface in the gut. The intestinal epithelial cells 
selectively produce and respond to type III IFNs. To study the type III IFN response to PEDV, a 
line of porcine intestinal epithelial cells was developed as a cell model for PEDV replication. 
Recombinant proteins IFN-λ1 and IFN-λ3 inhibited PEDV replication, indicating the anti-PEDV 
activity of type III IFNs. Of the total of 21 PEDV proteins, nsp1, nsp3, nsp5, nsp8, nsp14, nsp15, 
nsp16, ORF3, E, M, and N were found to suppress the type III IFN response. PEDV specifically 
inhibited IRF1 nuclear translocation. Peroxisomes are the innate antiviral signaling platforms for 
activation of IRF1-mediated IFN-λ production, and they were found to decrease in number in 
PEDV-infected cells. PEDV nsp1 blocked the nuclear translocation of IRF1 and reduces the 
number of the peroxisomes to suppress the IRF1-mediated type III IFN production. The 
conserved residues of nsp1 were crucial for IRF1-mediated IFN-λ suppression. Taken together, 
these studies provide the evidence that PEDV and its nsp1 protein, a potent multifunctional IFN 
antagonist, evade both type I and type III IFN responses and the molecular basis for this 
antagonism.  
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CHAPTER 1: LITERATURE REVIEW 
1. 1 INTRODUCTION  
1.1.1 Coronavirus enteritis in pigs1 
Coronavirus enteritis is a highly contagious viral disease in pigs characterized by severe 
diarrhea, vomiting, and dehydration accompanied with a high mortality, especially in neonatal 
piglets less than 2 weeks of age. Transmissible gastroenteritis virus (TGEV) is a frequent cause 
for endemic and epidemic viral enteritis in neonates and older pigs (Kim et al., 2000; Laude et al., 
1993), and recently porcine epidemic diarrhea virus (PEDV) has become a major concern in the 
swine industry in the US since its emergence in April 2013. As with TGEV, PEDV causes severe 
enteritis in newborn piglets but the mortality can be much higher reaching up to 100% during 
epidemics (Debouck and Pensaert, 1980; Song and Park, 2012). PED is first described in the UK 
in the early 1970s and has since become endemic in some parts of Europe. Highly virulent 
PEDV has recently emerged in Asia and subsequently in the U.S. (Chen et al., 2014; Marthaler et 
al., 2013; Mole, 2013; Stevenson et al., 2013). PEDV has quickly spread to most states, and as of 
November 2017, 39 states have become endemic for PEDV, raising a significant economic 
concern (www.aphis.usda.gov/animal-health/secd). Porine delta-coronavirus (PDCoV) is a 
newly identified swine enteric coronavirus first described in Hong Kong, China, in a surveillance 
study in 2012 (Woo et al., 2012). PDCoV is an additional enteric virus emerged in the US in 
February 2014 (Wang et al., 2014). PDCoV has been identified in the feces and intestinal 
samples of pigs experiencing severe diarrhea without PEDV and TGEV (Wang et al., 2014). 
Retrospective studies show that PDCoV has been present in the US at least since August 2013 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
This chapter has appeared as an article in Virus Research. The original citation is: Zhang, Q., Yoo, D., 2016. 
Immune evasion of porcine enteric coronaviruses and viral modulation of antiviral innate signaling. Virus Res. 226, 
128-141. The copyright owner, Elsevier B.V., permits that author can include the article, in full or in part, in a 
thesis, or dissertation, for a wide range of scholarly, non-commercial purposes.  
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(McCluskey et al., 2016; Sinha et al., 2015). PDCoV has also spread to at least 20 states of the 
US (www.aphis.usda.gov/animal-health/secd), Korea, and China (Dong et al., 2015; Lee and Lee, 
2014). PDCoV infection seems clinically milder with a lower death rate of 30%-40% in neonates 
than typical PEDV infection (Wang et al., 2014), but co-infection with PEDV, TGEV, or porcine 
rotavirus is common and results in a severe form of disease (Marthaler et al., 2014; Wang et al., 
2014). Clinical symptoms by PDCoV are reproducible in both gnotobiotic pigs and conventional 
pigs, and present diarrhea accompanied by severe histopathological lesions such as villi atrophy 
in the absence of other pathogens (Chen et al., 2015; Jung et al., 2015c; Ma et al., 2015). 
Although the clinical signs and pathological lesions are indistinguishable among PEDV, TGEV, 
and PDCoV (Jung et al., 2014), these coronaviruses are antigenically distinct, and thus cross-
protection is absent (Lin et al., 2015). Pathogenesis of these coronaviruses may include 
destruction of enterocytes and villous atrophy of the intestinal mucosa in the jejunum and ileum 
(Debouck and Pensaert, 1980; Jung et al., 2014).  
Coronaviruses are enveloped viruses containing the genome of single-stranded positive-
sense RNA. The coronavirus genome ranges of 28-30 Kb in length and is currently the largest 
known viral RNA genome. Coronaviruses are grouped in the Coronavirinae subfamily of the 
family Coronaviridae, comprising of 4 genera; Alpha-, Beta-, Gamma- and Delta-coronaviruses 
(http://www.ictvonline.org/virustaxonomy.asp [ICTV, 2017]). Evolutionary studies suggest that 
Alphacoronavirus and Betacoronavirus are originated from bats while Gammacoronavirus and 
Deltacoronavirus are likely from birds (Woo et al., 2012). In humans, coronaviruses infect the 
respiratory tract and cause symptoms ranging from common colds to severe pneumonia and 
acute respiratory distress. Severe acute respiratory syndrome coronavirus (SARS-CoV) and 
Middle East respiratory syndrome coronavirus (MERS-CoV) belong to Betacoronavirus and 
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cause lower respiratory tract infections of significant public concerns (Gralinski and Baric, 2015). 
Among swine enteric coronaviruses, TGEV and PEDV belong to Alphacoronavirus and share a 
similar genome organization, whereas PDCoV belongs to Deltacoronavirus 
(http://www.ictvonline.org/virustaxonomy.asp).  
The PEDV genome is approximately 28 Kb in length with the 5’-cap and 3’-
polyadenylated tail. The genome is arranged with ORF1a-ORF1b-S-ORF3-E-M-N in order with 
both termini flanked with untranslated regions (UTRs) (Duarte et al., 1993). ORF1a codes for a 
large polyprotein pp1a, while ORF1b is expressed as the pp1ab fusion protein via the ribosomal 
frameshifting. These polyproteins are proteolytically cleaved to 16 nonstructural proteins, nsp1 
through nsp16, by the proteinase activity of nsp3 and nsp5. The TGEV genome is similar to that 
of PEDV and arranged as ORF1a-ORF1b-S-ORF3a-ORF3b-E-M-N-ORF7 in order (Alonso et 
al., 2002). For PEDV, ORF3 encodes the sole accessory protein, whereas for TGEV, three 
accessory proteins are encoded by ORF3a, ORF3b, and ORF7 (Brian and Baric, 2005). The 
PDCoV genome is the smallest of the three coronaviruses with 26 Kb in length, and includes two 
accessory genes of NS6 and NS7 with the gene order of ORF1a-ORF1b-S-E-M-NS6-N-NS7 
(Woo et al., 2012). Notably, PDCoV lacks the nsp1 gene and thus codes for only 15 nsps in total. 
Genomic similarities and dissimilarities for coronaviruses are illustrated in Fig. 1.1. 
 
1.1.2 Early response to viral infection 
Upon virus infection, a host reacts quickly to an invading virus by producing type I 
interferons (IFN-α/β) and elicits an antiviral state in infected cells and uninfected neighbor cells. 
Three different types of IFNs are known: type I IFNs (IFN-α/β), type II IFN (IFN-γ), and type III 
IFNs (IFN-λ) (Table 1.1). For humans, type I IFNs contain 13 subtypes of IFN-α and a single 
	   4 
subtype for IFN-β, IFN-ε, IFN-κ, and IFN-ω. For pigs, IFN-α is produced from as many as 17 
functional genes. For type II IFN, only a single subtype of IFN-γ is reported for pigs, which is 
mainly produced in immune cells. Type III IFNs include IFN-λ1 (interleukin 29 [IL-29]), IFN-λ2 
(IL-28A), IFN-λ3 (IL-28B), and IFN-λ4 (Kotenko et al., 2003; Prokunina-Olsson et al., 2013; 
Sheppard et al., 2003).  
Different types of IFNs signal through different receptors. IFN-α/β signal through a 
heterodimeric complex composed of a single chain of IFN-α receptors 1 (IFNAR1) and 2 
(IFNAR2), which is believed to be expressed on the surface of all nucleated cells (Gibbert et al., 
2013; Pestka et al., 2004). IFN-γ forms a homodimer for signaling through the IFN-γ receptor 
(IFNGR) complex, which is composed of a dimer of two transmembrane-spanning receptors 
[IFN-γ receptors 1 (IFNGR1) and 2 (IFNGR2)] with broad tissue distributions. IFN-λ signals 
through heterodimers of interleukin-10 receptor 2 (IL10R2) and IFN-λ receptor 1 (IFNLR1). 
While IL-10R2 is widely distributed in different cell types, IFNLR1 is largely restricted to 
epithelial cells (Sommereyns et al., 2008), and thus subtypes of IFN-λ limit their antiviral 
functions to epithelial cells. All IFNs activate the Janus kinase (JAK)-signal transducer and 
activator of transcription (STAT) signaling pathway to establish an antiviral state. Since 
IFNGR1/2 are widely distributed, most cell types are capable of responding to IFN-γ (Valente et 
al., 1992). While the IFN-γ has pleiotropic effects on immune cells, a direct antiviral activity is 
rather limited. In contrast, both IFN-α/β and IFN-λ induce a potent antiviral state by regulating 
the expression of hundreds of interferon stimulating genes (ISGs). Even though IFN-α/β and 
IFN-λ utilize different receptors for downstream signaling, their induction and antiviral 
mechanism are similar, and in vivo studies for IFN-λ show a high degree of redundancy of these 
two IFN systems in lung epithelial cells (Ank et al., 2008; Mordstein et al., 2008; Mordstein et 
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al., 2010), raising a question why two seemingly redundant antiviral systems exist. The IFN 
signaling cascades are summarized in Fig. 1.2. 
Swine enteric viruses are mostly transmitted via the fecal-oral route and a possible 
aerosol transmission, and some of them are highly infectious. TGEV infects and replicates 
primarily in small intestinal enterocytes and to a lesser extent in the respiratory tract (Kim et al., 
2000). PEDV and PDCoV also infect the small intestinal enterocytes (Jung et al., 2015c; Jung 
and Saif, 2015), and thus intestinal epithelial surface is the first line of host defense to prevent 
enteric viral infections. Due to the distinctive features of the intestinal epithelial mucosal surface, 
induction and signaling of IFNs are unique. Coronaviruses have a large genome and have 
evolved to carry redundant mechanisms to counteract the host innate immune response. For 
SARS-CoV, at least 11 viral proteins have been identified as type I IFN antagonists (Kindler and 
Thiel, 2014; Shi et al., 2014a; Totura and Baric, 2012). By contrast, acute infection of TGEV 
induces a high level of IFN-α in newborn pigs (La Bonnardiere and Laude, 1981). Despite the 
variation of genome organization, swine enteric coronaviruses seem to utilize similar but distinct 
mechanisms for activation and evasion of host innate immunity on the intestinal epithelial 
surface.  
 
1.2 PRODUCTION OF TYPE I IFNS AND THE IFN SIGNALING  
The host innate immune system utilizes PRRs (pattern-recognition receptors) to sense 
and respond to PAMPs (pathogen-associated molecular patterns) of invading viruses (Kawai and 
Akira, 2011). This recognition of the membrane-bound PRRs triggers the activation of IFN 
induction pathway. Toll-like receptors (TLRs) are among the best-characterized groups of PRRs 
(Kawai and Akira, 2011). TLRs constitutes a family of single transmembrane proteins with 
	   6 
ectodomains containing the leucine-rich repeats for recognition of PAMPs and a cytosolic TIR 
(toll/IL-1 receptor) domain as a key domain transducing signals to downstream adaptors 
including TRIF (TIR-containing adaptor protein inducing IFN-β) and MyD88 (myeloid 
differentiation primary response gene 88) (Kawai and Akira, 2010). Among TLRs, TLRs 3, 7, 8, 
9, and 13 are involved in endosomal nucleic acid sensing. TLR3 is the dsRNA sensor and 
responds to poly(I:C), a synthetic RNA analog (Kariko et al., 2004; Okahira et al., 2005). TLR7 
and TLR8 recognize ssRNA derived from RNA viruses (Diebold et al., 2004; Heil et al., 2004), 
whereas TLR9 senses CpG DNA motifs in the genome of DNA viruses (Vollmer et al., 2004). 
TLR13 has recently been identified as the sensor for bacterial 23S ribosomal RNA (Oldenburg et 
al., 2012). The RLR (RIG-I-like receptor) family is responsible for the sensing of cytosolic RNA. 
The RLR members include RIG-I (activated retinoic acid-inducible gene I), MDA5 (melanoma 
differentiation gene 5), and LPG2 (laboratory of genetics and physiology 2). RIG-I and MDA5 
respond to poly(I:C) with their specificities based on the length of dsRNA. RIG-I senses shorter 
dsRNA (~300 bp) containing a 5’-triphosphate panhandle structure, whereas MDA5 recognizes 
long dsRNA (>4 kb) fragments (Kato et al., 2008; Schlee et al., 2009; Schmidt et al., 2009). 
Cytoplasmic DNA sensors have been addressed including STING (stimulator of IFN genes) and 
cGAS (cyclic GMP-AMP synthase) for cytosolic DNA sensing (Ishikawa and Barber, 2008; Sun 
et al., 2013; Wu et al., 2013). For type I IFNs production, activated RIG-I or MDA5 binds to the 
mitochondrial adaptor protein MAVS/IPS-1 and recruits TRAF3 (TNF receptor-associated factor 
3) and TRAF6. TRAF3 activates downstream IKK (IκB kinase)-related kinases such as TBK1 
(TANK-binding kinase 1) and IKKε for induction of IRF3/IRF7-dependent type I IFN 
production (Fitzgerald et al., 2003; Sharma et al., 2003). TRAF6 leads to TAK1 activation, 
followed by NF-κB activation for type I IFN and other cytokine productions (Rajsbaum and 
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Garcia-Sastre, 2013). Within the IFN-β promoter, there are four regulatory cis elements, namely, 
positive regulatory domains (PRDs) I, II, III, and IV. PRD I/III, PRD II, and PRD IV are binding 
sites for IRFs, NF-κB, and ATF-2/c-Jun (AP-1), respectively (Honda et al., 2006). The 
expression of IFN-β requires the assembly of these regulatory factors on PRDs to form an 
enhanceosome complex which recruits CBP for IFN production (Randall and Goodbourn, 2008). 
Following production and secretion, IFNs bind to the cell surface receptors to trigger the 
activation of JAK-STAT pathway for the IFN-signaling cascade. The three different IFN systems 
signal through distinct IFN receptors. Type I IFNs and type III IFNs trigger the formation of 
ISGF3 complex for production of hundreds of ISGs. In contrast, type II IFN triggers the 
phosphorylation of STAT1 and subsequent formation of IFN-γ activation factor (GAF) for 
antiviral genes expression (Schneider et al., 2014).   
Expression of the membrane-bound PRRs is cell type-dependent. Specific molecular 
features of the PRRs and the cell type that recognizes them are two main factors for the 
specificity in IFN subtype production (Hoffmann et al., 2015). Nearly all nucleated cells are 
capable of producing IFN-β through activation of IRF3 and NF-κB, but IFN-α subtypes are 
primarily produced by leukocytes (Cantell et al., 1981). Plasmacytoid dendritic cells (pDCs) are 
the most potent type I IFN producers with up to a hundred to a thousand times more IFN-α than 
other cell types (Siegal et al., 1999). Activated pDCs migrate to the lymph nodes and potentially 
influence various cell types through the secreted IFNs. How IFN responses vary during virus 
infection is still unclear. A recent study shows that different IFN responses depend on the 
activation of pDCs by interactions with infected cells or virus alone (Frenz et al., 2014). Levels 
of total IFN-α production in pDCs vary greatly with invading virus, time, and amount of 
inoculum (Thomas et al., 2014). Another study shows that pDCs produce a highly uniformed 
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IFN-α profile regardless of the PAMP (Szubin et al., 2008). Similar to IFNs-α/β, IFN-λ can be 
induced in different cell types by various viruses. IFN-λ can be expressed in a variety of cell 
types of the hematopoietic lineage, which also produces IFNs-α/β in abundance. Among the 
nonhematopoietic cells, epithelial cells are potent producers for IFN-λ. The IFN-λ response is 
largely restricted to the epithelium such that lung epithelial cells respond to IFNs-α/β and IFN-λ 
whereas intestinal epithelial cells respond exclusively to IFN-λ (Mordstein et al., 2010; Pott et al., 
2011; Sommereyns et al., 2008).  
 
1.3 ROLE OF IFNS ON THE INTESTINAL EPITHELIAL SURFACE 
1.3.1 Intestinal epithelial barrier 
Small intestinal epithelial cells (IECs) form a physical barrier to segregate the mucosal 
immune system and commensal microbial communities in the lumen. The Paneth and goblet 
cells secrete mucus and antimicrobial proteins to exclude invading bacteria and viruses from the 
epithelial surface, and renewal of the epithelial cell layer is controlled by the intestinal stem cells 
in the crypts. Secreted IgA (sIgA) also contributes to the barrier function. The lamina propria is 
made of stromal cells, B cells, T cells, dendritic cells, and macrophages. Intraepithelial 
lymphocytes (IELs) are localized between IECs, and these cells constitute a large and highly 
conserved T cell compartment, which serves through cytolysis of dysregulated IECs and renewal 
of IECs. Microfold (M) cells are found in the gut-associated lymphoid tissues (GALT) of the 
Peyer’s patches and the mucosa-associated lymphoid tissue (MALT) of other parts of the 
gastrointestinal tract, and they are specialized for antigen sampling and initiation for mucosal 
immune responses (Peterson and Artis, 2014). Unlike the lung epithelium, the intestinal 
epithelium has to maintain the tolerance to the symbiotic gastrointestinal microflora while 
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mounting an effective immune response during infection. The intestinal epithelial barrier is 
depicted in Fig. 1.3.  
 
1.3.2 Roles of IFN-α/β and IFN-λ in the intestine 
Type I IFNs (IFNs-α/β) are major cytokines to restrict viral infections. Recent studies 
however shed a new light on the importance of IFN-λ for restricting viral infection in the 
intestinal epithelium. In the rotavirus model, IFNs-α/β rather play a minor role for restricting 
viral infections, and instead, IFN-λ plays a major role to inhibit viral replication in the intestinal 
epithelium (Angel et al., 1999; Pott et al., 2011). IECs strongly respond to IFN-λ but only 
marginally respond to IFNs-α/β in vivo. The effects of IFNs-α/β and IFN-λ are 
compartmentalized with the major effect of IFNs-α/β on the intestinal lymphocytes and IFN-λ on 
the epithelial cells (Pott et al., 2011). Distinct roles of IFNs-α/β and IFN-λ for controlling 
systemic and local dissemination of rotavirus, respectively, have been suggested. IFNs-α/β 
produced by mucosal pDCs can enhance B cell response to promote viral clearance and 
protection against re-infection (Deal et al., 2013). For rotavirus, significance of IFNs-α/β seems 
to vary depending on the viral strains, host, and synergy with other types of IFNs, but IFN-λ 
determines localized intestinal epithelial antiviral defense. A recent finding shows that activated 
IELs upregulate the IFNs-α/β and IFN-λ expression to mount a rapid antiviral state for protection 
of IECs (Swamy et al., 2015). Activation of IELs in vivo rapidly provokes ISGs expression 
through the IFN-α and IFN-λ receptors. Thus, activation of IELs offers an overt means to 
promote an innate antiviral potential of the intestinal epithelium.  
Resistance of invading viruses in the gut epithelium relies mainly on IFN-λ, not IFNs-α/β, 
which raises a question on the ubiquitous expression of receptors for IFNs-α/β. A recent study 
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shows that mouse IECs minimally express functional type I IFN receptors and thus do not 
respond to type I IFNs, explaining why the IFNs-α/β system is unable to compensate the IFN-λ 
deficiency during enteric epitheliotropic viral infections (Mahlakoiv et al., 2015). This study 
shows that virus-infected IECs are potent producers of IFN-λ, suggesting that the gut mucosa 
possesses a compartmentalized IFN system in which epithelial cells respond predominantly to 
IFN-λ, whereas other cells of the gut rely on IFNs-α/β for antiviral defense. Timely production of 
IFN-λ in IECs drives rapid clearance of intestinal viral infections and limits viral shedding in the 
feces. The intestinal epithelium responds exclusively to IFN-λ in a non-redundant fashion to 
control epitheliotropic viruses (Pott et al., 2011). For reovirus, IFN-λ restricts initial viral 
replication and reduces viral shedding in the feces, whereas IFNs-α/β are critical for the 
prevention of systemic infection. Similarly, norovirus infection also requires IFN-λ to control 
persistent enteric infection, although IFNs-α/β restrict the systemic spread (Nice et al., 2015).  
In the gut, the protective effect of the innate immunity, in particular IFN-λ, is 
counteracted by intestinal commensal bacteria (Baldridge et al., 2015). PEDV infection causes 
the decrease of commensal bacteria present in the healthy gastrointestinal tract and induces an 
unbalanced shift of gut microbiota (Koh et al., 2015; Liu et al., 2015b), suggesting a possible 
modulation of IFN-λ response by PEDV. The border surface of the intestinal epithelium is the 
major entry site for enteric viruses, and specific mechanisms are needed for the fail-safe 
protection of such multi-layered surfaces. Although IFN-λ production by IECs is required, it is 
not sufficient for protection of the epithelium from rotavirus-induced cell damages. The 
production and release of IL-1α by IECs following rotavirus infection enhances IL-22 production. 
A recent study identifies a cooperation of IFN-λ and IL-22 to synergistically curtail mucosal 
viral infection (Hernandez et al., 2015). The receptors for IL-22 and IFN-λ are restricted to 
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epithelial cells, and simultaneous engagement of both receptors on IECs is required for 
restriction of rotavirus infection, suggesting a second layer control is necessary (Hernandez et al., 
2015). Downregulation of IFNLR1 and interference of the STAT1 signaling may be an important 
strategy for viral evasion (Sen et al., 2014).  
After stimulation with poly(I:C) and infection with reovirus, both IECs and 
hematopoietic cells in the intestinal epithelium express IFN-λ strongly and quickly, but do not 
express IFNs-α/β genes (Mahlakoiv et al., 2015). Thus, mechanisms seem to have evolved to 
produce IFN-λ specifically and potently in the intestinal epithelium. Since common pathways are 
believed to be utilized for induction of both IFNs-α/β and IFN-λ (Onoguchi et al., 2007), the 
IFNs-α/β pathway is specifically blocked in IECs by an unknown mechanism. Another study 
shows that peroxisome-bound MAVS may preferentially activate IFN-λ expression (Odendall et 
al., 2014). Nlrp6 (nucleotide-binding oligomerization domain-like receptor 6) is an intracellular 
protein specific for tissues and cell-types with the highest expression in IECs (Elinav et al., 
2011). Nlrp6 binds to viral RNA via the RNA helicase Dhx15 as a RNA sensor and triggers 
MAVS-dependent expression of IFN-α/β and IFN-λ plus ISGs, and thus plays an important role 
for intestinal antiviral response (Wang et al., 2015b).  
Using gene-knockout mice for specific IFN receptors, IFN-λ has been identified to play 
an important role in the defense against SARS-CoV and other respiratory viral infections 
(Mordstein et al., 2010). Fecal shedding of SARS-CoV can be detected from mice lacking both 
receptors for IFN-α/β and IFN-λ but not from mice lacking single receptors, suggesting that IFN-
λ controls viral infections in epithelial cells of both respiratory and gastrointestinal tracts. 
Relative contributions of the various IFN subtypes for restricting enteric coronavirus infections 
remain elusive. Both TGEV and PEDV can infect and replicate in PAMs in the respiratory tract 
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in vivo (Park and Shin, 2014). PEDV has also been shown to infect macrophages infiltrated in 
the lamina propria and modulates immune responses after infection of monocyte-derived DCs 
(MoDCs) and intestinal DCs (Gao et al., 2015; Lee et al., 2000). In summary, IFN-λ seems to be 
critical to efficiently restrict enteric coronavirus infections in the intestinal epithelial surface, 
including PEDV, TGEV, and possibly PDCoV infections, and in turn, these viruses may 
modulate the host IFN-λ response. It is of great interest to investigate how such enteric 
coronaviruses regulate the IFN-λ response in pigs. A full-length infectious cDNA clone is 
available for PEDV, and it will be useful to study individual gene functions using replicating 
mutants in vivo. As such, we will be able to better understand the pathogenic mechanisms of 
porcine enteric coronaviruses and host responses to such infections (Beall et al., 2016; Jengarn et 
al., 2015).  
 
1.4 MODULATION OF IFN RESPONSE BY PORCINE ENTERIC CORONAVIRUSES 
1.4.1 Aminopeptidase N (CD13) as the cellular receptor and viral tissue tropism 
For coronaviruses, S protein and its interaction with a receptor on susceptible cells 
determine the host range and viral tropism (Bosch et al., 2003; Gallagher and Buchmeier, 2001). 
Unlike many other coronaviruses, cell culture adaptation of PEDV triggers mutations in the S 
protein sequence (Lawrence et al., 2014) and requires the supplement of an exogenous protease, 
typically trypsin, to activate the S protein to induce membrane fusion after binding to the cellular 
receptor (Hofmann and Wyler, 1988; Park et al., 2011; Wicht et al., 2014). The trypsin 
dependency of PEDV in vitro is consistent with the tissue tropism of trypsin-rich small intestine 
in pigs. Some of cell-adapted PEDV strains lose the trypsin-dependency (Nam and Lee, 2010; 
Wicht et al., 2014). PEDV-infected cells produce distinct cytopathic effects including cell fusion, 
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multinucleated syncytia formation, vacuolation, and detachment due to apoptotic cell death (Kim 
and Lee, 2014). A recent study shows that heparan sulfate on the cell-surface may function as an 
attachment factor for PEDV (Huan et al., 2015). As with TGEV, PEDV also utilizes 
aminopeptidase N (APN; CD13) as a functional receptor. APN is a heavily glycosylated 
transmembrane protein and is expressed by most cells of myeloid origin including monocytes, 
macrophages, granulocytes, and their hematopoietic precursors (Chen et al., 1996; Mina-Osorio, 
2008; Riemann et al., 1999). It is also abundantly expressed in the brush border of epithelial cells 
from the small intestine and renal proximal tubules and some other cell membranes. In the small 
intestine, it plays a role in the final digestion of peptides generated from hydrolysis of proteins 
by gastric and pancreatic proteases (Kruse et al., 1988). TGEV utilizes APN as receptor for entry 
into swine testis (ST) cells, which however cannot render efficient propagation of PEDV 
(Delmas et al., 1992). This differentiation may be due to the relatively low level expression of 
APN on ST cells (Li et al., 2007). Over-expression of APN enhances PEDV infection, and an 
increased APN density enhances the PEDV susceptibility in cultured ST cells (Li et al., 2007; 
Nam and Lee, 2010; Oh et al., 2003). Porcine intestinal tissues are more sensitive for high-titer 
virus production for PEDV natural infection, which may due to the abundant expression of APN 
in porcine intestinal brush border membrane (Li et al., 2007). Collectively, the high-level 
expression of APN at the intestinal barrier correlates with the efficient replication of both TGEV 
and PEDV, and infectivity of PEDV is dependent on APN density. Additionally, PEDV also 
infects cultured cells of pigs, humans, monkeys, and bats (Liu et al., 2015a; Zhang et al., 2016), 
which suggests that PEDV may utilize APN of other species origin. Yet, Vero cells lack of APN 
mRNA transcripts (Li et al., 2016), and do not express detectable APN protein even by mass 
spectrometry analyses (Guo et al., 2014; Li et al., 2007; Shirato et al., 2011a,b; Zeng et al., 2015). 
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A Recent study showed that genetic ablation of APN expression had no effect on their 
susceptibility to PEDV, demonstrating that APN is not required for PEDV cell entry (Li et al., 
2017b). This suggests that PEDV may utilize other unidentified receptors or co-receptors for 
efficient entry. Both PEDV and TGEV infect alveolar macrophages besides small intestinal 
epithelial cells (Laude et al., 1984; Park and Shin, 2014) . PEDV also infect infiltrated 
macrophages in the lamina propria in vivo (Lee et al., 2000). Even though the clinical signs of 
epidemic PEDV and TGEV infections are indistinguishable, it is of great interest to investigate 
whether the cell and tissue tropism contributes to the differential pathogenesis in vivo.  
 
1.4.2 Activation of IFNs-α/β by TGEV 
Porcine enteric coronaviruses replicate in IECs and are transmitted via a fecal-oral route. 
The viral entry and release for TGEV are restricted to the apical surface of polarized epithelial 
cells (Rossen et al., 1994). Experimental infection of newborn piglets with TGEV induces a 
strong and early IFN-α production in serum and intestinal secretions (La Bonnardiere and Laude, 
1981). The blocking of the viral receptor still induces IFN-α response, indicating that the entry is 
not needed for IFN induction in leukocytes (Riffault et al., 1997). Early and strong IFN-α 
production can also be induced in nonimmune cells after exposure to TGEV-infected epithelial 
cells (Charley and Laude, 1988). The rapid and massive release of IFN-α in serum is mediated 
by M and E proteins of TGEV (Charley and Laude, 1988; Laude et al., 1992; Riffault et al., 
1997). A specific point mutation in the M protein results in lower IFN-α induction as compared 
to wild-type virus (Splichal et al., 1997), and the virus-like particles made of M and E proteins 
induce IFN-α production in porcine leukocytes as almost efficiently as fully infectious TGEV 
(Baudoux et al., 1998). However, reconstituted virosomes lose the ability to induce IFN-α 
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production, indicating that the native envelope structure is essential (Riffault et al., 1997). 
Immunohistochemistry analysis of the tissues from TGEV-infected piglets show that IFN-α-
producing cells (IPCs) are almost exclusively detected in the intestinal tissues and mesenteric 
lymph nodes (MLNs) at an early time of infection such as 6 h and disappeared by 24 h (Riffault 
et al., 2001). The majority of IPCs are localized between enterocytes in the epithelial layer, the 
lamina propria, around the Peyer’s patches, and are accumulated in the MLNs (Riffault et al., 
2001). The number of IPCs in spleen or peripheral lymph nodes is limited, and thus circulating 
IFN-α is likely originated from the gut and MLNs triggered by virus (Riffault et al., 2001). IPCs 
in pigs are identified as pDCs (Calzada-Nova et al., 2010). Interestingly, gut-associated IPCs 
express swine leucocyte antigen II (SLA II) and are distinct from TGEV-positive cells, 
suggesting that these cells may be the mucosal counterparts of the intestinal pDCs (Riffault et al., 
2001). Contrary to pDCs that produce high levels of IFN-α and TNF-α after infection, porcine 
monocyte-derived DCs do not respond to TGEV (Guzylack-Piriou et al., 2006). The frequency 
of intestinal pDCs, however, is low comparing to other DCs, and thus the limited populations of 
intestinal pDCs may not be a major subset of antigen-presenting DCs. The production of IFN-α 
by intestinal pDCs in MLNs may flood the T cell area to influence the immune outcome 
(Charley et al., 2006). In addition to the production of IFN-α/β, TGEV induces phosphorylation 
and nuclear translocation of STAT1 in virus-infected cells and enhances the expression of ISGs 
(An et al., 2014). TGEV infection also promotes the p53 signaling to regulate apoptosis, and the 
viral nucleocapsid protein is responsible for this action and the cell cycle arrest (Ding et al., 
2014a; Huang et al., 2013a).  
IFN-α has been shown to inhibit TGEV protein expression without reducing viral RNA in 
TGEV-infected cells (Jordan and Derbyshire, 1995). Infection of TGEV upregulates the 
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expression of 2’-5’-oligoadenylate (2’-5’A) synthetase for inhibition of viral replication 
(Bosworth et al., 1989; Jordan and Derbyshire, 1995). Swine IFN-α has been shown to enhance 
the protection from TGEV and alleviate clinical signs in piglets when orally co-administered 
with Salmonella enterica serovar Typhimurium expressing swine IFN-α with or without cytokine 
IL-18 (Kim et al., 2010; Lee et al., 2011). The viral load is significantly reduced in intestinal 
segments of piglets when treated with an IFN inducer before challenge, but no reduction in viral 
yields is seen when simultaneously inoculated with TGEV and IFN-α, suggesting that IFN may 
be more useful prophylactically (Jordan and Derbyshire, 1994).  
 
1.4.3 PEDV pathogenesis and innate signaling 
PEDV is cytolytic with an acute necrosis in IECs, leading to villous atrophy in the small 
intestine (Jung et al., 2014). The high mortality of PEDV in piglets is associated with extensive 
dehydration resulting from severe villous atrophy. The severe dehydration may be due to the 
extensive structural destruction and disorganization of tight junctions and adherens junctions 
during infection in nursing piglets (Jung et al., 2015b). The slower turnover of the enterocytes, 
which is mediated by the regeneration of crypt stem cells in nursing piglets compared to weaned 
piglets, is probably responsible for the age-dependent resistance to PED (Jung et al., 2015a). 
PEDV antigens are mainly observed in villous enterocytes of the small and large intestines. 
PEDV also infect macrophages infiltrated in the lamina propria in vivo (Lee et al., 2000). 
Experimental infection of TGEV shows that the lung is the tract sustaining viral replication and 
IFN synthesis (La Bonnardiere and Laude, 1983). TGEV can replicate in porcine alveolar 
macrophages (PAMs) in vitro and induces a marked synthesis of type I IFNs (Laude et al., 1984). 
Similarly, PEDV can also infect and replicate in PAMs in vivo (Park and Shin, 2014), suggesting 
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an extra-intestinal replication of PEDV. Additionally, PEDV has been shown to induce apoptotic 
cell death in vitro and in vivo through the caspase-independent mitochondrial apoptosis-inducing 
factor (AIF) pathway (Kim and Lee, 2014). Another study claims that PEDV may not induce the 
death of enterocytes in the small intestine through apoptosis pathway in infected pigs (Jung and 
Saif, 2015).  
After binding to APN, PEDV is internalized into target cells by direct membrane fusion, 
and the genomic RNA is released into the cytosol for replication. The sensing of viral nucleic 
acids by PRRs in the endosome or cytosol initiates the innate immune signaling. Like other 
coronaviruses, PEDV likely replicates in the double membrane vesicles to hide the viral RNA 
from sensing by PRRs and to attenuate the innate immune response (Angelini et al., 2013; 
Snijder et al., 2006). A recent study shows that TLR2, TLR3, and TLR9 may contribute to NF-
κB activation in response to PEDV infection in IECs in vitro but does not cause RIG-I activation 
(Cao et al., 2015b). TLR2 on the plasma membrane responds to viral glycoproteins on the 
envelope to induce production of IFNs and inflammatory cytokines, while TLR3 and TLR9 are 
localized largely in the endosome to sense dsRNA and CpG DNA, respectively (Boehme and 
Compton, 2004). This suggests that PEDV may initiate the innate immune response through its 
surface glycoprotein and viral nucleic acids in the endosomes. PEDV activates the ERK 
(extracellular signal-regulated kinase) pathway early during infection independently from viral 
RNA replication (Kim and Lee, 2015). Knockdown or inhibition of ERK suppresses viral 
transcription, protein expression, and progeny production, which suggests that the activation of 
ERK pathway is beneficial and required for PEDV replication (Kim and Lee, 2015). Proteomics 
analysis of PEDV-infected cells shows differential expression of proteins involved in apoptosis, 
signal transduction, and stress responses (Zeng et al., 2015), and ERK1 is significantly 
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downregulated during PEDV infection. Thus, the ERK pathway modulation by PEDV is of 
further interest to study. In one study, six different signaling pathways have been shown to be 
differentially regulated by PEDV, which includes the RLR, Rap1, PI3K-Akt, MAPK, JAK-
STAT, and TLR signaling pathways (Sun et al., 2015), suggesting the modulation of host innate 
immunity by PEDV.  
For PDCoV, little is known about the viral modulation of host immunity. The PDCoV N 
protein forms non-covalently linked oligomers localized in the nucleolus (Lee and Lee, 2015). 
The N protein alters the expression of cellular proteins relevant to cell division, metabolism, 
stress response, protein biosynthesis and transport, cytoskeleton networks, and cell 
communication (Lee and Lee, 2015). Notably, PDCoV N protein upregulates two members of 
the heat shock protein 70 (HSP70) family. In two lines of swine cells (LLC-PK1 and ST), which 
are used to isolate and propagate PDCoV (Jung et al., 2016), apoptosis is induced in vitro, but no 
apoptosis is observed in vivo in PDCoV-infected intestinal enterocytes (Jung et al., 2016). This 
suggests that a better cell system is needed to mimic in vivo conditions for PDCoV infections, 
and for this purpose IECs, intestinal enteroids, or organoids may be useful (Finkbeiner et al., 
2012; Jung et al., 2016). 
PEDV infection in suckling pigs does not alter the natural killer (NK) cell activity 
compared to weaned pigs that show significantly higher NK cell activities in the blood and ileum 
(Annamalai et al., 2015). Interestingly, PEDV infection seems to stimulate a marked induction of 
serum IFN-α in suckling pigs at 1-day postinfection which then declines to the basal level by 5-
day post-infection (Annamalai et al., 2015). In weaned pigs however, PEDV infection causes a 
slight induction of serum IFN-α at 3-day postinfection and a decrease to the basal level at 5-day 
postinfection. The peak production of serum IFN-α coincides with the peak of viral RNA 
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shedding in the feces and serum of suckling pigs or serum in weaned pigs and the onset of 
diarrhea. PEDV infection differentially modulates inflammatory cytokines in both suckling and 
weaned pigs and induces a similar level of TNF-α and IFN-α (Annamalai et al., 2015). 
According to this study, PEDV is capable of modulating IFN-α production especially in weaned 
pigs. Since PEDV infection occurs in the small intestine as with TGEV, it is of interest to 
examine IFN-α in the intestinal secretions and how PEDV modulates type I IFN induction in the 
intestinal pDCs. Intestinal DCs are highly effective antigen-presenting cells distributed beneath 
the epithelial lining. Unlike TGEV, PEDV infects MoDCs and produces high levels of IL-12 and 
INF-γ without alteration of the IL-10 expression (Gao et al., 2015). Interaction between PEDV 
and MoDCs affects the stimulation of T cell response in vitro. PEDV may also enhance the 
ability of porcine intestinal DCs to sample antigens and activate T-cell proliferation in vivo (Gao 
et al., 2015). How the intestinal pDCs respond to PEDV infection and modulate innate immune 
signaling remains to be determined.  
 
1.4.4 Evasion of IFN response by PEDV  
IFNs-α/β play an important role in restricting viral infections, and enteric coronaviruses 
have evolved redundant mechanisms to counteract the host innate immunity for optimal viral 
adaptation and replication. Even though TGEV activates IFNs-α/β production, its accessory 
protein 7 modulates IFNs-α/β expression by interacting with PP1 and prolongs viral 
dissemination for increased survival (Cruz et al., 2011). Accumulating evidence shows that 
PEDV also has an ability to evade host IFN response. PEDV does not activate IFN-β expression 
even after poly(I:C) stimulation in virus-infected cells (Xing et al., 2013). It appears that PEDV 
infection inhibits IRF3 nuclear translocation and thus blocks IRF3-mediated IFN induction. IECs 
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are major target cells of PEDV in pigs, and in these cells, PEDV blocks the activation of 
MAVS/IPS-1 and IRF3 nuclear translocation in the RIG-I-mediated pathway and do not induce 
IFN-β expression (Cao et al., 2015a).  IPEC-J2 cells are epithelial cells derived from the jejunum 
of a colostrum-deprived neonatal pig of 12 h of age (Zhao et al., 2014; Dr. A. Blikslager, North 
Carolina State University). These cells however appear to be non-permissive for PEDV infection 
(unpublished data), and thus they are less useful than the initial anticipation for the study of 
PEDV innate immune evasion.  
PEDV dramatically decreases the level of ubiquitin (Ub)-conjugated proteins in the 
cytoplasm. Papain-like proteinase 2 (PLP2) in nsp3 of PEDV contains a deubiquitinase (DUB) 
activity to process the cytosolic K48- and K63-linked polyubiquitin chains (Xing et al., 2013). 
PLP2 in nsp3 of both α-CoV and β-CoV could process both lysine-48- and lysine-63-linked 
polyubiquitin chains of the cytosolic proteins (Chen et al., 2014; Clementz et al., 2010). SARS-
CoV PLP2 reduces the levels of ubiquitinated forms of RIG-I, STING, TRAF3, TBK1, and IRF3 
in the STING-TRAF3-TBK1 complex for inhibition of the type I interferon signaling pathway 
(Chen et al., 2014). Similarly, PEDV PLP2 interacts with deubiquitinated RIG-I and STING to 
antagonize IFN response. PLP2 of SARS-CoV specifically deubiquitinates MDM2 (mouse 
double minute 2 homolog) and degrades p53 to suppress IFN signaling (Yuan et al., 2015). 
Similarly, PEDV upregulates MDM2 expression, degrades p53, and significantly inhibits IRF7 
expression, suggesting that PEDV PLP2 may also target the p53 pathway for innate immune 
evasion and inhibit p53-dependent apoptosis (Yuan et al., 2015). Collectively, PEDV 
differentially modulates ubiquitination levels in the cytoplasm and the nucleus for modulation of 
innate immune responses.  
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PEDV infection leads to activation of the NF-κB pathway in IECs (Cao et al., 2015b). In 
another study, PEDV normally induces activation of NF-κB and AP-1 following poly(I:C) 
stimulation at 24 h postinfection (Xing et al., 2013). These studies represent a relatively late 
stage for PEDV infection. PEDV may inhibit NF-κB activation at an early stage for optimal 
survival and then activates it for inflammation at the late stage. For porcine reproductive and 
respiratory syndrome virus (PRRSV), which is an arterivirus of the Nidovirales order, NF-κB is 
activated 30 min after infection (Fu et al., 2012). Thus, how PEDV inhibits NF-κB during an 
early time of infection is of question and needs to be explored. For SARS-CoV, the N protein 
activates NF-κB (Liao et al., 2005) whereas the M protein suppresses NF-κB probably through a 
direct interaction with IKKβ (Fang et al., 2007). For PEDV, the E and N proteins cause ER stress 
leading to activation of the NF-κB pathway for up-regulation of IL-8 and Bcl-2 (Xu et al., 2013a; 
Xu et al., 2013b), and the M protein of PEDV is reported to induce a cell cycle arrest at the S 
phase via the cyclin A pathway (Xu et al., 2015). In other study, the N protein blocks the IFN-β 
production and ISGs expression, leading to suppression of the IRF3 and NF-κB activities (Ding 
et al., 2014b). The N protein is an RNA-binding protein and shuttles between the cytoplasm and 
nucleus (Shi et al., 2014b). Furthermore, N interacts with TBK1 and sequesters its association 
with IRF3 to block the phosphorylation and nuclear translocation of IRF3 leading to inhibition of 
IRF3-mediated IFN production (Ding et al., 2014b). The nsp5 protein of PEDV is a 3C-like 
proteinase and has been shown as an IFN antagonist. The cysteine proteinase activity of nsp5 
cleaves NEMO which is an essential NF-κB modulator and disrupts the RIG-I/MDA5 signaling 
(Wang et al., 2015a). Modulation of innate immune response and signaling by PEDV infection is 
summarized in Table 1.2. 
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For betacoronavirus SARS-CoV, nsp14 is an exoribonuclease and nsp15 is an 
endoribonuclease, and both function through a specific digestion of dsRNA and subsequent 
removal of RNA-PAMPs, leading to suppression of IFN responses (Kindler and Thiel, 2014). 
SARS-CoV nsp16 is a 2’-O-methlytransferase that modifies the 5’ cap structure of viral RNA 
and functions to avoid detection by the host immune system (Totura and Baric, 2012). PEDV 
nsp14, nsp15, and nsp16 correspond to nsp14, nsp15, and nsp16 of SARS-CoV and the innate 
immune evasion functions remain to be examined. The M protein plays an important role in viral 
assembly and induction of PEDV neutralizing antibodies, and ORF3 is the sole accessory protein 
of PEDV and its role for pathogenesis remains enigmatic. Some strains of cell-adapted PEDV 
display internal deletions in the ORF3 gene (Park et al., 2008), suggesting that ORF3 relates to 
adaptation and pathogenicity. ORF3 has also been shown to function as an ion channel protein 
and thus the suppression of ORF3 expression inhibits viral production (Wang et al., 2012). 
Additionally, ORF3 delays the S phase in dividing cell and suppresses the cell cycle progression 
(Ye et al., 2015). A contradictory data exists that ORF3 causes an inability to recover progeny 
virus from a full-length infectious clone, suggesting that ORF3 negatively modulates PEDV 
replication in vitro (Jengarn et al., 2015). However, the deletion of entire ORF3 by targeted RNA 
recombination has been possible and ORF3 appears nonessential for PEDV replication in vitro 
(Li et al., 2013). ORF3 facilitates the vesicle formation in ORF3-expressing cells (Ye et al., 
2015), implicating an important role of ORF3 for innate immune evasion. The viral antagonists 
may target different signaling pathways to modulate the host innate immunity synergistically and 
efficiently during infection. The modulation of type I IFN responses by PEDV and the IFN 
antagonism by PEDV proteins is shown in Fig. 1.2.  
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1.4.5 Coronavirus nsp1 as a multifunctional IFN antagonist  
Coronavirus nsp1 is the N-terminal cleavage product of polyproteins pp1a and pp1a/b 
processed by the papain-like proteinase 1 (PLP1) activity of nsp3 (Ziebuhr, 2005). The nsp1 
gene is one of the most divergent genes among four different genera. Only the genome of α-CoV 
and β-CoV codes for nsp1, whereas the genome of γ-CoV and δ-CoV lacks the nsp1 gene (Woo 
et al., 2010; Woo et al., 2012; Ziebuhr, 2005; Ziebuhr et al., 2007). The nsp1 gene of α-CoV is 
much smaller than that of β-CoV and the sequence homology is also limited. The PEDV nsp1 
gene encodes for 110 amino acids with the predicted molecular migration of 12 kD. The protein 
sequence of nsp1 does not harbor any known cellular functional motifs (Connor and Roper, 2007) 
and thus is a genus-specific genetic marker (Snijder et al., 2003). However, nsp1 of α-CoV and 
β-CoV shares similar functions. Coronavirus nsp1, especially β-CoV nsp1, regulates host cell 
and viral gene expression (Narayanan et al., 2014). The nsp1 protein of α-CoV and β-CoV is a 
potent IFN antagonist, and among all coronaviruses, SARS-CoV nsp1 is best characterized. 
SARS-CoV nsp1 inhibits the reporter gene expression under the constitutive promoters as well 
as the IFN-β promoter (Kamitani et al., 2006). As with SARS-CoV nsp1, murine hepatitis 
coronavirus (MHV) nsp1 and HCoV-229E nsp1 affect the cellular gene expression by 
suppressing IFN-β, IFN-stimulated response element (ISRE), and SV40 promoter (Zust et al., 
2007). MHV nsp1 facilitates viral replication in mice by suppressing IFN-α/β through an 
unknown mechanism. MHV nsp1 and SARS-CoV nsp1 are distributed in the cytoplasm of virus-
infected cells (Brockway et al., 2004; Kamitani et al., 2006), and SARS-CoV nsp1 suppresses 
IFN mRNA accumulation without altering the IRF3 dimerization (Kamitani et al., 2006). SARS-
CoV nsp1 blocks the NF-κB, IRF3, and IRF7 activities. SARS-CoV nsp1 also inhibits IFN-
dependent signaling by interfering STAT1 phosphorylation (Wathelet et al., 2007). Bat-CoV 
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nsp1 inhibits type I IFNs and ISGs production (Tohya et al., 2009), HCoV-229E nsp1 and 
HCoV-NL63 nsp1 also inhibits the IFN-β, ISRE, ISG15 activities as well as the SV40, HSV-TK 
and CMV promoters (Wang et al., 2010; Zust et al., 2007).  
The emerging enteric coronaviruses PEDV has caused epidemic and endemic infections 
in pig populations in many countries and have become a major economic threat to the pork 
industry. The intestinal epithelial surface is the first line of defense to restrict the enteric viral 
infections, and both IFN-α/β and IFN-λ are important antiviral cytokines that viruses have 
evolved to counteract. Since enteric coronaviruses infect intestinal epithelial surface, several 
questions remain to be answered (Fig. 1.3). Firstly, the type I IFN antagonists of PEDV need to 
be identified. Secondly, whether PEDV and PDCoV selectively activate and/or modulate IFN-λ 
production and whether IFN-λ plays a protective role on the intestinal surface. Thirdly, how 
different cell types such as IECs, pDCs, and IELs in the intestinal barrier induce different types 
of IFNs and function for mucosal defense. Additionally, the intestinal epithelium constantly 
interacts with commensal bacteria and opportunistic viral infections, and thus IFN systems must 
be able to deal with these organisms without severe inflammation and tissue damages. Thus, 
better research models for cells and animals are needed to truly reflect viral evasions from innate 
immune defense. Lastly, specific cytokine mediators are produced in IECs, and how they 
respond to porcine enteric viral infections is of an additional interest.  
 
1.5 HYPOTHESIS AND OBJECTIVES OF THE THESIS 
Viruses infect and replicate in the host cells to complete their life cycle. The virus-host 
interactions provide valuable information on the understanding of viral pathogenesis. The 
immune response, especially the early innate immune response is essential to protect host cells 
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against invading viruses. In turn, viruses have developed sophisticated mechanisms to counteract 
host innate immunity and to establish productive infection. Especially, RNA viruses with a 
relative small coding capacity have evolved to arm with multifunctional innate immune 
antagonists. 
Both type I and type III interferons (IFNs) are important innate immune components 
against viral infections. Suppression of type I IFNs have been observed for both arteriviruses and 
coronaviruses in the order Nidovirales. For PRRSV, an arterivirus, six viral proteins have been 
identified as IFN antagonists, whereas for SARS-CoV, a betacoronavirus, eleven proteins have 
been identified as IFN antagonists. For PEDV, an alphacoronavirus, the current understanding on 
the modulation of innate immune signaling is rather limited.  Modulation of innate immune 
response by PEDV at the intestinal surface needs to be investigated. 
In the present study, PEDV modulation of host innate immune responses will be studied 
and the molecular basis for this modulation will be investigated. A suitable cell system to study 
the innate modulation by PEDV will be identified. The IFN viral antagonists will be identified. 
Important functional motifs and residues in the IFN antagonist will be determined, and PEDV 
modulation of cytokine expressions will be addressed. Interactions between viral IFN antagonist 
and host cells will be determined for a better understanding for evasion mechanisms. This study 
will form the basis for pathogenic mechanisms of PEDV and may facilitate the design of an 
effective control measure for PED.  
 
1.5.1 Principle hypothesis 
PEDV has the capacity to suppress the induction of both type I and type III IFNs. It is 
anticipated that PEDV encodes multiple IFN antagonists. The most potent IFN antagonist will be 
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further studied for its molecular action and structural requirements.  Due to the unique features of 
intestinal mucosal surface and the crucial role of type III IFN for the intestinal antiviral defense, 
PEDV will modulate the type III IFN response during infection.  
 
1.5.2 Specific aims 
Specific aim 1: Suppression of type I IFN induction by PEDV and identification of IFN 
antagonists. Type I IFN antagonists will be identified and the molecular basis for evasion 
strategy will be examined. 
 
Specific aim 2: Examination of cytokine expression profile by PEDV and the molecular basis 
for temporal modulation of NF-κB activity. Viral proteins regulating the NF-κB activity will be 
identified and the mechanism of action will be explored.  
 
Specific aim 3: Modulation of type III IFN induction by PEDV in intestinal epithelial cells. A 
porcine intestinal epithelial cell model for PEDV will be developed and how PEDV modulates 
the induction and signaling of IRF1-mediated type III IFNs in the porcine intestinal epithelial 
cells will be examined.  
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1.6 FIGURES AND TABLES  
 
 
Fig. 1.1: Comparative genome organization of the representative coronaviruses from each genus in 
the family Coronaviridae. Swine enteric coronaviruses (TGEV, PEDV, and PDCoV) are indicated in 
bold underlined. Structural proteins are presented in green. Putative accessory proteins are shown in blue. 
Nonstructural proteins in ORF1a/b are presented in grey or other colors. Papain-like proteinases (PLP1 
and PLP2), coronavirus 3C-like proteinase (3Cpro), RNA-dependent RNA polymerase (RdRp), two viral 
nucleases (nsp14 as exonuclease and nsp15 as endonuclease), and 2’-O-methytransferase (2MT; nsp16) 
are indicated by respective nsp numbers. The genome for Alaphacoronavirus and Betacoronavirus 
contains the nsp1 gene in different lengths, whereas the genome for Gammacoronavirus and 
Deltacoronavirus lacks the nsp1 gene. TGEV, transmissible gastroenteritis coronavirus; PEDV, porcine 
epidemic diarrhea virus; NL63, human coronavirus NL63; BCoV, bovine coronavirus; SARS-CoV, 
severe acute respiratory syndrome coronavirus; MERS-CoV, middle east respiratory syndrome 
coronavirus; IBV, avian infectious bronchitis virus; PDCoV, porcine deltacoronavirus; HE, 
hemagglutinin-esterase; S, spike; E, envelope; M, membrane; N, nucleocapsid; I, internal open reading 
frame. 
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Fig. 1.2: Modulation of type I IFN response by PEDV proteins. After binding to the celluar receptor 
APN, PEDV is internalized into target cells by direct fusion of viral-cellular membranes, and the viral 
genomic RNA is released into the cytosol for replication. The single-stranded viral RNA as well as 
dsRNA as a replicative intermediate are sensed by host innate nucleic acids sensors in the cytoplasm and 
the endosome. The activation of  innate immune sensors further initiates the production of type I 
interferons or pro-inflammatory cytokines after binding of activated NF-κB,  AP-1, IRF3, and IRF7 to the 
respective PRD regions. Type I IFNs are secreted and bind to the cell surface receptors of both virus-
infected and non-infected neighbor cells to induce the nuclear localization of ISGF3 complex. Activation 
of JAK-STAT pathway induces the production of hundreds of interferon stimulating genes (ISGs) for 
establishment of the antiviral state. The PEDV IFN antagonists intervene the IFN signaling pathway at 
different stages. The modulation of the type I IFN response by PEDV and  PEDV proteins are shown in 
yellow boxes.  
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Fig. 1.3: Infection of porcine enteric coronaviruses and innate immune defense at the intestinal 
epithelial barrier. PEDV suppresses IFN-α/β production and PEDV-specific viral  antagonists have been 
identified (see text). Some questions need to be explored for host-PEDV/PDCoV interactions and their 
pathogenic mechanisms. Question marks (red) indicate unknown mechanisms that remain to be studied as 
described in the text. IEC, intestinal epithelial cells; IEL, intraepithelial lymphocytes; DC, dendritic cells. 
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Table 1.1: Types of interferons, antiviral functions, and their cellular receptors. 
 
IFN  
 
Subtype 
 
Celluar source 
Antiviral 
function 
IFN 
receptor 
Receptor 
distribution 
 
 
 
 
Type I 
IFN 
IFN-α (17 
for pig, and 
13 for 
human), 
IFN-β (1),  
IFN-ε (1),  
IFN-κ (1), 
IFN-ω (1) 
Nearly all 
nucleated cells 
produce IFN-β. 
IFN-α subtypes are 
primarily 
produced by 
leukocytes. 
pDCs are the most 
potent type I 
IFN producers. 
IFN-κ and IFN-ε 
produced in a 
tissue-specific 
manner.   
 
Potent antiviral 
activities. 
 
IFNAR1 
and 
IFNAR2  
  
Nearly all 
nucleated cells, 
except intestinal 
epithelial cells 
(IECs). 
 
Type II 
IFN 
IFN-γ (1) Made primarily by 
immune cells 
such as CD4 
and CD8 T 
cells, NK and 
NKT cells, DCs, 
and 
macrophages. 
More of an 
interleukin 
than an 
interferon. 
Modest antiviral 
activity. 
IFNGR1 
and 
IFNGR2 
Broad tissue 
distribution. 
Type 
III IFN 
IFN-λ (4) A variety of human 
primary cell 
types of 
hematopoietic 
lineage.  
Epithelial cells are 
the potent 
producers for 
type III 
IFNs among the 
nonhematopoieti
c cells. 
Largelyrestricted 
to 
epithelium.  
lung epithelium 
responds to 
both type I 
and III IFNs. 
IECs respond 
exclusively 
to type III 
IFNs.  
 
IFNLR1 
and 
 IL-
10R2 
 
IL-10R2 is 
widely 
distributed 
across cell 
types. 
 IFNLR1 is 
mainly 
restricted to 
epithelial 
cells. 
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Table 1.2: Modulation of innate immune response and signaling by PEDV. 
 
Modulation of innate immune responses 
by PEDV 
 
Model 
 
References 
 
Suppression of IFN-β induction upon poly(I:C) 
stimulation and inhibits IRF3 nuclear translocation. 
 
Vero E6 cells 
 
 
Xing et al., 2013 
 
Lack of poly(I:C)-mediated IFN-β induction and 
blocking activation of IPS-1 in RIG-I-mediated 
pathway. 
 
Intestinal epithelial 
cells (IECs) 
 
Cao et al., 2015a 
 
 
Ativation of NF-κB pathway through TLR2, TLR3, 
and TLR9. 
 
IECs 
 
Cao et al., 2015b 
 
Activation of extracellular signal-regulated kinase 
(ERK) pathway early during infection. 
 
Vero cells 
 
Kim and Lee, 2015 
PEDV infection causes undetectable natural killer 
(NK) cell activity in suckling piglets compared to 
weaned pigs. 
 
Pigs 
 
Annamalai et al., 2015 
A marked induction of serum IFN-α in suckling pigs 
at 1 day post infection, but it is declined significantly 
to the base level at 5 days post-infection. 
 
Pigs 
 
Annamalai et al., 2015 
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CHAPTER 2: SUPPRESSION OF TYPE I INTERFERON PRODUCTION BY PORCINE 
EPIDEMIC DIARRHEA VIRUS AND DEGRADATION OF CREB-BINDING PROTEIN 
BY NSP12 
 
2.1 ABSTRACT 
Type I interferons (IFN-α/β) are the major components of the innate immune response of 
hosts, and in turn many viruses have evolved to modulate the host response during infection. We 
found that the IFN-β production was significantly suppressed during PEDV infection in cells. To 
identify viral IFN antagonists and to study their suppressive function, viral coding sequences for 
the entire structural and nonstructural proteins were cloned and expressed. Of 16 PEDV 
nonstructural proteins (nsps), nsp1, nsp3, nsp7, nsp14, nsp15 and nsp16 were found to inhibit the 
IFN-β and IRF3 promoter activities. The sole accessory protein ORF3, structure protein envelope 
(E), membrane (M), and nucleocapsid (N) protein were also shown to inhibit such activities. 
PEDV nsp1 did not interfere the IRF3 phosphorylation and nuclear translocation but interrupted 
the enhanceosome assembly of IRF3 and CREB-binding protein (CBP) by degrading CBP. A 
further study showed that the CBP degradation by nsp1 was proteasome-dependent. Our data 
demonstrate that PEDV modulates the host innate immune responses by degrading CBP and 
suppressing ISGs expression. 
 
2.2 INTRODUCTION 
Porcine epidemic diarrhea (PED) is a highly contagious acute enteric disease 
characterized by vomiting, watery diarrhea, and severe dehydration of up to 80-100% mortality 
in suckling piglets (Song and Park, 2012; Sun et al., 2012a; Debouck and Pensaert, 1980; Junwei 
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et al., 2006). PED was first reported in England in feeder and fattening pigs during 1970s (Wood, 
1977), and reemerged  in Asia since 2010 with greater virulence and economic losses (Chen et 
al., 2013; Li et al., 2012; Puranaveja et al., 2009; Yang et al., 2013). In the US, PEDV appeared 
for the first time in 2013 and severely affected most pig-producing states (Chen et al., 2014; 
Marthaler et al., 2013; Mole, 2013; Stevenson et al., 2013). The causative agent is porcine 
epidemic diarrhea virus (PEDV), which belongs to the Alphacoronavirus genus in the family 
Coronaviridae (http://ictvonline.org/virustaxonomy.asp). PEDV is an enveloped virus with a 
single-stranded positive-sense RNA genome of approximately 28 kb in length with the 5'-cap 
and the 3'-polyadenylated tail. The PEDV genome is arranged with ORF1a, ORF1b, S, ORF3, E, 
M, N, in order with both termini flanking with the 5’- and 3’-untranslated regions (UTRs) 
(Duarte et al., 1993). ORF1a codes for the large polyprotein PP1a, while ORF1b is always 
expressed as a fusion protein PP1a/b with PP1a through a ribosomal frameshifting. PP1a and 
PP1a/b are further processed to 16 nonstructural proteins, nsp1 through nsp16. ORF3 codes for 
an accessory protein which is likely an additional nonstructural protein, whereas S, E, M and N 
genes code for four structural proteins (Song and Park, 2012).  
During viral infection, the sensing of foreign nucleic acids in the cytosol leads to the 
activation of an innate immune response to produce type I interferons (IFN-α/β) and establishes 
an antiviral state. The type I IFNs and IFN-mediated response provide a first line of defense 
against viral infection. The host innate immune system deploys the pattern-recognition receptors 
(PRRs) to sense and respond to the pathogen-associated molecular patterns (PAMPs) of virus 
(Kawai and Akira, 2011). This recognition triggers the activation of retinoic acid-inducible gene 
I (RIG-I) or melanoma differentiation gene 5 (MDA5), which further binds to the mitochondrial 
adaptor protein MAVS/IPS-1 and recruits TNF receptor-associated factor 3/6 (TRAF3 and 
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TRAF6). TRAF3 activates IκB kinase (IKK)-related kinases such as TANK-binding kinase 1 
(TBK1) and IKKε for phosphorylation of interferon regulatory factors 3 and 7 (IRF3/IRF7) and 
type I IFN production (Fitzgerald et al., 2003; Sharma et al., 2003). TRAF6 leads to TANK1 
activation, followed by NF-kB activation and cytokine production (Rajsbaum and Garcia-Sastre, 
2013). Upon TBK1 activation, phosphorylated IRF3 undergoes homodimerization and unveils 
the nuclear localization signal leading to the nuclear translocation, where it forms a complex 
with the transcription co-activator CREB (cAMP responsive element binding)-binding protein 
(CBP)/p300 (Dragan et al., 2007; Lin et al., 1998; Panne et al., 2007). The IRF3-CBP/p300 
complex further binds to the positive regulatory domain (PRD) I–IV regions of the IFN-β 
promoter to assemble the enhanceosome together with NF-κB and other factors to turn on the 
transcription of type I IFN genes (Honda and Taniguchi, 2006). The IRF3-CBP/p300 interaction 
is crucial for IFN transcription. Following production and secretion, IFN molecules bind to the 
cell surface receptors and trigger the activation of Janus kinase-signal transducers and activators 
of transcription (JAK-STAT) signaling cascade. Phosphorylated STAT1 and STAT2 associate to 
form a heterodimer, which in turn recruits the IFN-regulatory factor 9 (IRF9) to form the IFN-
stimulated gene factor 3 (ISGF3). ISGF3 translocates to the nucleus and induces genes regulated 
by IFN-stimulated response elements (ISRE), resulting in expression of hundreds of antiviral 
genes and establishment of an antiviral state (Stark and Darnell, 2012).  
In turn, many viruses have evolved to counteract the host innate immune defense and 
such viral functions are often redundant. For nidoviruses, eleven and six viral proteins have been 
described as IFN antagonists for severe acute respiratory syndrome coronavirus (SARS-CoV) 
and porcine reproductive and respiratory syndrome virus (PRRSV), respectively (Huang et al., 
2014; Kindler and Thiel, 2014; Shi et al., 2014; Sun et al., 2012b; Totura and Baric, 2012). For 
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Betacoronaviruses, nsp1 has been reported as a multifunctional viral antagonist for innate 
immune response (Huang et al., 2011b; Narayanan et al., 2008; Wang et al., 2010). For PEDV, 
the viral modulation of innate immune signaling is poorly understood. PEDV infects Vero cells, 
but these cells are type I IFN-deficient due to a chromosomal deletion (Desmyter et al., 1968). In 
the present study, we identified MARC-145 cells as a suitable line of cells for PEDV infection 
and for study of innate immune modulation. We showed that PEDV suppressed the type I 
interferon production and ISGs expression in these cells, and identified nsp1, nsp3, nsp7, nsp14, 
nsp15, nsp16, E, M, N and ORF3 as the viral IFN antagonists. We showed that PEDV nsp1 
caused the CBP degradation by the proteasome-dependent pathway. The CBP degradation is a 
novel mechanism of coronavirus nsp1 for IFN suppression and our study provides a new insight 
into the immune modulation and evasion strategy of PEDV. 
 
2.3 MATERIALS AND METHODS 
2.3.1 Cells, viruses, antibodies and chemicals 
HeLa cells (NIH AIDS Research and Reference Reagent Program, Germantown, MD) 
and MARC-145 cells (Kim et al., 1993) were maintained in minimum essential medium (MEM) 
and Dulbecco's modified Eagle's medium (DMEM) (Mediatech, Manassas, VA), respectively, 
supplemented with 10% heat inactivated fetal bovine serum (FBS) (Hyclone, Logan, UT). Vero 
cells (ATCC® CCL-81TM) were grown in DMEM supplemented with 10% FBS. The IPEC-J2 
cell line is a continuous line of epithelial cells derived from the jejunum of a 12 hours old, 
unsuckled mixed breed piglet and was obtained from Dr. Anthony Blikslager (North Carolina 
State University). IPEC-J2 was maintained in DMEM/F12 with 5% FBS supplemented with 5 
µg/ml of insulin/selenium/transferrin (Life Technologies), and 5 ng/ml of epidermal growth 
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factor (Life Technologies). PEDV (USA/Colorado/2013; GenBank: KF272920) was obtained 
from Agricultural Research Service US Department of Agriculture (Ames, IA). PEDV was 
propagated in MARC-145 cells with DMEM or Vero cells with MEM supplemented with 0.3% 
tryptose phosphate broth (Sigma, St. Louis, MO), 0.02% yeast extract (Teknova, Hollister, CA), 
and trypsin 250 (Sigma-Aldrich, St. Louis, MO). The trypsin concentration was 2 µg/ml for 
MARC-145 cells and 5 µg/ml in Vero cells. The recombinant vesicular stomatitis virus 
expressing green fluorescent protein (VSV-GFP) was kindly provided by Dr. A. Garcia-Sastre 
(Mount Sinai Hospital, New York, NY).  
Polyinosinic: polycytidylic acid [(poly (I:C)], DAPI (4’, 6-diamidino-2-phenylindole), 
and cycloheximide (CHX), rat anti-FLAG mAb were purchased from Sigma (St. Louis, MO).  
Human recombinant IFN-β and MG132 were purchased from Calbiochem (San Diego, CA). 
Anti-β-actin mAb (sc-47778), anti-CBP mAb (sc-7300), anti-hsp90 mAb (sc-69703), anti-PARP 
pAb (sc-7150), and anti-IRF3 pAb (sc-9082) were purchased from Santa Cruz Biotechnologies 
Inc. (Santa Cruz, CA). Anti-phospho-IRF3 PAb (Ser396) were purchased from Cell Signaling 
(Danvers, MA). Rabbit anti-PEDV M pAb was kindly provided by Dr. Y. Fang (Kansas State 
University, Manhattan, KS). Mouse anti-PEDV N mAb was purchased from Medgene 
(Brookings, SD). Lipofectamine 2000 Transfection Reagent was purchased from Invitrogen 
(Carlsbad, CA). QIAamp Viral RNA mini kit and RNeasy mini kit were purchased from 
QIAGEN (Venlo, Limburg). Power SYBR Green PCR master mix was purchased from Life 
Technologies (Carlsbad, CA). Alexa Fluor 594-conjugated (goat anti-rabbit, red) and 488-
conjugated (goat anti-mouse, green) secondary antibodies and Pierce™ ECL Western blotting 
substrate were purchased from Thermo Scientific (Waltham, MA).  
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2.3.2 Plasmids and gene cloning  
The firefly luciferase genes were used as reporters with its expression under the control 
of various promoters as indicated below. The plasmid pIFN-β-Luc contains the entire IFN-β 
enhancer-promoter. The plasmid p4×IRF3-Luc contains four copies of IRF3 binding region PRD 
I-III of the IFN-β promoter. pIFN-β-Luc and p4×IRF3-Luc were obtained from Dr. Stephan 
Ludwig at Heinrich-Heine-Universität, Düsseldorf, Germany (Ehrhardt et al., 2004). The Renilla 
luciferase plasmid pRL-TK (Promega) contains the herpes simplex virus thymidine kinase 
(HSV-tk) promoter and was included in all experiments to serve as an internal control. Active 
stimulator pMAVS/IPS-1 was obtained from Dr. J. Shisler (University of Illinois, Urbana, IL). 
pIRF3 was kindly provided by Dr. B. Gotoh (University of Fukui, Fukui, Japan). pDsRed2-ER 
and pDsRed2-Mito were purchased from Clontech.  
Plasmids with the FLAG tag for expression of nsp1 through nsp16, and the S, S1, S2, 
ORF3, E, M and N genes were cloned from the viral genomic RNA by standard reverse 
transcription and PCR techniques using indicated primers (Table 2.1). Twenty-three viral genes 
were amplified and cloned into the eukaryotic expression vector pXJ41 using indicated 
restriction enzymes. The nsp1 to nsp16, ORF3, and N genes were expressed as fusion proteins 
with the N-terminal FLAG tag, and the S, S1, S2, E, and M genes were expressed as fusion 
proteins with the C-terminal FLAG tag to avoid the functional disruption of the signal sequence. 
The constructs were confirmed by sequencing, immunofluorescence, and western blot. PRRSV 
nsp1α and its cystine mutant P-nsp1α(m) (C28S) are described elsewhere (Han et al., 2013; Song 
et al., 2010).  
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2.3.3 DNA transfection and luciferase reporter assay 
HeLa cells were seeded in 12-well plates and grown to 80% confluency prior to 
transfection. Individual viral protein genes, luciferase reporters, and pRL-TK as an internal 
control were transfected at a ratio of 10:10:1 in a total of 1.05 µg/well using Lipofectamine 2000 
according to the manufacturer's instruction (Invitrogen). At 24 h post-transfection, cells were 
stimulated by transfection with 0.5 µg/well of poly(I:C) for 12 h. Cells were then lysed and 
luciferase assays were performed using the Dual Luciferease assay system according to the 
manufacturer's instructions (Promega). Values were normalized using the Renilla luciferase 
activity as the internal control and presented in fold-changes. Three independent assays were 
performed with each assay in triplicate. 
 
2.3.4 Relative quantitative real-time RT-PCR  
Total RNA was extracted from HeLa or MARC-145 cells using RNeasy mini kit 
according to the manufacturer’s instructions (QIAGEN). The RNA was treated with DNase I to 
remove contaminating genomic DNA. Reverse transcription (RT) reaction was performed with 1 
µg of total RNA using random primers and M-MLV reverse transcriptase (Invitrogen). SYBR 
Green real-time PCR was conducted in the ABI 7500 real-time PCR system according to the 
manufacturer’s instructions (Life Technologies). The real-time PCR primers for IFN-β, ISG15, 
ISG56 and β-actin were listed in Table 2.2. For each sample, the β-actin gene was amplified and 
used as an internal control. Specific amplification was confirmed by sequencing PCR products. 
The threshold cycle for target genes and the difference between their Ct values (ΔCt) were 
determined. The relative transcript levels of target gene are equal to 2−ΔΔCt threshold method 
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(Livak and Schmittgen, 2001) and are shown as fold changes relative to the respective untreated 
control samples.  
 
2.3.5 VSV-GFP interferon bioassay  
HeLa cells were seeded in 6-well plates and transfected with 2 µg of plasmid. At 24 h 
post-transfection, cells were stimulated by transfection with 1 µg of poly(I:C) for 12 h. 
Supernatants were harvested for bioassay. For PEDV, MARC-145 cells were infected with 
PEDV at an MOI of 1 for 12 h prior to poly(I:C) stimulation. Supernatants from virus-infected 
cells were UV-irradiated for 30 min to remove infectivity prior to bioassay. The supernatants 
were then serially diluted by 2-fold. MARC-145 cells were freshly grown in 96-well plates and 
incubated with 100 µl of each dilution for 24 h. Cells were then infected in 100 µl of VSV-GFP 
at 104 PFU/ml for 16 h and GFP expression was examined by inverted fluorescence microscopy 
(Nikon Eclipse TS100, 10x10). Each dilution was examined twice in triplicate each.  
 
2.3.6 Indirect immunofluorescence assay (IFA) and confocal microscopy  
Cells were seeded on coverslips and transfected with plasmids or infected with PEDV. 
For transfection of HeLa cells, total 2 µg of individual plasmids were transfected for 24 h using 
Lipofectamine 2000 according to the manufacturer's instructions (Invitrogen). Cells were then 
either treated with poly(I:C) for 12 h or IFN-β for 40 min. Cells were fixed with 4% 
paraformaldehyde in PBS overnight at 4 ℃ and permeabilized using 0.1% Triton X-100 for 15 
min at room temperature (RT). After blocking with 1% BSA in PBS at RT for 30 min, cells were 
incubated with a primary antibody in PBS for 1-3 h. Cells were then washed three times with 
PBS and incubated with Alexa Fluor 488-labeled anti-mouse or anti-rabbit secondary antibody, 
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or Alexa Fluor 594-labeled anti-rabbit secondary antibody (Thermo Scientific) for 1 h at RT in 
the dark. Cells were incubated with DAPI for 5 min at RT for nuclear staining. After washing 
with PBS, cover slips were mounted on microscope slides using Fluoromount-G mounting 
medium (Southern Biotech, Birmingham, AL), and visualized by fluorescence microscopy 
(Nikon Eclipse TS100). Confocal microscopy was conducted as described elsewhere (Kannan et 
al., 2009).  
 
2.3.7 Cell fractionation  
HeLa cells were seeded in 6-well plates to 80% confluency and transfected with 2 
µg/well of nsp1 plasmid for 24 h. Cells were stimulated with 1 µg of poly(I:C) for 12 h and 
fractionated using the Nuclear/Cytosol Fractionation kit (BioVision, Milpitas, CA) with minor 
modifications. Briefly, cells were washed with cold PBS and collected using cell scrapers in 1 ml 
of cold PBS. Cell pellets were resuspended in 200 µl CEB-A buffer and incubated on ice for 10 
min.  After addition of CEB-B, tubes were vortexed and incubated on ice for 1 min. The cell 
lysates were then centrifuged at 4°C 5 min at 16,000xg and supernatants were collected as the 
cytosolic fraction. The cell pellets were suspended in NEB buffer and vortexed for 30 s and 
repeated 5 times every 10 min. The nuclear pellets were finally centrifuged for 10 min at 4°C 
16,000xg and kept the supernatants as the nuclear fraction. 
 
2.3.8 Western blot  
Cells were harvested in RIPA buffer [20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 
1 mM phenylmethanesulphonyl fluoride (PMSF), 0.1% SDS, 0.5% sodium deoxycholate, 1% 
NP-40] containing the proteinase inhibitors cocktail (Promega). Cells were frozen-thawed, 
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collected in the pre-cold tubes, and centrifuged to remove insoluble components. Total protein 
concentration was determined using Pierce BCA protein assay kit (Thermo Scientific). Equal 
amounts of proteins were resolved by SDS-PAGE and blotted to PVDF membranes (Millipore). 
After blocking with 5% nonfat dry milk in TBST (0.05% Tween-20) for 1 h, membranes were 
incubated with a primary antibody in TBST containing 5% nonfat dry milk overnight at 4°C, 
followed by washing and incubation with horseradish peroxidase (HRP)-conjugated secondary 
antibody for 1 h at RT. The membrane was visualized using Pierce ECL Western Blotting 
Substrate (Thermo Scientific) and images were taken by FluorChem™ R System according to 
the manufacturer’s instructions (ProteinSimple). 
 
2.3.9 Co-immunoprecipitation 
Co-immunoprecipitation (co-IP) was performed as described previously with 
modifications (Kim et al., 2010). Gene-transfected cells were lysed in lysis buffer [50mM Tris 
(pH 8.0), 150 mM NaCl, 5mM Na3VO4, 1mM PMSF, 100 mg/ml leupetin, 1% NP-40, 10% 
glycerol] supplemented proteinase inhibitors cocktail (Promega). Cell lysates were clarified by 
centrifugation at 4°C for 10 min at 16,000xg. Supernatants were transferred to fresh tubes and 
incubated with either FLAG- or IRF3-antibody at 4°C overnight, followed by incubation with 
protein G Agarose beads (Fast Flow, Millipore) at 4°C for 4 h. Pellets were collected by 
centrifugation and washed for five times. The final pellets were eluted with Laemmli sample 
buffer (Bio-Rad) and were subjected to western blot.  
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2.3.10 Statistical analysis  
Student’s t-test was used for all statistical analyses. Asterisks indicate the statistical 
significance. *, P<0.05, **, P<0.01 and ***, P<0.001. 
 
2.4 RESULTS 
2.4.1 Infection of PEDV in Vero and MARC-145 cells  
PEDV replicates in the cytoplasm of villous epithelial cells of the small and large 
intestines (Debouck and Pensaert, 1980; Sueyoshi et al., 1995). The viral antigen is also 
detectable in the macrophages that infiltrated the lamina propria (Lee et al., 2000). Histological 
studies showed that PEDV replicates the porcine respiratory tract in vivo and transformed 
alveolar macrophages (3D4) in vitro (Park and Shin, 2014). Vero cells are widely used for PEDV 
for diagnosis, virus isolation, and research, but these cells are type I IFN-deficient due to the 
chromosomal deletion (Desmyter et al., 1968). To study a possible regulation of innate immune 
signaling by PEDV, various cell lines were examined for susceptibility. Cells were infected with 
PEDV at an MOI of 0.1 in various trypsin concentrations and CPE was examined daily for up to 
5 days. In Vero and MARC-145 cells, apparent CPE of multinucleation was observed by 24 h 
post-infection (Fig. 2.1A, 2.1B, left panel). Trypsin activates the cleavage of S protein and 
induces membrane fusion to trigger infection (Park et al., 2011; Wicht et al., 2014). PEDV 
infection was characterized by syncytia formation (Hofmann and Wyler, 1988) and infection foci 
were visualized by anti-PEDV M and N antibodies, indicating the susceptibility of both cell 
types for PEDV infection (Fig. 2.1A, 2.1B, middle and right panel). The viral proteins were 
detected using specific antibodies by western blot and the specific bands were corresponding to 
the M and N proteins, further confirming the productive infection of these cells by PEDV (Fig. 
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2.1C). The optimal trypsin concentration for PEDV propagation was 5 µg/ml and 2 µg/ml for 
Vero and MARC-145 cells, respectively. MARC-145 cells have been used to study type I IFN 
signaling of porcine arterivirus (Kim et al., 2010; Overend et al., 2007; Patel et al., 2010), and 
thus infection of these cells by PEDV allowed us to study IFN  modulation and signaling cascade. 
 
2.4.2 Suppression of IFN-β production in PEDV-infected cells 
To determine whether PEDV infection antagonized the type I IFN response, IFN-β 
mRNA was determined in virus-infected cells. MARC-145 cells were infected with PEDV and 
stimulated with poly(I:C) followed by qRT-PCR for IFN-β mRNA using total RNA. As shown 
in Fig. 2.2A, PEDV infection did not induce the level of IFN-β mRNA expression whereas 
poly(I:C) alone induced the IFN-β gene expression effectively, indicating the suppression of 
IFN-β response by PEDV. To further evaluate the IFN-β response in PEDV-infected cells, a dual 
luciferase assay was performed. The results showed the suppression of IFN-β promoter activity 
in PEDV-infected cells upon poly(I:C) stimulation (Fig. 2.2B), demonstrating the modulation of 
IFN production by PEDV infection. IRF3 was additionally examined for its role for PEDV-
mediated IFN-β suppression. The IRF3 promoter activity was found to be inhibited (Fig. 2.2C). 
The suppression of IFN-β production was confirmed by bioassay using VSV-GFP. VSV is 
sensitive to type I IFN treatment and thus commonly used for IFN bioassays. Culture 
supernatants were collected from PEDV-infected cells and were UV-irradiated, followed by 
incubation with MARC-145 cells and infection with VSV-GFP. VSV grew normally (Fig. 2.2D), 
whereas it did not grow with supernatants collected from poly(I:C)-treated cells for up to 1:8 
dilution. VSV-GFP also grew normally with supernatants from both PEDV-infected cells with or 
without poly (I:C) stimulation, confirming the suppression of type I IFN production by PEDV.  
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2.4.3 Identification of viral IFN antagonists  
The viral IFN antagonism is often redundant, and at least 11 viral proteins have been 
identified as IFN antagonists for SARS-CoV (Kindler and Thiel, 2014; Shi et al., 2014; Totura 
and Baric, 2012). To identify such proteins for PEDV, we cloned PEDV genes representing nsps 
1 through 16, and structural genes for S, E, M, and N including the ORF3 accessory protein gene 
(Fig. 2.3A). Among these, nsp11 is a small oligopeptide generated from PP1a when ribosomal 
frameshifting does not occur and so was not included in this study. Each gene was inserted into 
the pXJ41 expression vector with the FLAG tag at either N- or C-terminus, and examined for 
IFN suppression. The protein expression of cloned genes was examined by immunofluorescence 
(Fig. 2.3B) and western blot (Fig. 2.3C) using anti-FLAG antibody. All genes were expressed as 
anticipated. HeLa cells were then co-transfected with an individual gene along with pIFN-β-Luc 
and pRL-TK, and reporter assays were conducted. PRRSV nsp1α (P-nsp1α) is known as an IFN-
β suppressor, and its cystine mutant P-nsp1α(m) (C28S) is an IFN suppression revertant (Han et 
al., 2013; Song et al., 2010), and so they were included as positive and negative controls, 
respectively. Poly(I:C) upregulated the IFN-β transcription in cells expressing pXJ41, GST, and 
P-nsp1α(m), while P-nsp1α suppressed the IFN-β promoter activity as expected (Fig. 2.3D, 3E). 
Of the nsps, nsp1, nsp3, nsp7, nsp14, nsp15 and nsp16 were shown to down-regulate the IFN-β 
activity (Fig. 2.3D). For structural proteins, E, M, and N were found to suppress the IFN 
induction (Fig. 2.3E), and ORF3 was additionally identified as an IFN suppressive protein (Fig. 
2.3E). The findings from the reporter assays were validated by VSV-GFP bioassays. The dilution 
corresponding to 50% of cells exhibiting GFP expression was determined as the end-point 
inhibition. For pXJ41, GST, and nsp9, GFP expression was evident and their end-point 
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inhibitions were determined as 1:64 (Fig. 2.3F). In contrast, the viral proteins identified as the 
luciferase suppressors showed an apparent inhibition of VSV-GFP replication and their end-
points were determined to 1:4 to 1:16 (Fig. 2.3F). These titers represent 4- to 16-fold lower than 
that of control. Taken together, these data demonstrate that PEDV has the ability for IFN 
suppression, and nsp1, nsp3, nsp7, nsp14, nsp15, nsp16, ORF3, E, M and N are the viral IFN 
antagonists.  
To determine the target for IFN inhibition, the IRF3 pathway was examined for 
individual viral proteins using the IRF3 luciferase reporter constructs. Upon stimulation, the 
IRF3-dependent luciferase expression was reduced by nsp1, nsp3, nsp7, nsp14, nsp15, nsp16, 
ORF3, E, M, and N, comparing to those of pXJ41 and GST (Fig. 2.3G). This suggests that the 
IRF3 signaling pathway was interfered by these viral proteins for the suppression of the IFN-β 
production. 
 
2.4.4 PEDV nsp1 antagonism is a nuclear event 
SARS-CoV is a betacoronavirus and its nsp1 triggers inhibition of type I IFN induction 
and downstream signaling, host mRNA decay and cleavage, and inhibition of protein translation 
(Huang et al., 2011b; Lokugamage et al., 2012; Narayanan et al., 2008; Tanaka et al., 2012). 
Transmissible gastroenteritis virus (TGEV) is an alphacoronavirus and its nsp1 inhibits host 
protein expression (Huang et al., 2011a). Nsp1 of alphacoronavirus and betacoronavirus lacks 
the overall sequence similarity (Narayanan et al., 2014), and thus  alphacoronavirus nsp1 may 
have a distinct basis for its biological function. Since nsp1 appeared the most potent suppressor 
in our study on PEDV, nsp1 was chosen to study the molecular basis for the IFN suppression. 
The subcellular localization was first examined by confocal microscopy in transiently expressing 
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cells. The nsp1 distribution was evident in the both nucleus and cytoplasm (Fig. 2.4A), which is 
consistent with TGEV nsp1 (Narayanan et al., 2014). Co-expression of nsp1 with either the 
endoplasmic reticulum or mitochondrial marker showed the site for cytoplasmic nsp1 in the 
endoplasmic reticulum (Fig. 2.4B). Quantitative RT-PCR was conducted to evaluate IFN-β 
suppression in nsp1-gene transfected cells. The expression of nsp1 significantly suppressed the 
IFN-β mRNA transcription (Fig. 2.5A), further validating the nsp1 antagonism against IFN-β 
production. Subsequently, the IFN-mediated antiviral gene expression was examined for ISG15 
and ISG56 by qRT-PCR. PEDV nsp1 reduced the poly(I:C)-stimulated mRNA levels of both 
ISG15 (Fig. 2.5B) and ISG56 (Fig. 2.5C), indicating the suppression of IFN signaling by nsp1. 
The suppression of IFN-β, IRF3, and NF-κB activations raises a possibility that nsp1 may target 
a component of the RIG-I like receptor (RLR) signaling pathway. To examine this premise, nsp1 
was co-expressed with one of the main components in the RLR signaling pathway, and IFN 
luciferase activities were determined at 24 h post-transfection. The over-expression of IPS-1, or 
IRF3 led to the robust activation of the IFN-β promoter as anticipated, whereas the activation 
was significantly inhibited by nsp1 (Fig. 2.6A, 2.6B). Collectively, it suggests that nsp1 targets 
the RLR pathway downstream of the IRF3 activation.  
IRF3 is a resident protein in the cytoplasm. When stimulated, it is phosphorylated and 
homodimerized, leading to the translocation to the nucleus (Dragan et al., 2007). To determine 
whether PEDV nsp1 targeted the IRF3-dependent pathway, the IRF3 phosphorylation was first 
examined. nsp1-gene transfected cells were stimulated with poly(I:C), and the IRF3 
phosphorylation was examined by western blot. As anticipated, the poly(I:C) stimulation led to 
IRF3 phosphorylation in pXJ41-transfected cells, and similarly, in nsp1-expressing cells, the 
IRF3 phosphorylation was evident and comparable to that of control (Fig. 2.7A, top panel, lane 
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4), suggesting that PEDV nsp1 exerts its suppression downstream of the IRF3 phosphorylation. 
Thus, the nuclear translocation of IRF3 was next examined. PRRSV nsp1α is known not to block 
the IRF3 nuclear localization, and so was used as a control in this study. Endogenous IRF3 was 
normally diffused and distributed in the cytoplasm, but translocated to the nucleus when 
stimulated by poly(I:C) (Fig. 2.7B, second panel). Similar to PRRSV nsp1α-expressing cells (Fig. 
2.7B, fourth panel), IRF3 also localized normally in the nucleus after stimulation in PEDV nsp1-
expressing cells (Fig. 2.7B, bottom panel), suggesting that the IFN suppression by PEDV nsp1 
may be a nuclear event. The IRF3 nuclear translocation in nsp1-expressing cells was further 
confirmed by cell fractionation and western blot analyses. While IRF3 was phosphorylated and 
localized in the nucleus after stimulation, PEDV nsp1 did not inhibit the IRF3 phosphorylation 
and nuclear translocation (Fig. 2.7C), further indicating that the nsp1-mediated IFN suppression 
was a nuclear event. 
 
2.4.5 Interruption of IRF3 and CBP association by nsp1 
After nuclear translocation, an IRF3 dimer associates with the CREB-binding protein 
(CBP). This complex then binds to the PRD I–III regions of the IFN-β promoter to assemble the 
basal transcription machinery complex together with NF-κB and other transcription factors to 
turn on the transcription of type I IFN genes (Honda and Taniguchi, 2006). Thus, the IRF3-
CBP/p300 interaction for the assembly of enhanceosome is crucial for IFN expression. Since 
PEDV nsp1 did not block the IRF3 phosphorylation and nuclear translocation in our study, it was 
hypothesized that nsp1 might disrupt the formation of enhanceosome in the nucleus. To address 
this, the IRF3/CBP association was first examined in nsp1-expressing cells. Cells were 
transfected with the nsp1 gene and stimulated with poly(I:C) followed by co-
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immunoprecipitation using anti-IRF3 antibody and immunoblot with anti-CBP antibody. In 
unstimulated cells, CBP was undetectable due to the absence of IRF3/CBP association (Fig. 2.8A, 
left lane), but IRF3/CBP association became evident upon stimulation (Fig. 2.8A, middle lane). 
In nsp1-expressing cells however, the association of IRF3 and CBP disappeared even upon 
stimulation (Fig. 2.8A, right lane) and the detectable level of IRF3 remained unchanged (Fig. 
2.8A, second panel). Absence of the association of CBP/IRF3 may occur when nsp1 binds to 
either IRF3 or CBP, or when IRF3 is unstable in the presence of nsp1. Since PEDV nsp1 was 
found to be a nuclear protein (Fig. 2.4A, 2.4B, 2.7B, 2.7C), nsp1 in the nucleus might interact 
with either IRF3 or CBP. However, neither the interaction between IRF3 and nsp1, nor between 
CBP and nsp1 was observed by co-immunoprecipitation in our study. IRF3 was also stable in the 
presence of nsp1 (Fig. 2.7A, 2.7C), indicating that the absence of IRF3/CBP association was not 
due to the instability of IRF3. Interestingly, the level of CBP was found to decrease in nsp1-
expressing cells (Fig. 2.8A), leading us to investigate the degradation of CBP by nsp1. 
 
2.4.6 Degradation of CBP by nsp1 is proteasome-dependent 
Some viruses including HTLV, adenovirus, and an orthormyxovirus Thogoto interact 
with CBP to modulate type I IFN induction, suppress protein expression, or promote virus 
infection (Ferrari et al., 2014; Jain et al., 2015; Jennings et al., 2005; Wurm et al., 2012; Zhang et 
al., 2008). Degradation of CBP has been described for the porcine arterivirus PRRSV as a 
strategy for IFN antagonism (Han and Yoo, 2014). Since the level of CBP was found to decrease 
in PEDV nsp1-expressing cells (Fig. 2.8A), CBP expression was validated in PEDV-infected 
cells by co-staining using anti-CBP antibody and anti-PEDV M pAb. In uninfected cells, CBP 
was predominately localized in the nucleus in MARC-145 and Vero cells (Fig. 2.8B, yellow 
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arrows). In contrast, CBP was depleted in virus-infected cells (Fig. 2.8B, white arrows), 
demonstrating that the CBP was degraded by PEDV. We further sought to study whether the 
CBP degradation by PEDV was mediated by nsp1 protein. CBP was exclusively nuclear in 
control cells, whereas it was depleted in nsp1-expressing cells (Fig. 2.9A). PRRSV nsp1α is 
known to degrade CBP in the nucleus (Han and Yoo, 2014), and in PRRSV nsp1α-expressing 
cells, CBP was significantly depleted (Fig. 2.9A). The CBP degradation was quantified by 
examining the ratio of nsp1-expressing cells showing CBP degradation out of the chosen number 
of nsp1-expressing cells (Fig. 2.9B). Approximately 92% of PRRSV nsp1α-expressing cells 
showed more than 80% reduction of CBP, which is in consistent with the previous report (Han et 
al., 2013). For PEDV nsp1-expressing cells, approximately 90% cells showed more than 80% 
reduction of CBP, while no CBP reduction was observed in control cells. This finding was 
confirmed by western blot. In PEDV nsp1-expressing cells, CBP degradation was evident 
compared to that of control cells (Fig. 2.9C, top panel, lane 3). To eliminate a possibility that the 
reduction of CBP might be due to the short half-life of CBP, cyclohexamide (CHX) treatment 
was conducted (Fig. 2.9D). At 24 h post-transfection, cells were treated with CHX to shut down 
the new protein synthesis for indicated times followed by western blot. In nsp1-expressing cells, 
CBP reduction was evident at the beginning of CHX treatment, and further decreased by 2 h 
post-treatment. The CBP degradation was complete by 4 h post-treatment, whereas nsp1 and β-
actin remained stable (Fig. 2.9D). Together, our data show that PEDV nsp1 was the viral protein 
contributing to the CBP degradation. Unlike PRRSV nsp1α, PEDV nsp1 does not contain a 
proteinase activity, and no direct interaction between CBP and nsp1 was identified in our study. 
It is thus unlikely that CBP would be a direct substrate of PEDV nsp1. Therefore, it was of 
interest to examine whether the CBP degradation was a proteasome-dependent process. The 
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treatment with MG132 blocked the CBP degradation by nsp1. As little as 5 µM of MG132 was 
sufficient to inhibit the CBP degradation, and 10 µM was able to restore the CBP level back to 
the control level (Fig. 2.9E). To eliminate the CBP degradation by nsp1 was cell-type specific, 
we further tested the CBP degradation by nsp1 in pig intestinal epithelial cell line (IPEC-J2 cells), 
which reported to be susceptible to PEDV (Zhao et al., 2014). CBP degradation in nsp1-
expressing cells was evident comparing to control cells (Fig. 2.9F, top panel). Additionally, The 
CBP degradation by nsp1 was also blocked by MG132 treatment in IPEC-J2 cells (Fig. 2.9F, 
bottom panel). This study indicates that the CBP degradation by PEDV nsp1 was proteasome-
dependent in the nucleus.  
 
2.5 DISCUSSION 
The innate immune system is the first line of host defense in response to viral infection. It 
initiates the production of type I IFNs and proinflammatory cytokines through the recognition of 
PAMPs by PRRs and establishes antiviral states, which are highly effective on resisting and 
controlling infections. In turn, many viruses have developed strategies to counteract the host 
innate immune response to establish productive infection. Previous studies have shown that 
PEDV infection fail to induce the IFN-β promoter activation and that PLP2 (papain-like 
proteinase 2) of PEDV antagonizes the IFN response by deubiquitinating RIG-I and STING 
(Xing et al., 2013b). The PEDV N protein suppresses the IRF3 and NF-κB activities and 
antagonizes the IFN-β production by disrupting the interaction between IRF3 and TBK1 (Ding et 
al., 2014). On the contrary, a recent study shows that PEDV infection induces NF-κB activation 
in intestinal epithelial cells with the N protein as the activator (Cao et al., 2015b). In the present 
study, we have identified MARC-145 as PEDV permissive cells, and used these cells as a model 
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to study the innate immune modulation for PEDV. We have shown the suppression of type I IFN 
production by PEDV, which is consistent to the recent finding in IECs (Cao et al., 2015a).  We 
also have identified multiple viral proteins responsible for this suppression. We have further 
determined PEDV nsp1 as the viral component promoting CBP degradation in the nucleus via 
the proteasome-dependent pathway.  
Many viruses in the order Nidovirales are able to modulate the host innate response, 
which plays an important role for their pathogenesis. In the family Arteriviridae, equine arteritis 
virus suppresses type I IFN production in equine endothelial cells (Go et al., 2014), and PRRSV 
also suppresses IFN production (Albina et al., 1998). PRRSV is susceptible to type I IFNs in 
cells and the suppression of type I IFN varies for different isolates (Albina et al., 1998; Lee et al., 
2004; Overend et al., 2007). Mouse hepatitis virus (MHV), which is a betacoronavirus, induces a 
high level of IFN-α secretion by plasmacytoid dendritic cells (pDCs) during infection 
(Cervantes-Barragan et al., 2007). However, other cell types infected by MHV such as 
macrophages, microglia, and oligodendrocytes produce extremely low levels of type I IFNs (Li 
et al., 2010; Roth-Cross et al., 2008; Zhou and Perlman, 2007). The MHV ns2 protein is 
dispensable for virus replication in cells but is required for induction of hepatitis in mouse 
(Schwarz et al., 1990). The 2′,5′-phosphodiesterase (PDE) activity of ns2 mediates the cleavage 
of 2′,5′-oligoadenylate and prevents the activation of RNase L, while enhancing viral growth and 
pathogenesis, thus ns2 is a viral IFN antagonist (Zhao et al., 2012). SARS-CoV, which is another 
member virus in the genus betacoronavirus, impairs the IFN response in virus-infected cells, and 
an IFN therapy has been suggested to be efficacious for SARS patients (Cinatl et al., 2004; 
Spiegel et al., 2005). MERS-CoV is also a betacoronavirus, and both MERS-CoV and SARS-
CoV do not induce a pronounced IFN-response in polarized airway epithelial cells (Calu-3), 
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alveolar adenocarcinoma cells (A549) and human monocyte-derived macrophages (Lau et al., 
2013; Zhou et al., 2014; Zielecki et al., 2013). Even though the acute infection of TGEV induces 
a high level of IFN-α in newborn pigs (La Bonnardiere and Laude, 1981), protein 7 counteracts 
the host antiviral response and influences viral pathogenesis (Cruz et al., 2013; Cruz et al., 2011). 
The 7a protein of an alphacoronavirus feline infectious peritonitis virus is a type I IFN 
antagonist (Dedeurwaerder et al., 2014). Type I IFNs of chickens inhibits viral replication and 
respiratory illness of the gammacoronavirus infectious bronchitis coronavirus (IBV) (Pei et al., 
2001). IBV delays the IFN response and the 3a and 3b accessory proteins have been identified as 
the IFN antagonists (Kint et al., 2015). Thus, modulation of type I IFN response seems to be a 
common evasion strategy of viruses in the order Nidovirales.  
We have shown in the present study the direct evidence that PEDV indeed downregulates 
type I IFNs production during infection. PEDV suppresses the IFN-β and IRF3 activities. Since 
IRF3 is a key element in the production of type I IFNs, our finding leads to a hypothesis that 
PEDV modulation of type I IFNs production targets the IRF3 signaling pathway. Interestingly, 
PEDV normally activates the NF-κB activity in Vero E6 cells (Xing et al., 2013b). A recent 
study confirms that PEDV infection in intestinal epithelial cells induces NF-κB activation (Cao 
et al., 2015b). In that study, nuclear localization of p65 increases by PEDV after 12 h through 48 
h. However, activation of NF-κB during viral infection is generally an early event. For PRRSV, 
NF-κB is activated 30 min after infection (Fu et al., 2012). Thus, how PEDV modulates NF-κB 
activation during early time of infection needs to be further investigated. We have identified at 
least ten viral IFN antagonists and all ten proteins inhibit the IRF3 activity. Whether these IFN 
antagonists modulate the NF-κB activity needs to be further investigated. The PEDV N protein 
suppresses Sendai virus-induced NF-κB activity in a dose-dependent manner (Ding et al., 2014). 
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In other study, N protein activates NF-κB in intestinal epithelial cells (Cao et al., 2015b). A 
possible explanation is that the NF-κB activation may be time-dependent and cell type-dependent. 
Together, the IRF3 signaling is likely the target by PEDV for type I IFNs modulation.  
At least eleven viral proteins have been identified as IFN antagonists for SARS-CoV 
(Kindler and Thiel, 2014; Shi et al., 2014; Totura and Baric, 2012), whereas ten proteins have 
been identified for PEDV in our study. Thus, coronaviruses seem to arm with multiple 
antagonists. A possible explanation for such a functional redundancy is that coronavirus 
genomes are the largest RNA known to biology and undergo continuous genetic evolution. When 
a functional mutation occurs in a major antagonist, other antagonists may complement the 
function to ensure efficient replication and adaptation in hosts. For SARS-CoV, nsp1 is a 
multifunctional protein with the suppressive activity for IFN and blocks the phosphorylation of 
STAT1 and degrades host cell mRNA (Totura and Baric, 2012). SARS-CoV nsp14 and nsp15 
works as exoribonuclease and endoribonuclease, respectively, thus specific digestion of dsRNAs 
and the consequent removal of RNA-PAMPs may lead to an inadequate activation of IFN 
response (Kindler and Thiel, 2014). SARS-CoV nsp16 contains 2’-O-methlytransferase activity 
and modifies the cap of viral RNAs in order to evade the detection by the host immune system 
(Totura and Baric, 2012). The SARS-CoV M protein impedes the formation of 
TRAF3·TANK·TBK1/IKKϵ complex for suppression of type I IFN production (Siu et al., 2014; 
Siu et al., 2009). The PLP2 domain of SARS-CoV nsp3 negatively modulates type I IFN 
pathway and functions as a viral deubiquitinase. In our study, the full length PEDV nsp3 indeed 
inhibit the IFN activity. All ten antagonists identified for PEDV correspond to the respected 
antagonists of SARS-CoV. The corresponding proteins of PEDV may share the similar motifs 
and functions with those of SARS-CoV. Additionally, SARS-CoV encodes several accessory 
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proteins. They are nonessential for viral replication but function as innate immune antagonists. 
For PEDV, ORF3 is the sole accessory protein, and a previous report shows that ORF3 functions 
as an ion channel protein and is relevant to infectivity and pathogenicity (Wang et al., 2012). 
ORF3 is nonessential for viral replication in vitro as shown by targeted RNA recombination (Li 
et al., 2013).  In our study, ORF3 is a potent IFN antagonist. The viral antagonists may target 
different pathways of the host innate immune signaling and their synergistic effects may shut 
down the host innate immune response more efficiently during the course of infection.  
CBP is a histone acetyltransferase and plays a key role in transcription regulation. The 
CBP/p300 coactivators interact with hundreds of transcription factors including STATs, c-Myc, 
PIAS1, p53, NF-κB, and IRF family (Bedford and Brindle, 2012; Goodman and Smolik, 2000; 
Long et al., 2004). For IFN expression, the assembly of an enhanceosome consisting of NF-κB, 
IRFs, ATF2/c-Jun, and the architectural protein HMG I(Y) is required in response to virus 
infection. The IFN enhanceosome recruits CBP/p300 for synergistic activation of transcription 
(Merika et al., 1998). Some viruses modulate the CBP activity for viral evasion. Two distinct 
regions in the simian virus 40 T antigen can independently alter the levels and loading 
of CBP/p300 transcripts onto polysomes for cell immortalization and transformation (Saenz 
Robles et al., 2013). African swine fever virus nuclear protein A238L inhibits the expression of 
TNF-α by displacing the CBP/p300 coactivators (Granja et al., 2006), and herpes simplex virus 1 
(HSV-1) ICP0 protein recruits activated IRF3 and CBP/p300 to the nuclear foci, which may 
result in reduced transcription of IFN-β and inhibition of the host response (Melroe et al., 2007). 
HSV-1 VP16 protein inhibits NF-κB activation and interferes the recruitment of IRF3 to CBP to 
block the IFN-β production (Xing et al., 2013a). The ML protein of Thogoto virus interferes with 
IRF3 function without blocking its nuclear translocation but interrupts the association of IRF3 
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with CBP (Jennings et al., 2005), which is similar to the function of PEDV nsp1. The ML protein 
was later found to interact with the RNA polymerase II transcription factor IIB (TFIIB), however, 
this interaction hardly interferes the host general gene expression but strongly suppresses both 
the IRF3- and NF-κB-regulated promoter activities (Vogt et al., 2008). Thus, it is hypothesized 
that the virus-mediated CBP degradation may play a specific and key role for IFN modulation 
with a little impact on general cellular gene transcriptions. The degradation of CBP is a novel 
strategy for IFN modulation and has been extensively studied in the family of Arteriviridae, 
especially for PRRSV (Han and Yoo, 2014). For PRRSV nsp1α, CBP degradation is associated 
with the zinc-finger motif and is likely the key mechanism for IFN suppression (Han et al., 2013). 
For PEDV, nsp1 is the most potent IFN suppressor among all viral antagonists without affecting 
the IRF3 phosphorylation and nuclear localization. In line with this, PEDV infection depletes the 
endogenous CBP. Furthermore, PEDV nsp1 disrupts the association of CBP-IRF3 and degrades 
CBP in a proteasome–dependent manner. SARS-CoV nsp1 inhibits type I IFN production, 
induces host mRNA degradation, and suppresses host protein translation (Narayanan et al., 2008). 
However, the domains of SARS-CoV nsp1 responsible for suppression of host gene expression 
and type I IFN production are absent in PEDV nsp1 (Huang et al., 2011b; Narayanan et al., 
2008). Even though nsp1s of alphacoronavirus and betacoronavirus share similar functions, they 
lack an overall sequence similarity and neither conserved motifs nor domains exist in viruses of 
alphacoronaviruses. Thus, it is plausible that nsp1 of alphacoronaviruses may have a distinct 
function regulating host innate immune responses and gene expression. TGEV nsp1 suppresses 
protein translation in cells and cell-free extracts. However, the suppression of protein translation 
by PEDV nsp1 may not be a general event since the β-actin shows the similar level of expression 
after infection and transfection. The lack of association of CBP-nsp1 and IRF3-nsp1 suggests 
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that the CBP degradation by nsp1 is an indirect event that needs to be further determined. Similar 
to TGEV nsp1, the subcellular localization of PEDV nsp1 is nuclear-cytoplasmic. The sequence 
of PEDV nsp1 does not harbor any known nuclear localization signal, and thus nsp1 may piggy-
bag a nuclear protein to enter the nucleus. The proteasome-dependent CBP degradation seems a 
unique viral tactic utilized to inhibit IFN-β production. It is of interest to study whether this is a 
common evasion strategy for coronaviruses.  
CBP localizes in the PML nuclear bodies, which are discrete nuclear foci that are 
disrupted in acute promyelocytic leukemia (Boisvert et al., 2001; Doucas et al., 1999; LaMorte et 
al., 1998). The PML nuclear bodies dynamically colocalize with numerous proteins including 
CBP, PML, p53, Rb, sp100, DAXX, eIF4E, and SUMO (Jensen et al., 2001). Upon inhibition of 
proteasome activity, PML, sp100, EBNA-5, SUMO-1, and the 20S proteasome subunit move to 
the nucleolus, suggesting that proteasomal degradation occurs at the nuclear loci (Boddy et al., 
1996). HAUSP, the ubiquitin-specific hydrolase in the PML nuclear bodies, removes ubiquitin 
moieties from proteins prior to proteasomal degradation (Everett et al., 1998). Thus, PML 
nuclear bodies may represent the sites where ubiquitinated proteins are processed by enzymes 
such as HAUSP prior to degradation in the nucleolus (St-Germain et al., 2008). Valproic acid, a 
histone deacetylase inhibitor, could induce CBP degradation through the ubiquitin-proteasome 
pathway, while increasing the colocalization of CBP with ubiquitin nuclear speckles and with 
PML nuclear bodies (St-Germain et al., 2008), suggesting that PML nuclear bodies may be the 
sites for the ubiquitin-dependent degradation of CBP. It is of interest to examine whether PEDV 
nsp1 promotes ubiquitination of CBP for degradation in the nucleus and whether this degradation 
associates with PML nuclear bodies.   
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PEDV infects Vero cells and MARC-145 cells. Porcine amino peptidase N (pAPN) has 
been identified as the major cell entry receptor for PEDV (Li et al., 2007; Nam and Lee, 2010). 
Transient expression of pAPN confers PEDV non-permissive canine kidney cells (MDCK) to be 
permissive for PEDV infection. pAPN also increases the PEDV infectivity in porcine small 
intestine epithelial cells (IECs) (Cong et al., 2015). The respiratory tract may support PEDV 
infection in pigs and the virus infects and replicates in transformed alveolar macrophages (3D4) 
in vitro (Park and Shin, 2014). Primate APN or receptor-independent pathways in Vero and 
MARC-145 cells may complement the function of pAPN for PEDV infection (Taguchi and 
Matsuyama, 2002).  
In summary, we have shown the suppression of type I IFN production by PEDV and have 
identified specific viral IFN antagonists. Among these antagonists, nsp1 is the most potent 
protein and functions to degrade CBP in the nucleus. Our data provides a novel insight into the 
understanding of the immune evasion strategy of PEDV.  
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2.6 FIGURES AND TABLES 
 
 
 
 
Fig. 2.1: PEDV infection in Vero and MARC-145 cells. (A) and (B), Immunofluorescence showing the 
expression of nucleocapsid (N, green) and membrane (M, red) proteins in PEDV-infected cells. Vero and 
MARC-145 cells were infected with PEDV at an MOI of 0.1. Cells were fixed with 4% paraformaldehyde 
in PBS and stained with mouse anti-N monoclonal antibody (mAb) or rabbit anti-M polyclonal antibody 
(pAb). Arrows show multi-nucleated cells by fusion. (C), Detection of the N and M proteins in PEDV-
infected cells. Cell lysates were prepared at 24 h post-infection, and Western blots were conducted using 
antibodies against N and M proteins.   
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Fig. 2.2: Suppression of IFN-β production by PEDV. (A), Inhibition of IFN-β gene transcription in 
virus-infected cells. MARC-145 cells were infected with PEDV at an MOI of 1 for 12 h in 12-well plates. 
Cells were transfected with poly(I:C) (0.5 µg/well) for 12 h, and qRT-PCR was conducted for IFN-β 
mRNA. Relative quantitation values for IFN-β mRNA are presented. (B, C), Regulation of IFN-β and 
IRF3 activities by PEDV. MARC-145 cells were co-transfected with pIFN-β-Luc (B), or pIRF3-Luc (C) 
along with pRL-TK in 12-well plates for 6 h followed by PEDV infection at an MOI of 1 for 12 h. Cells 
were then stimulated with poly(I:C) for 12 h, and cell lysates were prepared for dual-luciferase reporter 
assay. Results from three independent experiments were expressed as mean relative luciferase with 
standard deviation. Each experiment was carried out in triplicate. Asterisks indicate statistical significance 
calculated by the Student’s t test. *, P<0.05; **, P<0.01; ***, P<0.001. (D), VSV-GFP bioassay for IFN 
production. MARC-145 cells were infected with PEDV in 6-well plates at an MOI of 1 for 12 h and 
stimulated with poly(I:C) for 12 h. Cell culture supernatants were collected and UV-irradiated for 30 min. 
Fresh MARC-145 cells were grown in 96-well plates and incubated with supernatants of 2-fold serial 
dilutions of up to 1:32. After 24 h of incubation, cells were infected with VSV-GFP at an MOI of 0.1 for 
16 h. GFP expression was assessed by fluorescent microscopy. Each dilution was tested in triplicate.  
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Fig. 2.3: Cloning of PEDV genes and identification of viral proteins antagonizing type I IFN 
cascade. (A), Genome organization of PEDV. The PEDV genome is organized as 5’ UTR-ORF1a-
ORF1b-S(S1+S2)-ORF3-E-M-N-3’UTR in order. Sixteen nonstructural proteins encoded in ORF1a and 
ORF1b are depicted. (B) and (C), Confirmation of cloned gene expression. One µg of each of the cloned 
genes was transfected to HeLa cells and protein expression was determined by immunofluorescence and 
Western blot. (D) and (E), Regulation of poly(I:C)-induced IFN-β promoter activity by individual PEDV 
proteins. HeLa cells were seeded in 12-well plates and co-transfected with pIFN-β-Luc along with 
individual PEDV genes and pRL-TK at a ratio of 1:1:0.1. PRRSV nsp1α (P-nsp1α) is a known type I IFN 
suppressor, and the IFN-suppression of its mutant P-nsp1α(m) was lost. At 24 h post-transfection, cells 
were stimulated with poly(I:C) (0.5µg/ml) for 12 h and the luciferase activities were measured. The 
reporter experiments were repeated three times, each time in triplicate. Asterisks indicate the statistical 
significance. Statistical analysis was performed by Student’s t test using GST as a control. *, P<0.05, **, 
P<0.01 and ***, P<0.001. (F), VSV-GFP bioassay. The cell culture supernatants for IFN-β promoter 
luciferase assays were collected and diluted serially by 2-folds up to 1:64. Fresh MARC-145 cells were 
grown in 96-well plates and incubated with each dilution of supernatants for 24 h, and then infected with 
VSV-GFP at an MOI of 0.1 for 16 h. VSV replication was measured by monitoring the fluorescence by 
GFP expression using fluorescent microscopy. Data were presented as log2 sample dilution folds. (G), 
Inhibition of IRF3 promoter activation by PEDV proteins. The IFN antagonists were further examined for 
IRF3 activities by luciferase reporter assays.  
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Fig. 2.3 (cont.)  
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Fig. 2.3 (cont.)  
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Fig. 2.4: Subcellular localization of PEDV nsp1. HeLa cells were seeded on slides in 6-well plates and 
transfected with PEDV nsp1 gene (A), or co-transfected with nsp1 and pDsRed2-ER or pDsRed2-Mito 
(B). At 24 h post-transfection, cells were fixed and permeabilized with Triton X-100. Cells were then 
incubated with mouse anti-FLAG mAb for 1 h, followed by Alexa Fluor 488-conjugated goat anti-mouse 
(green) secondary antibody to visualize nsp1. The ER and mitochondrial proteins were fused with the ER 
and mitochondria targeting sequence (Clontech) and so directly visualized (red). Nuclei (blue) were 
stained with DAPI. Images were collected using a Zeiss LSM-510 META confocal laser-scanning 
microscope and processed with the LSM image browser (Zeiss).  
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Fig. 2.5: Inhibition of IFN-β and ISG expression by nsp1. HeLa cells were seeded in 12-well plates 
and transfected with the nsp1 gene for 24 h, and stimulated with poly(I:C) for 12 h. Total RNA was 
extracted and mRNA expression was evaluated by qRT-PCR for IFN-β (A), ISG15 (B), and ISG56 (C). 
Results were normalized using β-actin mRNA and expressed as relative changes in mRNA levels with 
respect to those in cells without stimulation. Data are presented from three independent experiments, each 
in triplicate. Statistical analysis was performed by Student’s t test. *, P<0.05; **, P<0.01; ***, P<0.001. 
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Fig. 2.6: Disruption of IRF3-mediated IFN signaling by nsp1. HeLa cells were seeded in 12-well 
plates and co-transfected with pMAVS/IPS-1 (A) or pIRF3 (B) along with the nsp1 gene, pRL-TK, and 
IFN-β-Luc reporter for 24 h. Cells were harvested to measure the firefly and renilla luciferase activities. 
Relative luciferase activity was defined as a ratio of the firefly luciferase to renilla luciferase activities. 
Data are presented as mean value ± standard deviation from three independent experiments. Statistical 
analysis was performed by Student’s t test. *, P<0.05; **, P<0.01; ***, P<0.001. 
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Fig. 2.7: IRF3 phosphorylation and nuclear translocation by nsp1. (A), HeLa cells were transfected 
with the nsp1-epressing plasmid for 24 h, followed by poly(I:C) stimulation for 8 h. Cells were lysed and 
subjected to Western blot to determine phosphorylated (p) IRF3. (B), Immunofluorescence staining for 
IRF3 nuclear translocation by nsp1. HeLa cells were transfected with the nsp1-expressing plasmid (2 
µg/well) in 6-well plates for 24 h and stimulated by poly(I:C) for 8 h. Cells were fixed and incubated with 
rabbit anti-IRF3 pAb and mouse anti-FLAG mAb for 1 h. PRRSV nsp1α does not inhibit the IRF3 
nuclear localization and was used as a control. Alexa Fluor 594-conjugated goat anti-rabbit and 488-
conjugated goat anti-mouse secondary antibodies were used to visualize IRF3 (red) and viral nsp1 (green), 
respectively. Nuclei (blue) were stained with DAPI. Yellow arrows indicate IRF3 localization in the 
nucleus in the absence of nsp1 expression. White arrows indicate IRF3 localization in the nucleus in 
nsp1-expressing cells. (C) Phosphorylation and nuclear localization of IRF3 by nsp1. HeLa cells were 
transfected with the PEDV nsp1 gene for 24 h, then stimulated with poly(I:C) for 8 h. Cells were lysed for 
nuclear-cytoplasmic fractionations and subcellular distribution of IRF3 and pIRF3. Hsp90 was used as a 
cytosolic protein marker and PARP was used as a nuclear protein marker. 
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Fig. 2.7 (cont.)  
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Fig. 2.8: Degradation of CBP in PEDV-infected cells. (A), Interruption of the IRF3 and CBP 
association by nsp1. HeLa cells were transfected with 2 µg/well of pXJ41-FLAG-nsp1 for 24 h and 
stimulated with poly(I:C) for 6 h. Cells were lysed and co-IP was carried out using rabbit anti-IRF3 and 
protein G-Agarose fast-flow beads (Millipore), followed by Western blot analysis using CBP antibody 
(panel 1, numbered from top) and IRF3 antibody (panel 2). Total cell lysates were probed for expression 
of CBP (panel 3), IRF3 (panel 4), nsp1 (panel 5), and β-actin as a loading control (panel 6). (B), 
Degradation of CBP in PEDV-infected cells. MARC-145 and Vero cells were seeded on coverslips 
placed on 6-well plates and grew to 80% confluency. Cells were infected with PEDV at an MOI of 0.1 for 
24 h. Cells were then fixed and co-stained with rabbit anti-M pAb and mouse anti-CBP mAb. Alexa Fluor 
594-conjugated goat anti-rabbit (red) and 488-conjugated goat anti-mouse (green) secondary antibodies 
were used to visualize protein expression. Nuclei (blue) were stained with DAPI. Yellow arrows indicate 
CBP in PEDV-uninfected cells. White arrows indicate CBP in PEDV-infected cells. 
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 Fig. 2.9 (cont.)  
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Fig. 2.9 (cont.): CBP degradation in the nucleus is mediated by nsp1. (A), CBP degradation by nsp1 
as determined by immunofluorescence assay. HeLa cells were transfected with PRRSV nsp1α which is 
known to degrade CBP in the nucleus, or PEDV nsp1. At 24 h post-transfection, cells were fixed and co-
stained with rabbit anti-FLAG pAb and mouse anti-CBP mAb. Alexa Fluor 594-conjugated goat anti-
rabbit and 488-conjugated goat anti-mouse (green) secondary antibodies were used to visualize nsp1 (red) 
and CBP (green). Nuclei (blue) were stained with DAPI. Yellow arrows indicate CBP in the absence of 
nsp1 expression, and white arrows indicate CBP in cells expressing viral nsp1. (B), Percent number of 
cells in which CBP was degraded by PEDV nsp1 and PRRSV nsp1α (P-nsp1α). Data are presented by % 
calculation of transfected cells showing more than 80% reduction of CBP fluorescent intensity compared 
to the control CBP staining out of 150 randomly chosen nsp1-expressing cells. (C), CBP degradation by 
nsp1 determined by Western blot. At 24 h transfection, cells lysates were prepared for Western blot using 
mouse anti-CBP mAb to examine the level of endogenous CBP. (D), PEDV nsp1-mediated degradation 
of CBP after cycloheximide (CHX) treatment. After 24 h transfection with the nsp1 gene, cells were 
treated with 100 µg/ml of CHX for indicated times, followed by Western blot using mouse anti-CBP mAb 
(top panel) and mouse anti-FLAG mAb for nsp1 detection (middle panel). (E), Inhibition of nsp1-
mediated CBP degradation by MG132. After 24 h transfection with the nsp1 gene, HeLa cells were 
treated with MG132 at indicated concentrations for 16 h. Cells lysates were prepared and western blot 
was conducted using mouse anti-CBP mAb (top panel) or mouse anti-FLAG mAb (middle panel). (F), 
The CBP degradation by PEDV nsp1 in porcine intestinal epithelial cells IPEC-J2. IPEC-J2 cells were 
maintained as described in the Material and Methods, and transfected with the PEDV nsp1 gene. At 24 h 
post-transfection, cells were treated with or without 10µM MG132 for 16h, and then fixed for IFA. 
Yellow arrows indicate CBP in the absence of nsp1 expression, and white arrows indicate CBP in cells 
expressing viral nsp1.  
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Table 2.1: Primers used for the cloning of PEDV nonstructural and structural genes. 
(Restriction enzyme recognition sequences are underlined. The FLAG tag is italicized and underlined.) 
Primer Sequence (5'-3') 
nsp1-F GCCGAATTCACCATGGATTACAAGGATGACGACGATAAGATGGCTAGCAACCATG 
nsp1-R GCCCTCGAGCTAACCACCACGACG 
nsp2-F GCCGGATCCACCATGGATTACAAGGATGACGACGATAAGAACATCGTGCCAG 
nsp2-R GCCGGTACCCTAACCACCTTTCTTC 
nsp3-F AGTCTCGAGACCATGGATTACAAGGATGACGACGATAAGGGTGATGTCAAATTC 
nsp3-R GCCAGATCTCTATGCACCCTTCTTATTTG 
nsp4-F GCCGGATCCACCATGGATTACAAGGATGACGACGATAAGGGTCTTCCTAGTTTTTC 
nsp4-R GCCCTCGAGCTACTGTAGAGTTGAATTG 
nsp5-F GCCGAATTCACCATGGATTACAAGGATGACGACGATAAGGCTGGCTTGCGTAAG 
nsp5-R GCCCTCGAGCTACTGAAGATTAACGCC 
nsp6-F GCCGAATTCACCATGGATTACAAGGATGACGACGATAAGAGTGGTTATGTTTC 
nsp6-R GCCCTCGAGCTACTGAACGGAAG 
nsp7-F GCCGAATTCACCATGGATTACAAGGATGACGACGATAAGTCTAAACTGACTG 
nsp7-R GCCCTCGAGCTACTGCAACATAC 
nsp8-F GCCGAATTCACCATGGATTACAAGGATGACGACGATAAGAGTGTTGCATCTAC 
nsp8-R GCCCTCGAGCTACTGGAGCTTGAC 
nsp9-F GCCGAATTCACCATGGATTACAAGGATGACGACGATAAGAATAATGAAATTATTCC 
nsp9-R GCCCTCGAGCTACTGCAAGCGTAC 
nsp10-F GCCGAATTCACCATGGATTACAAGGATGACGACGATAAGGCTGGTAAACAAACAG 
nsp10-R GCCCTCGAGCTATTGCATAATGGATC 
nsp12-F GCCGGATCCACCATGGATTACAAGGATGACGACGATAAGAGCACTGATATGGC 
nsp12-R GCCCTCGAGCTATTGTAAAACTGCAG 
nsp13-F GCCGAATTCACCATGGATTACAAGGATGACGACGATAAGTCTGCAGGGCTTTGTG 
nsp13-R GCCCTCGAGCTACTGCAAATCAG 
nsp14-F GCCGAATTCACCATGGATTACAAGGATGACGACGATAAGGCTAATGAGGGTTGTG 
nsp14-R GCCCTCGAGCTATTGCAAATTGTTAC 
nsp15F GCCGAATTCACCATGGATTACAAGGATGACGACGATAAGGGTCTTGAGAACATTGC 
nsp15R GCCCTCGAGCTACTGAAGTTGCGGAT 
nsp16F GCCGAATTCACCATGGATTACAAGGATGACGACGATAAGGCCAGTGAATGGAAG 
nsp16R GCCCTCGAGTCATTTGTTTACGTTG 
S-F  GCCGAATTCACCATGAAGTCTTTAACCTAC 
S-R  GCCCTCGAGTCACTTATCGTCGTCATCCTTGTAATCCTGCACGTGGACCTTTTC 
S1-F  GCCGAATTCACCATGATGAAGTCTTTAACCTAC 
S1-R  GCCCTCGAGTCACTTATCGTCGTCATCCTTGTAATCAATACTCATACTAAAG 
S2-F GCCGAATTCACCATGAGGACAGAATATTTACAG 
S2-R GCCCTCGAGTCACTTATCGTCGTCATCCTTGTAATCCTGCACGTGGACCTTTTC 
ORF3-F  GCCGAATTCACCATGGATTACAAGGATGACGACGATAAGATGTTTCTTGGAC 
ORF3-R GCCCTCGAGTCATTCACTAATTGTAG 
E-F  GCCGAATTCACCATGCTACAATTAGTG 
E-R GCCCTCGAGTCACTTATCGTCGTCATCCTTGTAATCTACGTCAATAACAGTAC 
M-F  GCCGAATTCACCATGTCTAACGGTTCTATTC 
M-R GCCCTCGAGTCACTTATCGTCGTCATCCTTGTAATCGACTAAATGAAGCAC 
N-F  GCCGGATCCACCATGGATTACAAGGATGACGACGATAAGATGGCTTCTGTCAG 
N-R  GCCCTCGAGTCAATTTCCTGTGTCGAAG 
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                             Table 2.2: Primers used for relative quantitative real-time PCR. 
Primer Sequence (5'-3') 
IFN-β-F GATTTATCTAGCACTGGCTGG 
IFN-β-R CTTCAGGTAATGCAGAATCC 
ISG15-F CACCGTGTTCATGAATCTGC 
ISG15-R CTTTATTTCCGGCCCTTGAT 
ISG56-F CCTCCTTGGGTTCGTCTACA 
ISG56-R GGCTGATATCTGGGTGCCTA 
β-actin-F ATCGTGCGTGACATTAAG 
β-actin-R ATTGCCAATGGTGATGAC 
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CHAPTER 3: INHIBITION OF NF-KB ACTIVITY BY THE PORCINE EPIDEMIC 
DIARRHEA VIRUS NONSTRUCTURAL PROTEIN 1 FOR INNATE IMMUNE 
EVASION3 
 
3.1 ABSTRACT 
Porcine epidemic diarrhea virus emerged in the US is known to suppress the type I 
interferons response during infection. In the present study using porcine epithelial cells, we 
showed that PEDV inhibited both NF-κB and proinflammatory cytokines. PEDV blocked the 
p65 activation in infected cells and suppressed the PRD II-mediated NF-κB activity. Of the total 
of 22 viral proteins, nine proteins were identified as NF-κB antagonists, and nsp1 was the most 
potent suppressor of proinflammatory cytokines. Nsp1 interfered the phosphorylation and 
degradation of IκBα, and thus blocked the p65 activation. Mutational studies demonstrated the 
essential requirements of the conserved residues of nsp1 for NF-κB suppression. Our study 
showed that PEDV inhibited NF-κB activity and nsp1 was a potent NF-κB antagonist for 
suppression of both IFN and early production of pro-inflammatory cytokines. 
 
3.2 INTRODUCTION  
Porcine epidemic diarrhea (PED) is an acute and highly contagious enteric disease 
characterized by severe enteritis, vomiting, watery diarrhea and a high mortality rate in neonatal 
piglets (Debouck and Pensaert, 1980; Junwei et al., 2006; Song and Park, 2012; Sun et al., 
2012a). The current virulent PED outbreaks started in China in the late 2010 and quickly spread 
to other countries in Asia, causing significant economic losses in the swine industry (Sun et al., 
2015; Sun et al., 2012a). PED emerged in the US for the first time in April 2013 and resulted in 
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more than 8 million deaths of pig in less than 8 months of the first outbreak. (Chen et al., 2014; 
Marthaler et al., 2013; Mole, 2013; Stevenson et al., 2013).  
Porcine epidemic diarrhea virus (PEDV) is a coronavirus belonging to the genus 
Alphacoronavirus of the Coronaviridae family (http://ictvonline.org/virustaxonomy.asp). The 
PEDV genome is a single-stranded, positive-sense RNA of ∼28 kb in length with a 5’-cap and a 
3’-polyadenylated tail. It encodes two polyproteins (pp1a and pp1a/b), an accessory protein 
(ORF3), and four structural proteins (spike S, envelope E, membrane M, and nucleocapsid N) 
(Duarte et al., 1993; Kocherhans et al., 2001). Pp1a and pp1a/b are processed to 16 nonstructural 
proteins (nsps) by the proteinase activity of nsp3 and nsp5. Among nsps, nsp1 is the most N-
terminal and first cleavage product (Ziebuhr, 2005).  
Virus-infected cells react quickly to invading viruses by producing type I interferons 
(IFN-α/β) and establish an antiviral state, which provides a first line of defense against viral 
infection. The viral nucleic acids are sensed by pattern-recognition receptors (PRRs) such as 
transmembrane toll-like receptors (TLRs) and cytoplasmic RNA/DNA sensors (Kawai and Akira, 
2011). This recognition leads to the activation of cytosolic kinases which promotes the activation 
of IFN regulator factor 3 (IRF3), IRF7, and nuclear factor-κB (NF-κB), and their subsequent 
translocation to the nucleus allows them to bind to their respective positive regulatory domain 
(PRD) for production of type I IFNs (Honda et al., 2006). The activated IRF3/IRF7 bind to the 
PRD I/III sequences and induces the expression of type I IFN genes (Hermant and Michiels, 
2014). For NF-κB, the activated form is translocated to the nucleus and triggers IFN-β 
expression by binding to the PRD II element (Escalante et al., 2002). Type I IFNs are then 
secreted and bind to their receptors on virus-infected cells as well as uninfected neighbor cells, 
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and activate the JAK/STAT pathway to produce hundreds of interferon-stimulating genes (ISGs) 
to establish an antiviral state (Stark and Darnell, 2012).  
In unstimulated cells, NF-κB (p50/p65 heterocomplex) remains associated with the 
inhibitory protein IκBα masking the nuclear localization signal (NLS) of NF-κB and sequesters 
the NF-κB·IκBα complex in the cytoplasm. The NF-κB signaling pathway may be activated by 
intracellular products such as IL-1 and TNFα that are induced by viral infections or extracellular 
stress such as phorbol esters and UV (Campbell and Perkins, 2006; Ghosh et al., 1998). 
Activated NF-κB then induces the production of proinflammatory cytokines and regulates a 
variety of gene expressions, which affects cell survival, differentiation, immunity, and 
proliferation (Hayden and Ghosh, 2012). TNFα binds to its receptor and initiates a signaling 
cascade culminating the activation of IκB kinase complex (IKKα/β). The IKK complex then 
phosphorylates IκBα to mediate ubiquitination and degradation and releases NF-κB. Released 
NF-κB is transported to the nucleus, where it binds to target sequences and initiates 
transcriptions (Hayden and Ghosh, 2012; Napetschnig and Wu, 2013; Verstrepen et al., 2008).  
To circumvent such responses of the cell, many viruses have developed various strategies 
to evade the host innate immunity. We have previously reported that PEDV suppresses the type I 
interferon and ISGs productions and have identified nsp1 as the potent viral IFN antagonist 
(Zhang et al., 2016). PEDV nsp1 causes the CREB-binding protein (CBP) degradation in the 
nucleus and antagonizes the IFN production and signaling (Zhang et al., 2016). Despite the 
importance of NF-κB during infection, regulation of NF-κB by PEDV is poorly understood. The 
PEDV N protein blocks the NF-κB activity and inhibits the IFN-β production and IFN 
stimulating genes (ISGs) expression (Ding et al., 2014). PEDV nsp5 is a 3C-like proteinase and 
cleaves the NF-κB essential modulator (NEMO) (Wang et al., 2015a), suggesting that PEDV has 
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the ability for NF-κB suppression. Although PEDV has been shown to activate NF-κB at a late 
stage of infection (Cao et al., 2015b; Xing et al., 2013), it is unclear whether it is time-dependent 
and TNFα-mediated. In the present study, we show the inhibition of NF-κB, and temporal 
regulation of type I IFNs and pro-inflammatory cytokines by PEDV. Among PEDV proteins, 
nsp1, nsp3, nsp5, nsp7, nsp14, nsp15, nsp16, ORF3, and E were identified as NF-κB antagonists 
with nsp1 being the most potent. We also showed that the conserved residues of nsp1 were 
crucial for NF-κB suppression. The nsp1-mediated NF-κB modulation may facilitate the 
replication and pathogenesis of PEDV. 
 
3.3 MATERIALS AND METHODS 
3.3.1 Cell culture, viral infection, and titration  
Two different lines of African green monkey kidney cells, MARC-145 (Kim et al., 1993) 
and Vero (ATCC® CCL-81TM), were grown in Dulbecco's modified Eagle's medium (DMEM) 
(Corning™ Cellgro™) supplemented with 10% heat-inactivated fetal bovine serum (FBS) 
(Gibco®) at 37°C in a humidified atmosphere of 5% CO2. HeLa cells (NIH AIDS Research and 
Reference Reagent Program, Germantown, MD) were maintained in minimum essential medium 
(MEM) (Corning™ Cellgro™) with 10% heat-inactivated FBS. LLC-PK1 (Perantoni and 
Berman, 1979) is a porcine kidney epithelial cell line derived from the kidney of a normal 
healthy male pig of three weeks of age and was obtained from Dr. K. Chang (Kansas State 
University, Manhattan, KS). LLC-PK1 cells were maintained in MEM with 5% FBS. RAW264.7 
cells were obtained from Dr. G. Lau (University of Illinois at Urbana-Champaign) and 
maintained in RPMI-1640 supplemented with 10% FBS. 
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The recombinant vesicular stomatitis virus expressing green fluorescent protein (VSV-
GFP) was kindly provided by Dr. A. Garcia-Sastre (Mount Sinai Hospital, New York, NY). 
PEDV (USA/Colorado/2013; GenBank: KF272920) was obtained from Agricultural Research 
Service US Department of Agriculture (Ames, IA). PEDV was propagated in FBS-free DMEM 
(or MEM) supplemented with 0.3% tryptose phosphate broth (Sigma, St. Louis, MO), 0.02% 
yeast extract (Teknova, Hollister, CA) containing varying concentrations of trypsin 250 (Sigma-
Aldrich, St. Louis, MO). The optimal trypsin concentration for Vero, MARC-145, and LLC-PK1 
cells was 5 µg/ml, 2 µg/ml, and 1 µg/ml, respectively. For PEDV growth curve, cells were 
infected at either low MOI (0.01 MOI) or high MOI (5 MOI) for 1 h and incubated further. 
Culture supernatants were collected at indicated times post-infection and titrated using the 50% 
tissue culture infective dose (TCID50) protocol. The viral titers were calculated using the 
Spearman-Karber equation (Mahy et al., 1996) and presented as the viral growth curve. 
 
3.3.2 Antibodies and chemicals  
Following antibodies were used for immunofluorescence assay (IFA) and Western blot 
(WB) analysis: mouse anti-PEDV N mAb (Medgene, Brookings, no. SD-1-5, 1:1,000 dilution 
for WB, 1:200 dilution for IFA); rabbit anti-p65 mAb (Cell Signaling Technology, no. 8242, 
1:1,000 dilution for WB, 1:200 for IFA); mouse anti-hsp90 mAb (Santa Cruz, no. sc-69703, 
1:1,000 for WB); rabbit anti-PARP pAb (Santa Cruz, no. sc-7150, 1:1,000 for WB); mouse anti-
IκBα mAb (Thermo Scientific, no. MA5-15132, 1:1,000 for WB); mouse anti-p-IκBα mAb (Cell 
Signaling Technology, no. 9246, 1:1,000 dilution for WB); rabbit anti-IKKα pAb  (Santa Cruz 
no. sc-7218, 1:200 for WB); mouse anti-IKKβ mAb  (Santa Cruz no. sc-56918, 1:200 for WB); 
rabbit anti-p-IKKα (Ser180)/IKKβ (Ser181) Ab (Cell Signaling Technology, no. 2681, 1:1,000 
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dilution for WB); mouse anti-β-actin mAb (Santa Cruz no. sc-47778, 1:2,000 for WB); rat anti-
FLAG Ab (Agilent Technologies, no. 200474, 1:2,000 for WB, 1:200 for IFA). 
Human TNFα was purchased from Cell Signaling Technology (no. 8902) and used at 15 
ng/ml or 20 ng/ml. Polyinosinic:polycytidylic acid (polyI:C) and DAPI (4’, 6-diamidino-2-
phenylindole) were purchased from Sigma (St. Louis, MO). Lipofectamine 2000 transfection 
reagent was purchased from Invitrogen (Carlsbad, CA). QIAamp Viral RNA mini kit and 
RNeasy mini kit were purchased from QIAGEN (Venlo, Limburg). Power SYBR Green PCR 
master mix was purchased from Life Technologies (Carlsbad, CA). Alexa Fluor 594-conjugated 
(goat anti-rabbit, red) and 488-conjugated (goat anti-mouse, green) secondary antibodies and 
Pierce™ ECL Western blotting substrate were purchased from Thermo Scientific (Waltham, 
MA). 
 
3.3.3 Plasmid constructs  
The firefly luciferase gene was under the control of the respective promoter as described 
below and used as a reporter. The plasmid pIFN-β-Luc contains the entire IFN-β enhancer-
promoter sequence and was obtained from Dr. S. Ludwig at Heinrich-Heine-Universität, 
Düsseldorf, Germany (Ehrhardt et al., 2004). The plasmid pNF-κB-Luc (Stratagene, La Jolla, CA) 
contains the NF-κB enhancer, which is responsive to the stimulation of TNFα. The plasmid 
pPRD II-Luc contains two copies of the NF-κB binding region PRD II of the IFN-β promoter 
and was kindly provided by Dr. S. Perlman at University of Iowa, IA (Zhou and Perlman, 2007). 
The plasmid pswTNFα-Luc contains swine TNFα promoter sequences and was obtained from Dr. 
F. A. Osorio at University of Nebraska-Lincoln, NE (Subramaniam et al., 2010). The Renilla 
luciferase plasmid pRL-TK (Promega) contains the herpes simplex virus thymidine kinase 
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(HSV-tk) promoter and was included as an internal control. Constructs expressing individual 
proteins of PEDV are described elsewhere (Zhang et al., 2016). PRRSV N (P-N), PRRSV nsp1β 
(P-nsp1β), PRRSV nsp1α (P-nsp1α), and PRRSV nsp1α cystine mutant P-nsp1α(m) (C28S) are 
described elsewhere (Han et al., 2013; Song et al., 2010). The higher order structure of PEDV 
nsp1 was predicted using DNASTAR (https://www.dnastar.com; Madison, WI) based on the X-
ray crystallographic structure of TGEV nsp1. PCR-based site-directed mutagenesis was 
performed to mutate amino acids of PEDV nsp1 and a series of nsp1 mutants were generated. 
The primers and the position of mutations for each mutant are shown in Table 3.1. Mutations 
were confirmed by DNA sequencing, and mutant protein expressions were examined by 
immunofluorescence assay and Western blot.  
 
3.3.4 RNA extraction and quantitative real-time RT-PCR  
Cells were washed with PBS and lysed with RLT lysis buffer (QIAGEN). Total cellular 
RNA was extracted using RNeasy mini kit according to the manufacturer’s instructions 
(QIAGEN). Genomic DNA contaminants were removed by treatment with DNase I (Promega).  
One µg of RNA was used for reverse transcription using random primers and M-MLV reverse 
transcriptase (Promega). Real-time quantitative PCR was performed using cDNA and SYBR 
Green PCR mix in the ABI 7500 real-time PCR system according to the manufacturer’s 
instruction (Life Technologies). The swine-specific real-time qPCR primers for IFN-α, IFN-β, 
TNFα, IL-1β, IL-6, IL-8, IL-15, IL-17, CXCL10, TGF-β3, MCP-1, RANTES, and β-actin are 
listed in Table 3.2. The β-actin gene was used as an internal control for each sample. Specific 
amplification was confirmed by the sequencing of PCR products and the melting curve analysis 
of qPCR. Threshold cycles for target genes and differences between Ct values (ΔCt) were 
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determined. Relative levels of transcripts of target genes were shown as fold changes relative to 
respective controls by the 2−ΔΔCt threshold method (Livak and Schmittgen, 2001).  
 
3.3.5 Dual luciferase reporter assay 
To identify the viral antagonists for NF-κB/PRD II promoter, dual luciferase reporter 
assays were conducted. HeLa cells were grown in 48-well plates to 80% confluency, and 
transfected with luciferase reporters, individual viral genes, and pRL-TK at a ratio of 10:10:1 
using Lipofectamine 2000 according to the manufacturer's instruction (Invitrogen). Cells were 
stimulated with 0.5 µg/ml of poly(I:C) or 15 ng/ml of TNFα at 12 h post-transfection for 12 h, 
and then lysed in 60 µl 1X Passive lysis buffer for 20 min at room temperature (RT) with 
constant shaking. To examine the NF-κB/PRD II promoter activity during PEDV infection, 
MARC-145 cells were grown in 12-well plates to 80% confluency, and transfected with 
luciferase reporters and pRL-TK at a ratio of 10:1 using Lipofectamine 2000. Cells were infected 
with PEDV at 1 MOI at 6 h post-transfection for 12 h, and stimulated with poly(I:C) for 12 h or 
TNFα for 9 h . Cells were then lysed in 100 µl 1X Passive lysis buffer for 20 min at RT. 
Supernatants of the cell lysates were subjected to dual Luciferase assays according to the 
manufacturer's instructions (Promega). All the values were normalized using the Renilla 
luciferase activity as the internal control and presented in fold changes. The data are represented 
as the mean value with a standard deviation from three independent experiments. 
 
3.3.6 Indirect immunofluorescence assay (IFA) and confocal microscopy  
Cells were grown on coverslips placed in 12-well plates to 80% confluency for 
transfection or infection. For transfection, HeLa cells were transfected with individual plasmids 
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using Lipofectamine 2000 according to the manufacturer's instructions (Invitrogen). For 
infection, LLC-PK1 cells were infected with PEDV at 0.01 MOI. At indicated times post-
treatment with poly(I:C) or TNFα, cells were washed once and fixed with 4% paraformaldehyde 
in PBS overnight at 4°C followed by permeabilization using 0.1% Triton X-100 for 15 min at RT.  
Cells were incubated in the blocking buffer (1% BSA in PBS) for 30 min at RT and then 
incubated with primary antibody diluted in 1% BSA for 1-3 h. After three washes, cells were 
incubated with fluorochrome-conjugated secondary antibody (Thermo Scientific) in the dark for 
1 h at RT, followed by treatment with DAPI for 10 min to stain the nuclei. After washing with 
PBS, cover slips were mounted on microscope slides using Fluoromount-G mounting medium 
(Southern Biotech, Birmingham, AL) and examined for fluorescence using the Nikon A1R 
confocal fluorescence microscope. The confocal microscopy images were processed using NIS-
Elements analysis software. 
 
3.3.7 Cell fractionation, Co-immunoprecipitation, and western blot analysis 
For cell fractionation, HeLa cells were grown in 6-well plates to 80% confluency for 
gene transfection. Cells were then stimulated with 15 ng/ml TNFα for 12 h and lysed and 
fractionated using the Nuclear/Cytosol Fractionation kit (BioVision, Milpitas, CA). Briefly, cells 
were washed once with cold PBS and collected with cell scrapers. Cell pellets were then 
resuspended in CEB-A buffer on ice for 10 min and after addition of CEB-B further incubated on 
ice for 1 min. The lysates were centrifuged at 4°C for 5 min at 16,000 x g, and the supernatants 
were collected as the cytosolic fraction. Cell pellets were resuspended in NEB buffer and 
vortexed for 30 s, which was repeated 5 times every 10 min. Cell pellets were centrifuged for 10 
min at 4°C at 16,000 x g, and the supernatants were kept as the nuclear fraction. 
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For co-immunoprecipitation, cells were lysed in lysis buffer [50 mM Tris (pH 8.0), 150 
mM NaCl, 5 mM Na3VO4, 1 mM PMSF, 100 mg/ml leupetin, 1% NP-40, 10% glycerol] 
supplemented with the proteinase inhibitors cocktail (Promega), followed by 
immunoprecipitation as described previously (Zhang et al., 2016). For Western blot, cells were 
harvested in RIPA buffer [20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM 
phenylmethanesulphonyl fluoride (PMSF), 0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40] 
containing the proteinase inhibitors cocktail (Promega). Cells were lysed on ice for 30 min, 
sonicated, and centrifuged to remove insoluble components. For Western blot, proteins were 
resolved by SDS-PAGE and transferred to an Immobilon-P membrane (Millipore). The 
membranes were blocked with 5% nonfat dry milk or 5% BSA in TBST (0.05% Tween-20) for 1 
h and then incubated with primary antibody at 4°C overnight. After three washes, the membranes 
were incubated with horseradish peroxidase (HRP)-conjugated secondary antibody for 1 h at RT. 
The antibody-antigen complex was visualized using enhanced chemiluminescence detection 
reagents (Thermo). Images were taken by the FluorChem™ R System according to the 
manufacturer’s instructions (ProteinSimple). 
 
3.3.8 Statistical analysis  
The student's t test was used for statistical analyses using GraphPad Prism 6. Asterisks 
indicate the statistical significance as follow:  *, P<0.05, **, P<0.01 and ***, P<0.001.  
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3.4 RESULTS 
3.4.1 Inhibition of Type I IFNs production by PEDV in LLC-PK1 cells  
The primary target cells for PEDV in pigs are villous epithelial cells of the intestinal tract 
(Debouck and Pensaert, 1980; Lee et al., 2000; Sueyoshi et al., 1995). Vero cells are commonly 
used for the study of PEDV, but these cells are deficient for type I IFN genes, and we have 
previously identified MARC-145 as an additional cell line permissive for PEDV. In these cells, 
PEDV has been shown to inhibit type I IFN production (Zhang et al., 2016). However, MARC-
145 cells are originated from monkey kidney epithelium, and porcine epithelial cells will serve a 
better model to study the innate immune regulation for PEDV. To this aim, we identified LLC-
PK1 as a permissive cell line for PEDV. LLC-PK1 is of porcine kidney epithelial cells, and we 
found that these cells efficiently supported PEDV infection. Even at an MOI of 0.01, almost 100% 
of LLC-PK1 cells became infected by 24 h of infection (data not shown). Western blot analysis 
of PEDV N protein confirmed the productive infection in LLC-PK1 cells (Fig. 3.1A). To 
examine the growth of PEDV, LLC-PK1, MARC-145, and Vero cells were infected with the 
virus at a low MOI (0.01), and the culture supernatants were collected to determine the titers at 
different times of infection. The growth curves show the productive infection of PEDV in these 
cells (Fig. 3.1B). Similar growth kinetics was observed for Vero and MARC-145 cells. PEDV 
induced extensive cell fusion in Vero cells and these cells died by 24 h post-infection (hpi). 
LLC-PK1 cells supported PEDV growth most efficiently, and the peak viral titer was as high as 
107.5 TCID50/ml at 48 hpi (Fig. 3.1B), compared to 105 TCID50/ml in MARC-145 cells. The one-
step growth curve for PEDV was determined by infecting with a high MOI of 5. Syncytia 
formation characteristic for PEDV was evident as early as 9 hpi in PEDV-infected cells (Fig. 
3.1C, arrows). The one step growth curve showed that PEDV replicated in LLC-PK1 cells most 
	   84 
effectively compared to MARC-145 and Vero cells (Fig. 3.1D). To examine the type I IFN 
regulation in LLC-PK1 by PEDV, cells were infected with the virus, and RT-qPCR was 
conducted for both IFN-α and IFN-β mRNAs. While poly(I:C) induced the production of IFN-α 
and INF-β in uninfected LLC-PK1 cells as anticipated, hardly any IFN-α/β were produced in 
PEDV-infected LLC-PK1 cells especially at 8-24 hpi (Fig. 3.1E). Even at 5 MOI, PEDV 
infection did not induce type I IFNs (Fig. 3.1F) and also inhibited the production of type I IFNs 
even when stimulated with poly(I:C) (Fig. 3.1G, 3.1H), further confirming the suppression of 
type I IFN production by PEDV. 
 
3.4.2 Inhibition of early production of pro-inflammatory cytokines by PEDV  
Evidence suggests that PEDV modulates innate immune response for optimal viral 
replication (Annamalai et al., 2015; Zhang et al., 2016; Zhang and Yoo, 2016). PEDV may also 
have the ability to modulate the production of pro-inflammatory cytokines for viral pathogenesis 
and virulence. To determine this possibility, we assessed the expression of pro-inflammatory 
cytokines in virus-infected cells. LLC-PK1 cells were infected with PEDV, and total RNA was 
prepared at different times to determine different cytokine gene expressions by RT-qPCR using 
specific primers (Table 3.2). PEDV infection caused down-regulation of TNFα during 8-12 hpi, 
but later times of 24-30 hpi, its expression was upregulated (Fig. 3.2A). The IL-1β mRNA levels 
were significantly downregulated at early times (8-24 hpi) and returned to the basal level by 30 
hpi (Fig. 3.2B). The IL-6 mRNA expression was also suppressed at 8-18 hpi but became 
activated at 30 hpi (Fig. 3.2C). Similarly, the IL-15 expression was inhibited at early times (8-18 
hpi) but activated later times of infection (24-30 hpi) (Fig. 3.2D). The IL-17 expression was also 
suppressed at 8-24 hpi but upregulated at 30 hpi (Fig. 3.2E), and the TGF-β3 expression was 
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inhibited at 12 and 24 hpi (Fig. 3.2F). These results demonstrate that PEDV regulated the 
production of pro-inflammatory cytokines in a time-dependent manner. This was confirmed in 
two other cell types, MARC-145 and Vero, using TNFα mRNA. PRRSV is known to suppress 
TNFα production (Subramaniam et al., 2010) and VSV is known to activate TNFα production 
(Garcia et al., 2009), and thus both viruses were included as controls. As anticipated, PRRSV 
inhibited the expression of TNFα at 18 hpi, whereas VSV activated the TNFα expression 
continuously over time (Fig. 3.2G). In both PEDV-infected MARC-145 cells and Vero cells, the 
TNFα expression was suppressed at early times (6-18 hpi) and became activated later (24 hpi), 
confirming the suppression of pro-inflammatory cytokines by PEDV at early times. 
 
3.4.3 Temporal regulation of TNFα-induced NF-κB activation by PEDV  
The NF-κB signaling is a central pathway regulating the production of proinflammatory 
cytokines (Blackwell and Christman, 1997). Viral infections can trigger NF-κB activation and 
produce TNFα and IL-1, which in turn may activate NF-κB in a positive regulatory loop (Barnes 
and Karin, 1997). This positive feedback mechanism may amplify and perpetuate local 
inflammatory reactions. To understand the basis for PEDV suppression of early proinflammatory 
cytokines, we first examined whether PEDV induced the NF-κB nuclear translocation. LLC-PK1 
cells were infected with PEDV and treated with TNFα, followed by co-staining with anti-p65 
mAb and anti-PEDV N mAb. Without TNFα treatment, p65 remained in the cytoplasm as 
anticipated. When stimulated with TNFα, however, p65 was translocated to the nucleus in 
uninfected cells (Fig. 3.3A, white arrows). Interestingly in PEDV-infected cells, p65 remained in 
the cytoplasm, and even after stimulation with TNFα, p65 was not translocated to the nucleus 
and remained in the cytoplasm in virus-infected cells (Fig. 3.3A, yellow arrows), indicating that 
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NF-κB activation by TNFα was inhibited by PEDV. Only a minimal fraction of PEDV-infected 
cells showed p65 in the nucleus at late infection. The ratios for p65 nuclear translocation were 
quantified in PEDV-infected cells (Fig. 3.3B). PEDV did not induce p65 nuclear translocation 
through 12 hpi, and only approximately 4% of PEDV-infected cells showed p65 in the nucleus at 
18-24 hpi in the absence of TNFα stimulation. The suppression of p65 in PEDV-infected cells 
after TNFα stimulation was proportional to viral replication with the peak at 10 hpi followed by 
a gradual decrease. This result indicates that PEDV suppresses early NF-κB activation. Two 
other cell types permissive for PEDV were examined for p65 nuclear translocation. Similar to 
LLC-PK1, both MARC-145 and ST cells showed the lack of p65 nuclear translocation when 
infected with PEDV and stimulated with TNFα (data not shown), indicating that the PEDV-
mediated NF-κB suppression was cell type-independent. The p65 phosphorylation remained 
unchanged at the basal level in PEDV-infected cells throughout the infection (data not shown), 
which further confirms the cell-type independent suppression of NF-κB by PEDV.  
 
3.4.4 Identification of PRD II and NF-κB antagonists for PEDV  
Once IRF3/7 and NF-κB translocate to the nucleus, they bind to their respective PRD 
domains for expression of type I IFNs. Activated IRF3/7 binds to PRD I/III element in the 
nucleus, whereas NF-κB binds to the PRD II element for IFN gene expression. Evidence shows 
that type I IFN suppression by PEDV is mediated through the IRF3/7 singling pathways (Cao et 
al., 2015a; Xing et al., 2013; Zhang et al., 2016). To examine whether PEDV inhibited PRD II, 
luciferase assays were performed. It was apparent that the PRD II activity was suppressed even 
when stimulated with poly(I:C) in PEDV-infected cells (Fig. 3.4A), demonstrating the significant 
inhibition of NF-κB-mediated IFN production by PEDV. We previously identified ten different 
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PEDV proteins as IFN antagonists (Zhang et al., 2016), and these proteins suppressed the PRD 
I/III activity. Thus to identify PRD II antagonists among the ten viral protein, PRD II luciferase 
assays were conducted for these proteins. PRRSV nsp1α (P-nsp1α) is known to inhibit PRD II 
and included as a positive control, and its cysteine mutant P-nsp1α(m) (C28S) was included as a 
negative control (Han et al., 2013; Song et al., 2010). Upon stimulation, PRD II-dependent 
luciferase activities were reduced in cells expressing nsp1, nsp3, nsp14, nsp15, ORF3, E, and N 
protein, compared to those of pXJ41 empty vector- and GST gene-transfected cells (Fig. 3.4B). 
These results indicate that NF-κB-mediated type I IFNs suppression also participate in type I IFN 
suppression by these viral proteins. 
In uninfected cells, NF-κB was activated up to 150 folds by TNFα stimulation (Fig. 3.5A). 
In PEDV-infected cells, however, NF-κB activation was blocked even after TNFα stimulation 
(Fig. 3.5A), suggesting a possible suppression of proinflammatory cytokines, in addition to the 
suppression of type I IFNs, by PEDV at early time of infection. It was of interest to first identify 
viral proteins inhibiting NF-κB, and therefore individual PEDV genes were examined. As 
anticipated, TNFα upregulated NF-κB in cells expressing GST and P-nsp1α (m), whereas P-
nsp1α suppressed the NF-κB activity (Fig. 3.5B). Of nsps of PEDV, nsp1, nsp3, nsp5, nsp7, 
nsp14, nsp15 and nsp16 appeared to downregulate the NF-κB activity, and similarly, the ORF3 
protein also downregulated NF-κB (Fig. 3.5B). Of structural proteins, only E protein was found 
to suppress the NF-κB activity (Fig. 3.5C). Among all NF-κB antagonists, nsp1 and nsp14 
appeared to be the most potent inhibitors.  
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3.4.5 Suppression of pro-inflammatory cytokines of PEDV nsp1  
PEDV nsp1 is a nuclear-cytoplasmic protein and antagonizes type I IFN production by 
degrading the CREB-binding protein in the nucleus (Zhang et al., 2016). In the present study, 
PEDV nsp1 also appeared to inhibit the activation of PRD II and NF-κB (Fig. 3.4B and Fig. 
3.5B). It seems that nsp1 blocks NF-κB so as to inhibit the production of IFNs and 
proinflammatory cytokines. Thus, it was of interest to examine whether nsp1 suppressed TNFα 
expression. PRRSV nsp1β (P-nsp1β) has been shown to suppress TNFα activation by inhibiting 
NF-κB and Sp1, and PRRSV N (P-N) does not interfere with TNFα activation (Subramaniam et 
al., 2010), and thus both constructs were included as controls. Similar to P-nsp1β, PEDV nsp1 
appeared to suppress the TNFα activation when stimulated with LPS (Fig. 3.6A). Suppression of 
proinflammatory cytokines by nsp1 was examined by RT-qPCR in nsp1-gene transfected cells, 
and the results showed that nsp1 significantly suppressed TNFα mRNA transcription (Fig. 3.6B), 
validating the nsp1 antagonism against TNFα expression. PEDV nsp1 also suppressed the 
expression of IL-8, CXCL10, MCP-1, and RANTES (Fig. 3.6B), indicating that PEDV nsp1 was 
able to antagonize TNFα-mediated NF-κB activation and suppressed the proinflammatory 
cytokines. 
 
3.4.6 Inhibition of IκBα phosphorylation and degradation by PEDV nsp1 and blockage of 
p65 nuclear transport 
Stimulation of cytokine receptors such as those in the TNF receptor superfamily by TNFα 
or IL-1 leads to activation of the IKK complex (IKKα/β). Activated IKK induces IκBα 
phosphorylation, resulting in its proteasomal degradation and release of NF-κB for nuclear 
translocation and subsequent activation of target gene expressions (Napetschnig and Wu, 2013). 
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The p65 subunit of NF-κB is a key transcription factor for downstream signaling, and in the 
present study, PEDV appears to inhibit p65 nuclear translocation (Fig. 3.3). To investigate the 
mechanism of NF-κB suppression by nsp1, nuclear translocation of p65 was first examined in 
nsp1-expressing cells. Without TNFα stimulation, nsp1, PEDV N, and PRRSV nsp1α did not 
activate p65, and it remained in the cytoplasm. When the N-expressing cells were stimulated 
with TNFα, p65 was activated and normally translocated to the nucleus as anticipated (Fig. 3.7A). 
In contrast, p65 was remained in the cytoplasm in PRRSV nsp1α-expressing control cells and 
PEDV nsp1-expressing cells after TNFα stimulation, indicating that PEDV nsp1 suppressed the 
p65 nuclear translocation. Only 10-13% of nsp1-expressing cells showed the p65 in the nucleus, 
whereas more than 90% of control cells showed p65 in the nucleus after TNFα stimulation (Fig. 
3.7B), confirming that PEDV nsp1 blocked p65 nuclear translocation. The cell fractionation 
study also confirmed the blockage of p65 nuclear translocation in nsp1-expressing cells (Fig. 
3.7C).  
Activated IKKβ phosphorylates IκBα for its degradation via ubiquitination. To examine 
whether nsp1-mediated NF-κB suppression was due to the prevention of IκBα phosphorylation 
and subsequent degradation, IκBα phosphorylation was examined by Western blot. In contrast to 
cells transfected with the empty vector, phosphorylation of IκBα was reduced, and the amount of 
IκBα was stable in nsp1-expressing cells as well as in PRRSV nsp1α-expressing control cells 
when treated with TNFα (Fig. 3.7D). This result demonstrates that nsp1 inhibited the IκBα 
phosphorylation. Similar to PRRSV nsp1α, the densitometric analysis for p-IkBα showed the 
significant inhibition of IκBα phosphorylation by nsp1 after TNFα treatment for 5 min (Fig. 
3.7E). The level of IκBα phosphorylation was further decreased by the increasing amount of 
nsp1 (Fig. 3.7F), suggesting that the suppression of IκBα phosphorylation by nsp1 was dose-
	   90 
dependent. TNFα caused the IκBα phosphorylation, but no phosphorylation of IκBα was 
observed in PEDV-infected cells (Fig. 3.7G), which confirmed that nsp1 suppressed IκBα 
phosphorylation. To examine whether nsp1 interferes with IKK activation, nsp1-expressing cells 
were stimulated with TNFα, and the IKKα/β phosphorylation was examined. The expression of 
IKKα/β was stable, and the phosphorylation of IKKα/β normally occurred in nsp1-expressing 
cells (Fig. 3.7H). The inhibition of IκBα phosphorylation and degradation was also observed (Fig. 
3.7H) and the densitometric analysis also showed this inhibition (Fig. 3.7I). This indicates that 
the inhibition by nsp1 takes place between steps of IKK and IκBα in the NF-κB signaling. 
Together, our data demonstrate that PEDV nsp1 interferes with the IκBα phosphorylation and 
degradation, resulting in the inhibition of p65 nuclear translocation.  
 
3.4.7 The highly conserved residues of nsp1 are crucial for NF-κB suppression  
Coronavirus nsp1 is the N-terminal cleavage product of the polyproteins pp1a and pp1ab 
and is one of the most divergent proteins among the four different genera in the Coronaviridae 
family (Ziebuhr, 2005). Nsp1 proteins of α-CoV are similar in their lengths and thus may share 
some functions (Narayanan et al., 2015). Similar to PEDV nsp1, transmissible gastroenteritis 
virus (TGEV) nsp1 also inhibits the IFN-β production (Zhang and Yoo, 2016). Thus, we made 
structural comparisons of PEDV nsp1 and TGEV nsp1. TGEV nsp1 displayed a six-stranded β-
barrel fold with a long α-helix on the rim of the barrel (Fig. 3.8A, left panel; Jansson, 2013), and 
PEDV nsp1 showed a similar structure, except two missing β-sheets (Fig. 3.8A, right panel), 
suggesting that PEDV nsp1 may have a unique mechanism for immune modulation. As with 
TGEV nsp1, the surface of PEDV nsp1 displayed two highly conserved areas. The first area was 
consisted of four conserved residues D13/E15/N93/N95, and the second area was consisted of 
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three conserved residues L98/E99/E100. These two areas made up two conserved circles placed 
on a protruding ridge and were potential surfaces for interaction with a partner molecule. Besides, 
two highly conserved residues (G38/F39) were connected to the hydrophobic core of PEDV nsp1, 
whereas G87 was highly conserved. We hypothesized that the change of the conserved residues 
might revert the IFN suppression function of nsp1. To examine this hypothesis, 13 nsp1 mutants 
were made based on the structural prediction. The mutated genes were individually expressed in 
cells and examined for their cellular distributions by confocal microscopy. Consistent with the 
previous report (Zhang et al., 2016), PEDV nsp1 appeared as a nuclear-cytoplasmic protein (Fig. 
3.8B). Among the nsp1 mutants, T23A, T68A, K70A, T68A/K70A, and L101A remained 
nuclear-cytoplasmic. G38A/F39A, F44A, G87A, G87E, L98A/E99A/E100A, and the deletion 
mutant Δ37-75 exhibited nuclear punctate patterns. N93A/N95A was perinuclear whereas Δ37-
51 became cytoplasmic, suggesting the deletion region was crucial for nuclear localization of 
nsp1. The results indicated that the highly conserved residues are crucial to maintain the higher 
order structure of nsp1. To determine the crucial residues for nsp1-mediated IFN suppression, 
luciferase assays for NF-κB and IFN-β were performed for individual mutants. While T23A, 
T68A, G87A, K70A, T68A/K70A, and L101A still retained the function of NF-κB suppression 
(Fig. 3.8C), G38A/F39A, F44A, G87E, N93A/N95A, L98A/E99A/E100A, and Δ37-75 lost the 
NF-κB suppression, indicating that the conserved residues in nsp1 are crucial for NF-κB 
suppression. The deletion mutant Δ37-51 retained NF-κB inhibition, further confirming that the 
suppression of NF-κB is a cytoplasmic event. N93A/N95A and L98A/E99A/E100A did not 
suppress the IFN-β production (Fig. 3.8D), indicating that the conserved residues are also crucial 
for type I IFN suppression. Unlike the NF-κB suppression, T23A, T68A, T68A/K70A, and 
G87A lost the IFN suppression function. Additionally, Δ37-51 was cytoplasmic and lost the IFN 
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suppression function, confirming that the IFN suppression by nsp1 is a nuclear event (Zhang et 
al., 2016). Our study indicates that the suppression of innate immune responses by PEDV nsp1 
relies on its highly conserved residues.   
 
3.5 DISCUSSION 
The innate immune system forms the first line of antiviral defense of a host. It activates 
the production of type I IFNs and proinflammatory cytokines controlled by IRF3/IRF7 and NF-
κB. Many viruses have evolved to counteract the host innate immunity for optimal viral 
adaptation and replication. Studies have shown that PEDV inhibits type I IFN production in 
virus-infected cells. Of 22 PEDV proteins, ten proteins appear to suppress the IFN production. 
The nsp1 protein antagonizes the IRF3 signaling by degrading CBP in the nucleus via the 
proteasome-dependent pathway (Zhang et al., 2016), and the nsp5 protein antagonizes NF-κB to 
suppress type I IFN production by cleaving NEMO (Wang et al., 2015a). The N protein 
suppresses IRF3 and NF-κB and inhibits IFN-β production (Ding et al., 2014). PEDV infection 
leads to activation of NF-κB at later times post-infection (Cao et al., 2015b; Xing et al., 2013). 
However, the basis for temporal regulation of NF-κB for the production of type I IFNs and 
proinflammatory cytokines is unknown. In the present study, we show that PEDV blocks TNFα-
mediated p65 nuclear translocation and have subsequently identified nine NF-κB antagonists. 
Among these, nsp1 is the most potent NF-κB inhibitor, which blocks the p65 nuclear 
translocation by inhibiting the phosphorylation and degradation of IκBα.  
Both coronaviruses and arteriviruses in the order Nidovirales are sensitive to type I IFNs 
and modulate the IFN response. Equine arteritis virus (EAV) inhibits type I IFN production in 
virus-infected equine endothelial cells (Go et al., 2014). Porcine reproductive and respiratory 
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syndrome virus (PRRSV) is also sensitive to type I IFNs and modulate the IFN production in 
cells and pigs (Albina et al., 1998; Lee et al., 2004; Overend et al., 2007). Mouse hepatitis 
coronavirus (MHV) induces extremely low levels of type I IFNs in macrophages, microglia, and 
oligodendrocytes of infected mice (Li et al., 2010; Roth-Cross et al., 2008; Zhou and Perlman, 
2007). SARS-CoV and MERS-CoV also do not induce type I IFN responses in virus-infected 
cells (Cinatl et al., 2004; Lau et al., 2013; Zhou et al., 2014). TGEV can induce a high level of 
IFN-α in newborn pigs (La Bonnardiere and Laude, 1981). However, the IFN expression is 
delayed and the IFN response inhibits TGEV replication in the early stage of infection (Zhu et al., 
2017). Protein 7 and nsp1 of TGEV have been shown to counteract the host antiviral response 
(Cruz et al., 2013; Cruz et al., 2011; Zhang and Yoo, 2016). Viruses often code for multiple IFN 
antagonists, and PEDV also encodes at least 10 IFN antagonists (Cao et al., 2015a; Xing et al., 
2013; Zhang et al., 2016). Activated NF-κB binds to PRD II in the nucleus, which is essential for 
NF-κB-mediated IFN-β production. The p65 subunit of NF-κB specifically functions as a key 
element for early phase IFN production after infection. The PEDV N protein inhibits NF-κB 
(Ding et al., 2014), suggesting that the NF-κB inhibition may lead to the suppression of type I 
IFNs. In the present study, we have shown that PEDV blocks NF-κB activation and suppresses 
NF-κB-mediated type I IFN production. Of the ten IFN suppressors, nsp7, nsp16, and M do not 
interfere with PRD II, suggesting the specific target of IRF3/7. Thus, targeting PRD II via NF-κB 
and PRD I/III via IRF3/7 results in synergistic effects on the viral IFN antagonism to allow 
efficient replication of the invading virus. 
The p65 subunit of NF-κB undergoes various post-translational modifications for 
activation. Not only for type I IFN induction, but NF-κB is also a key regulator for 
proinflammatory cytokines including TNFα, IL-6, and IL-8 (Lappas et al., 2002). 
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Proinflammatory cytokines initiate inflammation and disease progression during viral infection. 
IL-12 plays a critical role in the early inflammatory response and the generation of Th1 cells 
leading to cell-mediated immunity (Hsieh et al., 1993). Activation of NF-κB is critical for host 
defense and thus occurs rapidly after stimulation without additional protein translation. In turn, 
NF-κB is an attractive viral target for optimal replication during infection. For SARS-CoV, N 
protein activates NF-κB (Liao et al., 2005), whereas M protein suppresses NF-κB probably 
through a direct interaction with IKKβ (Fang et al., 2007). PEDV has also been shown to activate 
NF-κB later time post-infection (Cao et al., 2015b; Xing et al., 2013), and the N protein is the 
NF-κB activator for up-regulation of IL-8 and Bcl-2 (Xu et al., 2013b). The basis for PEDV-
mediated NF-κB modulation remains uncharacterized. We show in the present study that PEDV 
blocks the NF-κB activation and suppresses the production of early proinflammatory cytokines. 
The PEDV replication cycle is less than 12 h (Fig. 3.1D), and the inhibition of NF-κB during the 
early stage of infection may play a role to help viral replication. Nine viral proteins have been 
identified to regulate NF-κB, and it is of interest to study their individual mode of action for NF-
κB.  
For activation of NF-κB, the release of IκBα from NF-κB is crucial. In the latent state, 
NF-κB is sequestered in the cytosol by IκBα. In response to stimulation by TNFα or IL-1, a 
series of membrane-proximal events lead to activation of the IKK complex (IKKα/β/γ). The IKK 
complex is responsible for the phosphorylation of two serine residues in IκBα, which in turn 
leads to Lys48-linked polyubiquitination and degradation by the proteasome. Proteasomal 
degradation of IκBα frees and translocates NF-κB to the nucleus for binding to the κB DNA 
element in the specific promoters and enhancers of target genes (Napetschnig and Wu, 2013). 
Viruses have evolved to develop sophisticated strategies to modulate NF-κB signaling, and 
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ample examples are available. PRRSV nsp1α inhibits IκBα phosphorylation and degradation for 
suppression of type I IFNs (Song et al., 2010). Bocavirus NS1 and NS1-70 protein blocks the 
binding of p65 to the κB DNA element and inhibits TNFα-mediated activation of NF-κB (Liu et 
al., 2016). Molluscum contagiosum poxvirus (MCV) MC160 protein degrades IKKα and 
prevents TNFα-induced NF-κB activation (Le Negrate, 2012). Influenza virus NS1 protein 
specifically interacts with IKKα and IKKβ for inhibition of IKKβ-mediated phosphorylation and 
degradation of IκBα (Gao et al., 2012).  
PEDV nsp1 inhibits the phosphorylation and subsequent degradation of IκBα and blocks 
p65 from nuclear translocation. PEDV nsp1 does not interfere the phosphorylation of IKKα/β 
complex (Fig. 3.7H) nor interact with IκBα or IKKα/β (data not shown), suggesting a possible 
modulation of posttranslational modifications of IκBα such as SUMOylation. Unlike 
ubiquitination and degradation of IκBα, SUMOylation of IκBα inhibits NF-κB activation 
(Desterro et al., 1998). Breast cancer-associated gene 2 (BCA2) functions as an E3 SUMO-ligase 
and enhances the SUMOylation of IκBα, leading to improved sequestration of NF-κB in the 
cytoplasm, thereby preventing the expression of NF-κB-responsive genes (Colomer-Lluch and 
Serra-Moreno, 2017). It is of interest to examine whether PEDV nsp1 recruits an E3 SUMO-
ligase and enhances SUMOylation of IκBα.  
In coronaviruses, nsp1 proteins of α-CoV and β-CoV are potent IFN antagonists. The β-
CoV nsp1 protein regulates cellular and viral gene expressions. SARS-CoV nsp1 is consisted of 
180 amino acids and inhibits the translation of capped cellular mRNAs by blocking the 
formation of the 80S complex. It also recruits a cellular endonuclease to induce an 
endonucleolytic cleavage of host mRNAs (Narayanan et al., 2015). Unlike SARS-CoV nsp1, 
MERS-CoV nsp1 selectively targets host mRNAs for translation inhibition and mRNA 
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degradation but spares mRNAs of cytoplasmic origin (Lokugamage et al., 2015). The α-CoV 
nsp1 protein also inhibits the expression of reporter genes. The C-terminal portion of β-CoV 
nsp1 is crucial for host mRNA cleavage, and this region is lost in α-CoV nsp1, suggesting that α-
CoV nsp1 may have evolved a distinct mechanism for immune evasion. Unlike SARS-CoV nsp1, 
TGEV nsp1 does not bind to the 40S ribosomal subunit for suppression of host gene expression 
(Huang et al., 2011a). Surface electrostatics, shapes, and amino acid conservations between α-
CoV nsp1 and β-CoV nsp1 may contribute to different mechanisms for nsp1-induced 
suppression of host gene expression (Jansson, 2013). The structure of TGEV nsp1 is 
characterized by an irregular six-stranded β-barrel flanked by an α-helix. Most conserved 
residues are centered on the highly conserved β7 strand, which is likely involved in its structural 
stability. Two highly conserved patches on the surface of TGEV nsp1 are placed on a producing 
ridge formation, which forms potential sites for interaction with cellular proteins (Jansson, 2013). 
PEDV nsp1 also shows two highly conserved surface patches, and mutations of these regions 
alter their cellular distributions and functions for IFN and NF-κB suppressions. It is of interest to 
identify the cellular proteins that may interact with PEDV nsp1. The PEDV full-length infectious 
clone is available (Beall et al., 2016; Jengarn et al., 2015) and it will be useful to study nsp1 
function in pigs using replicating mutant viruses. 
In conclusion, we have shown that PEDV inhibits NF-κB activity and early production of 
proinflammatory cytokines. PEDV modulates TNFα-mediated p65 nuclear localization, and we 
have identified nine viral NF-κB antagonists. PEDV nsp1 interferes the phosphorylation and 
degradation of IκBα and blocks NF-κB activation. The conserved residues of nsp1 are crucial for 
nsp1-mediated NF-κB activity. Our study provides a better understanding for PEDV-mediated 
innate immune modulation and the basis for PEDV pathogenesis. 
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3.6 FIGURES AND TABLES 
 
Fig. 3.1: Suppression of type I IFN production in LLC-PK cells by PEDV. (A), Expression of N 
protein in PEDV-infected cells. Cells were infected with PEDV at an MOI of 0.01 for 24 h, and Western 
blot was conducted using anti-N mAb.  (B), multistep growth kinetics of PEDV in different lines of cells. 
MARC-145, Vero, and LLC-PK1 cells were infected with PEDV at an MOI of 0.01 and cell culture 
supernatants were collected at different times. Viral titers were determined in respective cells by the 50% 
tissue culture infectious dose (TCID50) protocol. (C), Cytopathic effects (CPE) of PEDV on different 
types of cells. Cells were infected with PEDV at an MOI of 5 and CPE was observed at different times. 
Arrows show multinucleated cells. (D), One step growth curve of PEDV. Cells were infected with PEDV 
at an MOI of 5, and culture supernatants were collected at indicated times to determine TCID50. (E) and 
(F), Suppression of type I IFN production by PEDV. LLC-PK1 cells were grown in 12-well plates and 
infected with PEDV either at a low MOI (0.01 MOI, panel E) or a high MOI (5 MOI, panel F). Cells were 
harvested at indicated times, and expressions of IFN-α and IFN-β were determined by RT-qPCR. Cells 
stimulated with poly(I:C) for 12 h were used as positive controls. (G) and (H), Stimulation for type I IFN 
production by poly(I:C) and suppression by PEDV. LLC-PK1 cells were infected with PEDV at an MOI 
of 0.01 for 12 h, and stimulated with poly(I:C) for 12 h. Cells were harvested and expression of IFN-α (G) 
and IFN-β (H) were determined by RT-qPCR.  
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Fig. 3.1 (cont.)  
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Fig. 3.2: Inhibition of early production of proinflammatory cytokines by PEDV. (A) through (F), 
Inhibition of pro-inflammatory cytokines at early times of infection. LLC-PK1 cells were infected with 
PEDV at an MOI of 0.01 and cells were harvested at indicated times for expression of pro-inflammatory 
cytokines by RT-qPCR. (G), Inhibition of the induction of TNFα by PEDV in Vero and MARC-145 cells. 
Cells were infected with PEDV at an MOI of 1 for indicated times and the production of TNFα was 
determined by RT-qPCR. PRRSV as a known inhibitor of TNFα and VSV as a known stimulator were 
included as controls.  Asterisks indicate statistical significance calculated by the Student’s t test. *, 
P<0.05; **, P<0.01; ***, P<0.001. 
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Fig. 3.3: PEDV-mediated inhibition of TNFα-stimulated p65 nuclear translocation. (A), Inhibition of 
TNFα-stimulated p65 nuclear localization by PEDV. LLC-PK1 cells were infected with PEDV for 12 h 
and stimulated with TNFα as the concentration of 15 ng/ml for 20 min. Cells were fixed and stained with 
anti-N antibody and anti-p65 antibody. White arrows indicate the non-infected cells, yellow arrows 
indicate the PEDV-infected cells. (B), LLC-PK1 cells were infected with PEDV and stimulated with 
TNFα at different times. Percentages of cells showing p65 nuclear localization were quantified by 
randomly counting 200 PEDV-infected cells. The data were obtained from three independent experiments. 
Asterisks indicate statistical significance calculated by the Student’s t test. *, P<0.05; **, P<0.01; ***, 
P<0.001.  
 
 
 
 
 
(B)
(A) PEDV%N%%%%%%%%%%%%%%%%%p65%%%%%%%%%%%%%%%%%%%DAPI%%%%%%%%%%%%%%%%%Merge%%%%
Mock
TNFα%(7)
Mock
TNFα%(+)
PEDV%(+)
TNFα%(7)
PEDV%(+)
TNFα%(+)
Mo
ck 6h 8h 10
h
12
h
18
h
24
h
Mo
ck 6h 8h 10
h
12
h
18
h
24
h
0
10
20
30
40
50
60
70
80
90
100
Pe
rc
en
ta
ge
 o
f p
65
 n
uc
le
ar
 lo
ca
liz
at
io
n
TNFα(+)
TNFα(-)
***
	   101 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.4: Inhibition of NF-κB-mediated IFN production by PEDV. (A), Inhibition of PRD II promoter 
by PEDV. MARC-145 cells were co-transfected with the pPRD II-Luc reporter plasmid along with the 
pRL-TK internal control for 6 h followed by PEDV infection at an MOI of 1 for 12 h. Cells were then 
stimulated with poly(I:C) for 12 h, and cell lysates were subjected to dual-luciferase reporter assays. 
Results from three independent experiments were presented as the mean relative luciferase values. 
Asterisks indicate statistical significance calculated by the Student’s t test. *, P<0.05; **, P<0.01; ***, 
P<0.001. (B), Inhibition of PRD II promoter by PEDV proteins. HeLa cells were co-transfected with the 
pPRD II-Luc reporter along with individual type I IFN antagonist for PEDV followed by stimulation with 
poly(I:C). Cell lysates were prepared and subjected to luciferase assays. PRRSV nsp1α (P-nsp1α) is 
known to inhibit the PRD II promoter and was included as a positive control. Its mutant P-nsp1α(m) 
(C28S) was included as a negative control (Han et al., 2013; Song et al., 2010). Results from three 
independent experiments were presented as the mean relative luciferase values with standard deviation. 
Asterisks indicate statistical significance calculated by the Student’s t test. *, P<0.05; **, P<0.01; ***, 
P<0.001. 
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Fig. 3.5: Identification of NF-κB antagonists of PEDV. (A), Suppression of TNFα-stimulated NF-κB 
activity by PEDV.  MARC-145 cells were co-transfected with pNF-κB-Luc along with pRL-TK in 12-
well plates for 6 h followed by PEDV infection at an MOI of 1 for 12 h. Cells were then stimulated with 
TNFα at the concentration of 15 ng/ml for 9 h, and cell lysates were prepared for dual-luciferase reporter 
assays. Results from three independent experiments were presented as the mean relative luciferase values 
with standard deviation. Asterisks indicate statistical significance calculated by the Student’s t test. *, 
P<0.05; **, P<0.01; ***, P<0.001. (B) and (C), Regulation of TNFα-induced NF-κB activity by 
individual PEDV proteins. HeLa cells were grown in 48-well plates and co-transfected with pNF-κB-Luc 
along with individual PEDV genes and pRL-TK at a ratio of 10:10:1. For nsp3, nsp5, and nsp16, 
transfection was conducted as described previously (Zhang et al., 2016). PRRSV nsp1α (P-nsp1α) is a 
known NF-κB promoter suppressor, and its mutant P-nsp1α(m) reverts its suppressive function. Both 
constructs were included as controls. Cells were stimulated with poly(I:C) (0.5µg/ml) at 12 h post-
transfection for 12 h and dual luciferase activities were determined. Results from three independent 
experiments were presented as the mean relative luciferase values with standard deviation. Asterisks 
indicate statistical significance calculated by the Student’s t test using GST as a control. *, P<0.05; **, 
P<0.01; ***, P<0.001.  
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Fig. 3.6: Suppression of proinflammatory cytokines by PEDV nsp1. (A), Suppression of TNFα 
promoter by nsp1. RAW cells were co-transfected with pswTNFα-Luc and individual viral genes along 
with pRL-TK for 24 h followed by stimulation with LPS (1 µg/ml) for 6 h. Firefly luciferase activities 
were determined and normalized using the Renilla luciferase internal control. PRRSV nsp1β (P-nsp1β) is 
known to suppress TNFα promoter and was included as a control (Subramaniam et al., 2010). Results 
from three independent experiments were presented as the mean relative luciferase values. Asterisks 
indicate statistical significance calculated by the Student’s t test. *, P<0.05; **, P<0.01; ***, P<0.001. 
(B), Inhibition of proinflammatory cytokines by nsp1. LLC-PK1 cells were transfected with PEDV nsp1 
gene for 12 h and stimulated with TNFα (15 ng/ml) and for 12h. Expressions of proinflammatory 
cytokines were determined by RT-qPCR. Asterisks indicate statistical significance calculated by the 
Student’s t test. *, P<0.05; **, P<0.01; ***, P<0.001. 
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Fig. 3.7 (cont.)  
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Fig. 3.7 (cont.): Inhibition of p65 nuclear translocation by nsp1 and inhibition of IκBα 
phosphorylation. (A) and (B), PEDV nsp1 blocks p65 nuclear translocation. HeLa cells were co-
transfected with pXJ41 (empty plasmid), nsp1, N, and PRRSV nsp1α for 24 h followed by stimulation 
with TNFα (15 ng/ml) for 20 min. Cells were then subjected to immunostaining. PRRSV nsp1α is known 
to inhibit p65 nuclear translocation and was included as a positive control. White arrows indicate p65 in 
mock-transfected cells, and yellow arrows indicate p65 in gene-transfected cells (panel A). The 
percentages of cells showing p65 activation were calculated by examining 200 gene-transfected cells in 
three independent experiments (panel B). Asterisks indicate statistical significance calculated by the 
Student’s t test. *, P<0.05; **, P<0.01; ***, P<0.001. (C), Cell fractionation and Western blot. HeLa cells 
were transfected with PEDV nsp1 gene for 24 h and then stimulated with TNFα for 12 h. Cells were 
subjected to nuclear-cytoplasmic fractionation to determine subcellular distribution of p65. Hsp90 is a 
cytosolic protein and was included as the cytosolic marker and PARP was included as a nuclear protein 
marker. (D), PEDV nsp1 inhibits IκBα phosphorylation and subsequent degradation. HeLa cells were 
transfected with PEDV nsp1 gene or PRRSV nsp1α (P-nsp1α) for 24 h and then stimulated with TNFα for 
indicated times. Cells were lysed and subjected to Western blot using IκBα antibody and phophso-IκBα 
antibody. P-nsp1α is known to inhibit IκBα phosphorylation and was included as a control. (E) and (I), 
Inhibition of IκBα phosphorylation by nsp1 by the densitometric analysis using the β-actin as an internal 
control. 7E corresponds to 7D, and 7I corresponds to 7H. Results from three independent experiments 
were presented as the mean values with standard deviation. Asterisks indicate statistical significance 
calculated by the Student’s t test comparing to the pXJ41 empty-vector-transfected cells. *, P<0.05; **, 
P<0.01; ***, P<0.001. (F) Inhibition of IκBα phosphorylation by nsp1 is dose-dependent. HeLa cells 
were transfected with an increasing amount of nsp1 and treated with TNFα for 5 min. Cells were lysed 
and subjected to Western blot using anti-IκBα and anti-phospho-IκBα antibodies. (G) Inhibition of IκBα 
phosphorylation by nsp1. LLC-PK1 cells were infected with PEDV at an MOI of 5 and cells were lysed at 
indicated times, followed by Western blot using anti-IκBα and anti-phospho-IκBα antibodies. Mock-
infected cells with the treatment of TNFα for 5 min were used as a control. (H), PEDV nsp1 does not 
interfere phosphorylation of IKKα/IKKβ. HeLa cells were transfected with PEDV nsp1 gene for 24 h and 
then stimulated with TNFα for indicated times. Cells were lysed and subjected to Western blot using 
antibodies for p-IKKα/IKKβ, IKKα, IKKβ, IκBα, and p-IκBα. 
 
 
 
 
 
 
 
 
 
 
 
	   106 
 
 
 
 
 
 
 
 
 
Fig. 3.7 (cont.)  
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Fig. 3.7 (cont.)  
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Fig. 3.8: Highly conserved residues of nsp1 are crucial for NF-κB suppression. (A), Predication of 
higher order structure of PEDV nsp1 based on the TGEV nsp1 structure. (B), Cellular distribution of nsp1 
mutants. Nsp1 mutants were expressed individually in HeLa cells followed by immunostaining. Confocal 
images showed their cellular distributions. (C) through (D), Conserved residues are crucial for nsp1-
mediated NF-κB/IFN-β suppression. HeLa cells were grown in 48-well plates and co-transfected with 
pNF-κB-Luc (panel C) or pIFN-β-Luc (panel D) along with individual PEDV nsp1 mutants and pRL-TK 
at a ratio of 10:10:1. Cells were stimulated with TNFα (panel C) or poly(I:C) (panel D) at 12 h post-
transfection for 12 h, and cell lysates were subjected to dual-luciferase reporter assays. Results from three 
independent experiments are presented as the mean relative luciferase values with standard deviation. 
Asterisks indicate statistical significance calculated by the Student’s t test using nsp1 as a control. *, 
P<0.05; **, P<0.01; ***, P<0.001.  
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Fig. 3.8 (cont.) 
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     Table 3.1: Primers used for the PEDV nsp1 mutants by PCR site-directed mutagenesis. 
Nsp1 
mutants Primer sequence (5'-3') 
T23A-F GACGGCTTCACTAGCAGCGCAAAAGCCAAAAGCTG 
T23A-R CAGCTTTTGGCTTTTGCGCTGCTAGTGAAGCCGTC 
G38A/F39A-
F GAAACGGCAGTGCATAGCTGCACTAGCGGCGGCCTC 
G38A/F39A-
R GAGGCCGCCGCTAGTGCAGCTATGCACTGCCGTTTC 
F44A-F CGAGATCGAAGGACACGGCACGGCAGTGCATAAATCCA 
F44A-R TGGATTTATGCACTGCCGTGCCGTGTCCTTCGATCTCG 
T68A-F CACTAAGCTTGGTAGCGCCGACCACCACCAT 
T68A-R ATGGTGGTGGTCGGCGCTACCAAGCTTAGTG 
K70A-F CACATACGCACTAAGCGCGGTAGTGCCGACCACC 
K70A-R GGTGGTCGGCACTACCGCGCTTAGTGCGTATGTG 
T68A/K70A-
F CACATACGCACTAAGCGCGGTAGCGCCGACCACCACCATG 
T68A/K70A-
R CATGGTGGTGGTCGGCGCTACCGCGCTTAGTGCGTATGTG 
G87A-F GTTAGAAAATAACAGCCAAGCACAAATGTTTTTGGGGCG 
G87A-R CGCCCCAAAAACATTTGTGCTTGGCTGTTATTTTCTAAC 
G87E-F AGTTAGAAAATAACAGCCACTCACAAATGTTTTTGGGGCGGCTAC 
G87E-R GTAGCCGCCCCAAAAACATTTGTGAGTGGCTGTTATTTTCTAACT 
N93A/N95A-
F 
TAAGCTCTAACTCTTCGAGGAAGTAAGCACAGGCAGAAAATAACAGCCAACCACAAA
TGT 
N93A/N95A-
R ACATTTGTGGTTGGCTGTTATTTTCTGCCTGTGCTTACTTCCTCGAAGAGTTAGAGCTTA 
L98A-F ACCAAAAGTAAGCTCTAACTCTTCGGCGAAGTAATTACAGTTAGAAAATAAC 
L98A-R GTTATTTTCTAACTGTAATTACTTCGCCGAAGAGTTAGAGCTTACTTTTGGT 
E99A/E100A
-F CGACCAAAAGTAAGCTCTAACGCTGCGAGGAAGTAATTACAGTTAG 
E99A/E100A
-R CTAACTGTAATTACTTCCTCGCAGCGTTAGAGCTTACTTTTGGTCG 
L101A-F CGACGACCAAAAGTAAGCTCTGCCTCTTCGAGGAAGTAATTACA 
L101A-R TGTAATTACTTCCTCGAAGAGGCAGAGCTTACTTTTGGTCGTCG 
Δ37-75F CCATGTTACATTGGCTTTTGCCAATGAAGCCGTCTCATA 
Δ37-75R TATGAGACGGCTTCATTGGCAAAAGCCAATGTAACATGG 
Δ37-51F CATGTTACATTGGCTTTTGCCAATGCTTTTGGCTTTTGCACTG 
Δ37-51R CAGTGCAAAAGCCAAAAGCATTGGCAAAAGCCAATGTAACATG 
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Table 3.2: Real-time PCR primer sets for cytokine genes used in this study. 
Genes Forward primer (5'-3') Reverse primer (5'-3') 
Accession 
no./references  
sIFN-α* GCCTCCTGCACCAGTTCTACA  TGCATGACACAGGCTTCCA  (Loving et al., 2006) 
sIFN-β AGTGCATCCTCCAAATCGCT  
GCTCATGGAAAGAGCTGTGG
T  
(de Los Santos et al., 
2006) 
sTNFα AACCTCAGATAAGCCCGTCG  ACCACCAGCTGGTTGTCTTT  
(Gudmundsdottir and 
Risatti, 2009) 
sIL-1β ACCTGGACCTTGGTTCTCTG CATCTGCCTGATGCTCTTGT NM_214055.1 
sIL-6 CTGGCAGAAAACAACCTGAACC  
TGATTCTCATCAAGCAGGTC
TCC  
(Duvigneau et al., 
2005) 
sIL-8 CCGTGTCAACATGACTTCCAA  
GCCTCACAGAGAGCTGCAG
AA  (Royaee et al., 2004) 
sIL-15 
GCTGTATCAGTGCAGGTCTTCC
T  
TTTCAGTATACAATGTGGCA
TCCA  
(Gudmundsdottir and 
Risatti, 2009) 
sIL-17 AATGCTGAAGGGAAGGAAGA CCCACTGTCACCATCACTTT NM_001005729.1 
sCXCL10 
CTGCATCAAGATCAGTGACAGA
C 
TTGTGGCAATGATCTCAACA
T NM_001008691.1 
sMCP-1 
GCAGCAAGTGTCCTAAAGAAGC
A  
GCTTGGGTTCTGCACAGATC
T  
(Gudmundsdottir and 
Risatti, 2009) 
sRANTES AGCATCAGCCTCCCCATATG  
TTGCTGCTGGTGTAGAAATA
TTCC  
(Gudmundsdottir and 
Risatti, 2009) 
sTGFβ3 CCTTCGACGTCACAGACACT TGTGACACGGACAATGAATG XM_005666355.2 
mTNFα CCTCTTCAAGGGCCAAGGCT TGGGCTCATACCAGGGCTTG U19850.1 
β-actin ATCGTGCGTGACATTAAG ATTGCCAATGGTGATGAC (Zhang et al., 2016) 
(Note: ‘s’ in the front of each gene denotes swine specific primers; ‘m’ for TNFα indicates monkey specific primers; β-actin 
primers were universal for swine, monkey, and human.) 
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CHAPTER 4: TYPE III INTERFERON RESTRICTION BY PORCINE EPIDEMIC 
DIARRHEA VIRUS INFECTION IS MEDIATED THROUGH IRF1 BY NSP1 PROTEIN 
 
4.1 ABSTRACT4 
Type III interferons (IFN-λs) play a vital role to maintain the antiviral state of the 
mucosal epithelial surface in the gut, and in turn, enteric viruses may have evolved to evade the 
type III IFN responses during infection. For the study of the immune evasion of porcine 
epidemic diarrhea virus (PEDV) from type III IFN response, a line of porcine intestinal epithelial 
cells was developed as a model for PEDV replication. IFN-λ1 and IFN-λ3 inhibited the PEDV 
replication, indicating the anti-PEDV activity of type III IFNs. Of the 21 PEDV proteins, nsp1, 
nsp3, nsp5, nsp8, nsp14, nsp15, nsp16, ORF3, E, M, and N were found to suppress the type III 
IFN activities, and the IRF1 signaling mediated the suppression. PEDV specifically inhibited 
IRF1 nuclear translocation. Peroxisomes are the innate antiviral signaling platforms for 
activation of IRF1-mediated IFN-λ production, and peroxisomes were found to decrease in 
number in PEDV-infected cells. PEDV nsp1 blocked the nuclear translocation of IRF1 and 
reduced the number of peroxisomes to suppress the IRF1-mediated type III IFN. Mutational 
studies showed the conserved residues of nsp1 were crucial for IRF1-mediated IFN-λ 
suppression. Our study for the first time provides the evidence that the porcine enteric virus 
PEDV downregulates and evades the IRF1-mediated type III IFN responses by reducing the 
peroxisomes.  
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4.2 INTRODUCTION  
A classic antiviral response in mammals is mediated by type I interferons (IFNs). Upon 
infection, host cells react quickly by producing type I IFNs (IFN-α/β), which triggers the 
production of hundreds of interferon-stimulating genes (ISGs) through the JAK-STAT pathway 
(Stark and Darnell, 2012). Thus, type I IFNs and ISGs are the major components for the 
establishment of a host antiviral state and provide the first line of defense against viral infections. 
Recently, types III IFNs (IFN-λ) have been identified as a distinct class of antiviral cytokines and 
inducers for expression of ISGs. Type III IFNs in humans constitute IFN-λ1 (interleukin 29 [IL-
29]), IFN-λ2 (IL-28A), IFN-λ3 (IL-28B), and IFN-λ4 (Hermant and Michiels, 2014; Kotenko et 
al., 2003; Prokunina-Olsson et al., 2013; Sheppard et al., 2003). For swine, IFN-λ1 and IFN-λ3 
have been described, but whether IFN-λ2 is expressed or deficient in pigs is unclear (Sang et al., 
2010). The induction process and mechanism of action for type I IFNs and type III IFNs are 
similar (Mordstein et al., 2010; Onoguchi et al., 2007; Sommereyns et al., 2008). While the 
induction of type I IFNs requires all components of IFN enhanceosome, type III IFNs can be 
produced by independent actions of IRF (interferon regulatory factor) and NF-κB (Thomson et 
al., 2009). Similar to type I IFNs, IRF3, IRF7, and NF-κB too are essential for type III IFNs, but 
IRF1 plays a particular role (Odendall et al., 2014). The mitochondrial antiviral-signaling 
(MAVS) protein localizes to the both mitochondria and peroxisomes and participates in 
activating an antiviral response. Mitochondrial MAVS is responsible for activation of a stable 
response mediated by type I IFNs, whereas peroxisomal MAVS induces a type III IFN-
dependent antiviral response (Dixit et al., 2010; Seth et al., 2005). Peroxisomal MAVS in the 
intestinal epithelial cells is particularly crucial for IRF1-dependent activation of type III IFN 
response (Odendall et al., 2014). 
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A main difference between the type I and type III IFN systems is that receptors for type I 
IFNs are seemingly ubiquitously expressed whereas receptors for type III IFNs are confined 
mostly to the mucosal epithelium (Sommereyns et al., 2008). Thus, type III IFN response is 
mostly limited to epithelial cells due to the highly restricted expression of specific receptors. 
Recent studies show that intestinal epithelial cells (IECs) express extremely low levels of type I 
IFN receptors and thus respond poorly to type I IFNs (Mahlakoiv et al., 2015). IECs produce 
abundantly type III IFNs but poorly type I IFNs, and thus selectively respond to type III IFNs. 
The robust response of type III IFNs to invading pathogens is due to the differentiation of IECs 
and upregulation of the biogenesis of peroxisomes (Odendall et al., 2014). For antiviral defense, 
IECs in the gut mucosa mainly respond to type III IFNs after viral infection, whereas other cell 
types in the gut rely on type I IFNs (Mahlakoiv et al., 2015). In turn, viruses have evolved to 
evade the type III IFN response. Hepatitis C virus NS3-4A cleaves peroxisomal MAVS to inhibit 
the peroxisome-dependent antiviral cellular response (Ferreira et al., 2016), and flavivirus also 
impairs the peroxisomal biogenesis for suppression of type III IFNs (You et al., 2015). 
Porcine epidemic diarrhea (PED) is an acute and highly contagious enteric viral disease 
characterized by watery diarrhea, vomiting, and dehydration, resulting in the high mortality in 
neonatal piglets (Debouck and Pensaert, 1980; Song and Park, 2012; Stevenson et al., 2013). 
PED was first recognized in England in 1971 but limited mostly to some parts of Europe until 
the 1990s when it appeared in Asia. In 2010, highly virulent PED outbreaks occurred in China 
(Sun et al., 2015; Sun et al., 2012a). In the US, PED was recognized first in April 2013, and in 
the following eight months, caused more than 8 million deaths of pigs resulting in the substantial 
economic losses (Chen et al., 2014; Marthaler et al., 2013; Mole, 2013; Stevenson et al., 2013). 
The causative agent is PED virus (PEDV) which is an enveloped, positive-sense, single-strand 
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RNA virus grouped in the genus Alphacoronavirus of the family Coronaviridae in the order 
Nidovirale (http://ictvonline.org/virustaxonomy.asp). The PEDV genome is 28 kb in length and 
codes for two large polyproteins pp1a and pp1ab, an accessory protein ORF3, and four structural 
proteins: spike (S), membrane (M), envelope (E), and nucleocapsid (N) (Kocherhans et al., 2001). 
The two large polyproteins are further processed to 16 nonstructural proteins, nsp1 through 
nsp16, by the proteinase activities of nsp3 and nsp5.  
We have previously shown that PEDV inhibits the type I IFN response in cells and that 
nsp1 is the major IFN antagonist (Zhang et al., 2016). The primary target cells for PEDV, 
however, are intestinal villous epithelial cells of swine and, to some extent, macrophages 
infiltrated to the lamina propria (Debouck and Pensaert, 1980; Lee et al., 2000; Sueyoshi et al., 
1995). So thus far, no information is available whether and how PEDV modulates type III IFN 
response in intestinal epithelial cells of swine. In the present study, we developed PEDV-
susceptible porcine intestinal epithelial cells and showed in these cells that PEDV suppressed 
type III IFN production. We further demonstrated that PEDV inhibited the IRF1 activation and 
reduced the peroxisomes in number. Our findings indicate that PEDV evades the IRF1-mediated 
type III IFN response in porcine intestinal epithelial cells by reducing the number of peroxisomes, 
which is likely the key mechanism to thwart early antiviral signaling that emanates from these 
organelles.  
 
4.3 MATERIALS AND METHODS 
4.3.1 Cell culture  
Porcine kidney epithelial cells (LLC-PK1), derived from a healthy male pig of three to 
four weeks of age (Perantoni and Berman, 1979), were obtained from Dr. K. Chang (Kansas 
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State University, Manhattan, KS). LLC-PK1 was maintained in modified Eagle's medium (MEM; 
Corning Cellgro) with 5% heat-inactivated fetal bovine serum (FBS; Gibco) at 37°C in a 
humidified atmosphere of 5% CO2. African green monkey kidney epithelial cells (MARC-145; 
Kim et al., 1993) and Vero (ATCC® CCL-81TM) were grown in high-glucose Dulbecco's 
modified Eagle's medium (DMEM; Corning Cellgro) supplemented with 10% heat-inactivated 
FBS. IPEC-J2 cells were obtained from Dr. A. Blikslager (North Carolina State University,	  
Raleigh, NC). IPEC-J2 is a continuous line of epithelial cells derived from the jejunum of a 12 
hours old, colostrum-unsuckled, mixed breed piglet (Schierack et al., 2006). These cells were 
maintained in DMEM/F12 with 5% FBS supplemented with 5 mg/ml of 
insulin/selenium/transferrin (Life Technologies) and 5 ng/ml of epidermal growth factor (Life 
Technologies). IPEC-DQ, a subline of IPEC-J2 cells, was maintained in RPMI-1640 
supplemented with 10% FBS.  
 
4.3.2 Virus stocks, titration, and infection of cells  
The Colorado strain of PEDV (USA/Colorado/2013; GenBank: KF272920) was obtained 
from Agricultural Research Service, US Department of Agriculture (Ames, IA). PEDV was 
propagated in FBS-free DMEM supplemented with 0.3% tryptose phosphate broth (Sigma, St. 
Louis, MO), 0.02% yeast extract (Teknova, Hollister, CA) with different concentrations of 
trypsin 250 (Sigma-Aldrich, St. Louis, MO). LLC-PK1 and Vero cells were used for PEDV 
propagation and titration. The optimal trypsin concentrations for Vero, IPEC-J2, MARC-145, 
LLC-PK1, and IPEC-DQ cells were 5 µg/ml, 5 µg/ml, 2 µg/ml, 1 µg/ml, and 1 µg/ml, 
respectively. For the anti-PEDV activity of IFN-λ1 and IFN-λ3, cell culture supernatants were 
collected at indicated times post-infection and titrated according to the 50% tissue culture 
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infective dose (TCID50) protocol. The viral titers were calculated using the Spearman-Karber 
equation. 
 
4.3.3 Antibodies and chemicals  
The following antibodies were used for immunofluorescence assay (IFA) and Western 
blot (WB): mouse anti-PEDV N mAb (Medgene, Brookings, SD; SD-1-5, 1:1,000 dilution for 
WB, 1:200 dilution for IFA), mouse anti-β-actin mAb (C-4) (Santa Cruz; sc-47778, 1:2,000 for 
WB), rat anti-FLAG Ab (Agilent Technologies;  200474, 1:2,000 for WB, 1:200 for IFA), rabbit 
anti-IRF1 pAb (C-20) (Santa Cruz;  sc-497, 1:1,000 for WB, 1:200 for IFA), rabbit anti-PMP70 
pAb as a peroxisomal membrane marker (Novus Biologicals;  NBP187258, 1:200 for IFA), 
mouse anti-pan cytokeratin mAb (C-11) (ThermoFisher Scientific; MA5-12231, 1:50 for IFA), 
mouse anti-Sucrase-Isomaltase mAb (A-12) (Santa Cruz; sc-393424, 1:50 for IFA), and Alexa 
Fluor 594-conjugated (goat anti-rabbit) and 488-conjugated (goat anti-mouse) secondary 
antibodies (Thermo Scientific; 1:200 for IFA).  
Recombinant IL-29/IFN-λ1 protein (no. 1598IL025) and recombinant IL-28B/IFN-λ3 
protein (no. 5259IL025) were purchased from Bio-Techne (Minneapolis, MN). 
Polyinosinic:polycytidylic acid [poly(I:C)] and DAPI (4’, 6-diamidino-2-phenylindole) were 
purchased from Sigma (St. Louis, MO). QIAamp Viral RNA mini kit and RNeasy mini kit were 
purchased from QIAGEN. Power SYBR Green PCR master mix was purchased from Life 
Technologies (Carlsbad, CA). Pierce ECL Western blotting substrate, methanol, and Triton X-
100 were purchased from Thermo Scientific (Waltham, MA). The fluoromount-G mounting 
medium was purchased from Southern Biotech (Birmingham, AL).  
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4.3.4 Plasmids and transfections  
Plasmids expressing individual proteins of PEDV were constructed by cloning genes as a 
fusion with a FLAG tag under the CMV promoter as described previously (Zhang et al., 2016). 
The PEDV nsp1 mutants were made by PCR-based site-directed mutagenesis and described 
elsewhere (Zhang et al., 2017b). Expression of each viral protein was confirmed by 
immunofluorescence and Western blot analysis. Firefly luciferase-based reporter assays were 
described elsewhere (Zhang et al., 2016). The wild type IFN-λ1 luciferase reporter construct (p-
55λ1-(-225/-36)-Luc) and its mutants (p-55λ1mut.IRF-Luc, p-55λ1mut.NF-κB-Luc, and p-
55λ1mut.IRF/mut.NF-κB-Luc) were described previously (Onoguchi et al., 2007). The plasmid 
pIRF1-Luc contained multiple copies of the IRF1 cis-acting enhancer element for measurement 
of the IRF1 transcriptional activity and was purchased from Thermo Scientific (Waltham, MA). 
The Renilla luciferase plasmid pRL-TK (Promega) contained the herpes simplex virus thymidine 
kinase (HSV-tk) promoter and was included to serve as an internal control. The activated 
stimulator pMAVS was obtained from Dr. J. Shisler (University of Illinois, Urbana, IL), and 
pMDA5 and pIKKε were kindly provided by Dr. B. Gotoh (Shiga University of Medical Science, 
Shiga, Japan). The activated pIRF3 was obtained from Dr. Y. Fang (Kansas State University, 
Manhattan, KS). The constitutively activated pRIG-I and pTBK1 were provided by Dr. S. Xiao 
(Huazhong Agricultural University, Wuhan, China). Transfections were performed using 
Lipofectamine 2000 according to the manufacturer’s instructions (Invitrogen, Carlsbad, CA).   
 
4.3.5 RNA isolation and quantitative PCR  
Cells were washed once with PBS and lysed directly in cell culture dishes. Total RNA 
was isolated using the RNeasy mini kit according to the manufacturer’s instructions (QIAGEN). 
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Possible contamination of cellular DNA was removed by treatment with DNase I. One µg of 
total RNA was transcribed to cDNA using M-MLV reverse transcriptase and random primers 
(Promega). The synthesized cDNA was subjected to quantitative PCR using the SYBR Green 
PCR mix according to the manufacturer’s instructions (Life Technologies) in the ABI 7500 real-
time PCR system. The RT-qPCR primers were listed in Table 4.1. The β-actin gene was used as 
an internal control for each experiment. The specificity was confirmed by the sequencing of PCR 
products and the melting curve analysis for qPCR. The threshold cycles for target genes and the 
difference in their Ct values (ΔCt) were determined. Relative transcriptions of target genes were 
presented as fold changes relative to the respective controls using the 2−ΔΔCt threshold method 
(Livak and Schmittgen, 2001).  
 
4.3.6 Dual luciferase reporter assay  
To examine activation of the IFN-λ1 promoter and its mutants during PEDV infection, 
MARC-145 cells were grown in 24-well plates to 80% confluency and transfected with 
luciferase reporter and pRL-TK at a ratio of 1:0.1 for 6 h. Cells were then infected with PEDV at 
1 MOI for 12 h followed by stimulation with poly(I:C) for 12 h. For screening of viral 
antagonists for IFN-λ1, HeLa cells were grown in 48-well plates to 80% confluency and 
transfected with a luciferase reporter, individual viral gene, and pRL-TK at a ratio of 1:1:0.1 for 
12 h using Lipofectamine 2000. To ensure a similar protein expression level of all the viral 
proteins, the transfection was conducted as described previously (Zhang et al., 2016) and protein 
expression level was validated for each luciferase assays. Of note, three-times more plasmids 
were transfected for nsp3 and nsp16 gene to ensure the comparable level of protein expression. 
Cells were stimulated with 0.5 µg/ml of poly(I:C) for 12 h. For examination of the IFN-λ 
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singling by nsp1, cells were transfected for 24 h with luciferase reporters, individual viral gene, 
activator, and pRL-TK at a ratio of 1:1:1:0.1. Transfection was performed using Lipofectamine 
2000 according to the manufacturer's instructions (Invitrogen). For dual luciferase assay, cells 
were lysed in 50 µl of Passive lysis buffer for 20 min at room temperature (RT) with gentle 
shaking and placed on ice. Twenty µl of the cell lysates were used for dual luciferase assays 
according to the manufacturer's instructions (Promega). Luciferase values were normalized using 
Renilla as the internal control. Results were presented as the mean values of fold-changes with 
standard deviations. Data were obtained from three independent experiments each in triplicate.  
 
4.3.7 Indirect immunofluorescence assay (IFA) and confocal microscopy  
Cells were grown on coverslips placed in 12-well plates to 80% confluency for PEDV 
infection. For staining of pan Cytokeratin and Sucrase-Isomaltase, cells were fixed with 4% 
paraformaldehyde in PBS overnight at 4°C and permeabilized using 100% methanol at -20°C for 
20 min. For transfection, cells were seeded on coverslips and grown to 80% confluency. A 
transfection mix was added to cells for 4 h followed by replacement with fresh medium, and 
cells were incubated for 12  h to allow gene expression. Cells were then transfected with poly(I:C) 
for 12 h and further incubated with fresh infection medium for additional 12 h. Cells were fixed 
with 4% paraformaldehyde in PBS overnight at 4°C and permeabilized using 0.1% Triton X-100 
for 15 min at RT. Cells were incubated with 1% BSA in PBS for 30 min at RT and then with 
primary antibody for 1 h. After three washes with PBS, cells were incubated with fluorochrome-
conjugated secondary antibody in the dark for 1 h. The cell nuclei were stained with DAPI for 10 
min. The coverslips were mounted on the microscope slides using Fluoromount-G mounting 
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medium. Fluorescence was visualized using a Nikon A1R fluorescence microscope. Confocal 
microscope images were processed using NIS-Elements analysis software (Nikon). 
 
4.3.8 SDS-PAGE and Western blot analysis  
Cells were lysed at indicated times in RIPA buffer [20 mM Tris (pH 7.5), 150 mM NaCl, 
1 mM EDTA, 1 mM phenylmethane sulfonyl fluoride (PMSF), 0.1% SDS, 0.5% sodium 
deoxycholate, 1% NP-40] containing the proteinase inhibitors cocktail (Promega) on ice for 30 
min. The cell lysates were then sonicated and centrifuged at 4°C at 12,000 rpm (Eppendorf, 
5415R) for 10 min to remove insoluble components. Protein concentrations were determined 
using the Pierce BCA protein assay kit (Thermo Scientific). Proteins were resolved by SDS-
PAGE and transferred onto an Immobilon-P membrane (Millipore). The membranes were 
blocked with 5% nonfat dry milk in TBST for 1 h and incubated with primary antibody at 4°C 
overnight. The membranes were then incubated with horseradish peroxidase (HRP)-conjugated 
secondary antibody for 1 h at RT. Proteins were visualized by enhanced chemiluminescence 
detection reagents (Thermo), and images were obtained by FluorChem™ R System according to 
the manufacturer’s instructions (ProteinSimple). 
 
4.3.9 Statistical analysis  
Statistical analyses were conducted using GraphPad Prism 6 for ANOVA analyses. 
Asterisks indicate the statistical significance.  *, P<0.05, **, P<0.01, and ***, P<0.001.  
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4.4 RESULTS 
4.4.1 Porcine intestinal epithelial cells (IPEC-DQ) and infection of PEDV  
Vero cells are widely used for PEDV isolation and propagation (Hofmann and Wyler, 
1988; Kusanagi et al., 1992), and ST and PK-15 cells also support PEDV replication (Liu et al., 
2015). We have reported MARC-145 (a subline of MA-104 African green monkey kidney cells) 
as an alternative cell line permissive for PEDV infection (Zhang et al., 2016). Due to the 
different degree of cytotoxicity to transfection and variable efficiencies for infection of PEDV, 
different cell types were used for different experiments. However, the primary target cells for 
PEDV in pigs are villous epithelial cells of the intestinal tract (Debouck and Pensaert, 1980; Lee 
et al., 2000; Sueyoshi et al., 1995). Thus, Vero, MARC-145, LLC-PK1, and ST cells may be less 
suitable to study for cell-virus interactions especially innate immunity in the intestinal epithelia 
and needed to be validated in a porcine intestinal epithelial cell model. IPEC-J2 is the line of 
porcine intestinal epithelial cells established from the jejunum of a colostrum-deprived neonatal 
pig at 12 h of age. Some researchers reported that IPEC-J2 cells were susceptible to PEDV (Guo 
et al., 2016; Zhao et al., 2014). However, we and others found that these cells were not 
susceptible to PEDV (Zhang and Yoo, 2016; Personal communications with D. Diel at South 
Dakota State University and M. Torremorell at University of Minnesota). IPEC-J2 cells were 
non-homogeneous, and as shown by IFA, only a few number of cells were shown to be PEDV-
positive. We subcloned IPEC-J2 cells by limited serial dilutions and were able to obtain a 
homogeneous subclone of cells, designated IPEC-DQ. These cells were examined first for their 
characteristics. Cytokeratin is the intracytoplasmic cytoskeleton protein of epithelial tissues, and 
the pan cytokeratin mAb staining showed the abundant expression of cytokeratins in IPEC-DQ 
as in LLC-PK1 and IPEC-J2, (Fig. 4.1A). Sucrase-isomaltase is a transmembrane glycoprotein 
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located in the brush border of the small intestine, and IPEC-DQ cells, as well as IPEC-J2, 
showed the expression of Sucrase-isomaltase, whereas it was absent in the LLC-PK1 kidney 
epithelial cells. The growth kinetics of IPEC-DQ cells was similar to that of IPEC-J2 cells with 
the same doubling time of approximately 53 h (data not shown). Based on these data, we 
concluded that IPEC-DQ retained the porcine intestinal epithelial phenotype. For examination of 
the susceptibility of IPEC-DQ for PEDV, cells were infected, and at 24 h postinfection, IFA and 
Western blot were conducted using viral specific antibody. Specific fluorescence was observed 
in PEDV-infected IPEC-DQ cells, indicating the efficient replication of PEDV in these cells. In 
contrast, IPEC-J2 cells did not show any PEDV-specific fluorescence even at an MOI of 5 (Fig. 
4.1B). Western blot analysis further confirmed the efficient and productive infection of PEDV in 
IPEC-DQ cells (Fig. 4.1C).  
Recent studies suggest that IFN induction and signaling in the intestinal epithelial cells 
are unique, and type III IFNs play a key role maintaining the antiviral state in the gut (Mahlakoiv 
et al., 2015; Nice et al., 2015; Pott et al., 2011). Intestinal epithelial cells express the high level 
of IFN-λ but not IFN-α/β upon poly(I:C) stimulation or enteric viral infections (Mahlakoiv et al., 
2015). Thus to examine whether IPEC-DQ cells also produced IFN-λ selectively, the induction 
levels for different types of IFNs were determined after stimulation with poly(I:C). More than 
1,700-folds increase of IFN-λ3 was observed in IPEC-DQ cells compared to IFN-α (Fig. 4.1D), 
suggesting that IPEC-DQ cells produced type III IFNs efficiently. These results showed that 
IPEC-DQ cells supported PEDV infection and induced the production of type III IFNs, 
demonstrating IPEC-DQ as a suitable cell model for the study of innate immune modulation by 
PEDV in the gut.   
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4.4.2 Antiviral activities of type III IFNs against PEDV 
For examination of the antiviral activities of type III IFNs against PEDV infection, cells 
were primed for 12 h with either IFN-λ1 or IFN-λ3 and inoculated with PEDV. Cells were 
washed once and were replenished with fresh infection medium containing respective IFN-λ. 
Cell culture supernatants were collected at 12 h, 18 h, 24 h, 36 h, and 48 h postinfection and viral 
titers were determined. The PEDV titers were reduced by IFN-λ1 and IFN-λ3 over time, 
indicating that these IFNs inhibited PEDV production (Fig. 4.2A). IFN-λ3 had a stronger 
antiviral activity against PEDV than IFN-λ1. For evaluation of whether this IFN-λ-mediated 
antiviral activity was dose-dependent, cells were pretreated with 10, 100, and 1000 ng/ml of 
IFN-λ1 or IFN-λ3 for 12 h, and were then infected with PEDV for 24 h in the presence of 
respective IFN. The treatment of cells with IFN-λ inhibited PEDV infection in a dose-dependent 
manner, being the higher concentration of IFN-λ the stronger inhibition of PEDV replication (Fig. 
4.2B). The immunofluorescence signal for PEDV N protein was decreased relative to the 
increase of IFN-λ1 and IFN-λ3 (Fig. 4.2C), further confirming that type III IFNs restricted 
PEDV infection in a dose-dependent manner. The anti-PEDV activity of type III IFNs was 
examined in three different treatment conditions.  Cells were treated with IFN-λ1 or IFN-λ3 at 
100 ng/ml for 12 h before, at the time, or after PEDV inoculation, and the culture supernatants 
were collected at 24 h postinfection for viral titration. Both IFN-λ1 and IFN-λ3 inhibited PEDV 
replication at comparable levels regardless of different treatment conditions, being the highest 
inhibition by treatment before infection (Fig. 4.2D). RT-qPCR was conducted for PEDV N gene 
expression, and both IFN-λ1 and IFN-λ3 reduced the amount of N mRNA in a dose-dependent 
manner (Fig. 4.2E) and in all three conditions (Fig. 4.2F). These data confirm that type III IFNs 
possess productive anti-PEDV activities.  
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4.4.3 Inhibition of type III IFN production by PEDV 
Type III IFNs play a critical role to maintain the antiviral state of the epithelium in the 
gut (Mahlakoiv et al., 2015; Nice et al., 2015; Pott et al., 2011). We have also shown that they 
inhibit PEDV infection (Fig. 4.2). Thus we hypothesized that PEDV might have evolved to 
modulate the type III IFN response of the host.  To investigate this possibility, we first assessed 
the expression of type III IFNs in PEDV-infected IPEC-DQ cells. Cells were inoculated with 
PEDV at an MOI of 5, and cell lysates were harvested at various times postinfection for RT-
qPCR. Transfection with poly(I:C) was used as a positive control, and the poly(I:C) stimulation 
induced the strong production of all subtypes of IFN-λ (IFN-λ1, IFN-λ3, and IFN-λ4), with the 
highest production for IFN-λ3 (Figs. 4.3A, 4.3B, and 4.3C). Infection of IPEC-DQ cells with 
PEDV caused slight induction of all subtypes of IFN-λ at 3 hpi but quickly downregulated their 
induction at 9 hpi and 12 hpi. We also evaluated the type III IFN induction in LLC-PK1 cells. At 
the MOI of 0.01, no apparent induction was observed throughout the observation period. 
Transcripts for each subtype of IFN-λ were also negligible at 12-24 hpi (data not shown). At the 
high MOI of 5, type III IFNs were still not inducible, and the levels of respective mRNAs were 
negligible (data not shown), suggesting the suppression of type III IFN responses by PEDV was 
not cell type-dependent. For examination of whether PEDV could induce the activation of type 
III IFN at any time of infection, cells were transfected with the IFN-λ1 luciferase reporter and 
inoculated with PEDV to determine the viral regulation of reporter activity. The IFN-λ1 
promoter-driven luciferase activity was barely detectable in PEDV-infected cells compared to 
the intense activity in poly(I:C)-stimulated cells (Fig. 4.3D), suggesting that PEDV infection 
failed to induce IFN-λ1 expression. 
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The observation that PEDV did not induce the type III IFN response indicated that PEDV 
had an ability to suppress type III IFN response during infection. For this possibility, IFN-λ1 
reporter assays were performed in PEDV-infected cells. Cells were transfected with the 
luciferase reporter and inoculated with PEDV, followed by stimulation with poly(I:C). Treatment 
of mock-infected cells with poly(I:C) upregulated the IFN-λ1 promoter activity up to 125 folds. 
In sharp contrast, the IFN-λ1 activity in PEDV-infected cells was significantly suppressed even 
after stimulation with poly(I:C) (Fig. 4.3E), suggesting the virus-mediated suppression of type III 
IFN response. For confirmation of the IFN-λ suppression by PEDV, RT-qPCR for IFN-λ 
transcripts was conducted in cells infected with the virus and stimulated with poly(I:C). The 
poly(I:C) stimulation upregulated the expression of IFN-λ1, IFN-λ3, and IFN-λ4 in mock-
infected cells as anticipated, however, PEDV infection significantly inhibited their expressions 
(Figs. 4.3F, 4.3G, and 4.3H), confirming the suppression of type III IFN response by PEDV.  
 
4.4.4 Identification of type III IFN antagonists of PEDV 
For identification of the type III IFN viral antagonists, individual proteins of PEDV were 
examined for IFN-λ suppression by reporter assays. The expression levels of individually cloned 
viral protein were first examined by Western blot (Fig. 4.4A) using anti-FLAG antibody as 
described previously (Zhang et al., 2016). All genes were expressed well as anticipated. The 
poly(I:C) stimulation upregulated the IFN-λ1 transcription in cells expressing GST or empty-
vector transfected cells as expected, indicating that cells typically recognize dsRNA and activate 
the IFN-λ1 promoter. Of the nsps, nsp1, nsp3, nsp5, nsp8, nsp14, nsp15, and nsp16 were shown 
to downregulate the IFN-λ1 promoter activity (Fig. 4.4B), and the accessory protein ORF3 also 
inhibited the IFN-λ1 activity. Of the structural proteins, E, M, and N were identified as type III 
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IFN antagonists (Fig. 4.4C).  
Among the type III IFN antagonists, nsp1 appeared to be one of the most potent 
suppressor (Fig. 4.4B). We examined whether the suppression of IFN-λ1 activity by nsp1 was 
dose-dependent. Cells were co-transfected with p-55λ1-(-225/-36)-Luc and increasing amounts 
of nsp1 gene, and luciferase assays were performed. The luciferase activities decreased when the 
amounts of nsp1 increased (Fig. 4.4D), indicating that PEDV nsp1-mediated IFN-λ1 inhibition 
was dose-dependent. To further confirm the suppression of type III IFN expression by nsp1, RT-
qPCR was conducted for mRNA quantification. While poly(I:C) alone upregulated the IFN-λ1, 
IFN-λ3, and IFN-λ4 expression, nsp1 inhibited their expressions significantly (Figs. 4.4E, 4.4F, 
and 4.4G). Taking together, these data demonstrate that PEDV encodes multiple antagonists for 
suppression of type III IFN, and nsp1 is the most potent antagonist. 
 
4.4.5 Suppression of type III IFN production mediated by the interference of IRF and NF-
κB  
Expression of IFN-λ is dependent on the activation of the transcriptional factors IRF1, 
IRF3, IRF7, or NF-κB. A cluster of the IRF-binding and NF-κB-binding sites has been identified 
as the cis-acting elements for IFN-λ expression (Onoguchi et al., 2007). For determination of the 
transcription factors required for PEDV-mediated IFN-λ1 inhibition, a series of promoter 
mutants was used for reporter assays. The wild type reporter p-55λ1-(-225/-36)-Luc contains the 
binding sites for both IRF and NF-κB for IFN-λ1 expression. The reporter mutants p-
55λ1mut.IRF-Luc, p-55λ1mut.NF-κB-Luc, and p-55λ1mut.IRF/mut.NF-κB-Luc contain the 
binding-site mutation for IRF, NF-κB, and both IRF and NF-κB, respectively. Cells were 
transfected with individual reporter mutants and infected with PEDV, followed by stimulation 
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with poly(I:C) and determination of the luciferase activities. Although the mutation of the IRF-
binding or NF-κB binding abrogated the IFN-λ1 activation compared to the activity by wild-type 
promoter (Fig. 4.3E), the mutants still retained the ability to activate IFN-λ1 when stimulated 
with poly(I:C) (Fig. 4.5A). PEDV infection, however, suppressed the luciferase activity of the 
mutants. These results indicate that both IRF and NF-κB are involved in the PEDV-mediated 
IFN-λ suppression. Expression of type III IFNs in the intestinal epithelial cells is mainly 
dependent on IRF1 activation, whereas IRF3 and IRF7 play a minimal role (Odendall et al., 
2014). We thus examined whether the PEDV suppression of type III IFN response was due to the 
IRF1 interference. Poly(I:C) stimulation of cells upregulated the IRF1 activity as anticipated. In 
virus-infected cells, however, IRF1 activity was significantly inhibited (Fig. 4.5B).  
To determine if other viral antagonists for IFN-λ also suppressed the IRF1 activity, 
reporter assays were conducted. A strong luciferase activity was observed in cells transfected 
with the empty vector or in the GST-expressing cells as anticipated when stimulated with 
poly(I:C) (Fig. 4.5C). In contrast, the IRF1 activity was suppressed by nsp3, nsp5, nsp14, nsp15, 
nsp16, ORF3, E, and M in addition to nsp1 even after poly(I:C) stimulation. Of the total of 11 
viral IFN-λ antagonists, nsp8 and N did not inhibit the IRF1 activity, suggesting that these two 
proteins may function through other pathways than the IRF1-mediated pathway. Nsp1 was also 
examined for its ability for suppression of IRF-mediated and NF-κB-mediated IFN-λ1 responses. 
Indeed, PEDV nsp1 suppressed the activities of the IFN-λ1 promoter mutants (Fig. 4.5D), 
indicating that nsp1 inhibited type III IFNs by suppressing both IRF1 and NF-κB.  
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 4.4.6 Inhibition of RIG-I/MDA5 and suppression of IRF1  
Since PEDV nsp1 appeared to be a potent suppressor for type III IFNs and inhibited the 
IRF1 activity, the IRF3 and IRF1 signaling pathways were examined. We first determined the 
IRF3 signaling. IRF3-mediated type III IFN signaling is activated when transfected with a 
constitutively activated adaptor protein. Cells were co-transfected with p-55λ1-(-225/-36)-Luc, 
PEDV nsp1 gene, and a plasmid expressing activated RIG-I, MDA5, MAVS, TBK1, IKKε, or 
IRF3 along with the pRL-TK internal control, and reporters were determined. The transfection of 
these active molecules significantly upregulated the IFN-λ1 promoter activities (Fig. 4.6A-4.6E). 
In contrast, these activities were suppressed when PEDV nsp1 was expressed. These results 
indicated that PEDV nsp1 possessed the ability to suppress IRF3-dependent type III IFN 
expression. PEDV nsp1 also inhibited the IFN-λ1 promoter activated by IRF3 (Fig. 4.6F), which 
suggests that IRF3-mediated type III IFN suppression might be a nuclear event.  
PEDV nsp1 has been found to degrade the CREB-binding protein (CBP) in the nucleus, 
resulting in the suppression of type I IFN production (Zhang et al., 2016). The IRF3-mediated 
type III IFN production also relies on the enhanceosome formation (Odendall et al., 2014) and 
thus the CBP degradation by nsp1 in the nucleus may also affect type III IFN suppression. 
However, IRF1-mediated type III IFN induction can be independent of the enhanceosome 
assembly (Thomson et al., 2009). We thus investigated whether PEDV nsp1 inhibited the RIG-
I/MDA5-mediated IRF1 activation. Transfection with an activated form of RIG-I or MDA5 was 
found to upregulate the IRF1 activity, and PEDV nsp1 suppressed this activity (Figs. 4.6G-4.6H). 
The overexpression of MAVS also upregulated the IRF1 activity, but PEDV nsp1 suppressed the 
IRF1 activity (Fig. 4.6I). Since MAVS in the peroxisomes is crucial for activation of IRF1-
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mediated IFN-λ production (Odendall et al., 2014), our finding suggests that the suppression of 
IRF1-mediated type III IFN production occurs downstream of the MAVS activation.  
 
4.4.7 Inhibition of IRF1 nuclear translocation by PEDV and nsp1  
To investigate the basis of inhibition of IRF1-mediated type III IFN response by PEDV, 
the expression kinetics of IRF1 was examined in virus-infected cells. IPEC-DQ cells were 
infected with PEDV at an MOI of 5, and Western blot was conducted to investigate IRF1 
expression at different times. The expression of PEDV N protein indicated the productive 
infection. The expression level of IRF1 was not altered by PEDV infection (Fig. 4.7A). The 
IRF1 protein contains a functional nuclear localization signal (NLS) located immediately 
downstream of the DNA-binding domain and is usually hidden to result IRF1 diffusely 
distributed in the cytoplasm. When stimulated, IRF1 is instantly activated and translocates to the 
nucleus (Lau et al., 2000). To examine whether PEDV blocked the IRF1 nuclear translocation, 
IPEC-DQ cells were infected with PEDV for 12 h and stimulated with poly(I:C), followed by 
antibody staining for IRF1. IRF1 became translocated to the nucleus when stimulated by 
poly(I:C) (Fig. 4.7B, second panel, yellow arrow). Similarly in PEDV-infected cells, IRF1 
remained in the cytoplasm (Fig. 4.7B, third panel), indicating that PEDV infection failed to 
activate IRF1 nuclear translocation. Furthermore, IRF1 in virus-infected cells remained in the 
cytoplasm even after poly(I:C) stimulation (Fig. 4.7B, bottom panel, white arrow), indicating 
that the IRF suppression by PEDV was a cytoplasmic event. In IPEC-DQ cells, IRF1 was 
typically diffused throughout the cell, but poly(I:C) stimulation rendered IRF1 to the nucleus 
(Fig. 4.7C, second panel, yellow arrow). The IRF1 expression and its cellular distribution, 
however, were not altered in nsp1-expressing cells (Fig. 4.7C, third panel), and when nsp1-
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expressing cells were stimulated, IRF1 in the nucleus was significantly reduced (Fig. 4.7C, 
bottom panel, white arrow). This data suggests that the IRF1-mediated type III IFN antagonism 
by nsp1 occurred upstream of the IRF1 activation. 
 
4.4.8 Reduction of peroxisomes in number in PEDV-infected cells 
MAVS localizes in the mitochondria and peroxisomes for a coordinated activation of 
effective innate immune responses (Dixit et al., 2010; Seth et al., 2005). The mitochondrial and 
peroxisomal MAVS pathways result in different but complementing responses: mitochondrial 
MAVS is associated with the activation of a stable response with delayed kinetics (type I IFN-
dependent), while peroxisomal MAVS is responsible for a rapid but short-lived antiviral 
response (type III IFN-dependent) (Dixit et al., 2010). The peroxisomal MAVS in the intestinal 
epithelial cells preferentially triggers the IRF1-mediated expression of IFN-λ genes (Odendall et 
al., 2014). Differentiation of intestinal epithelial cells upregulates the biogenesis of peroxisomes 
and promotes robust type III IFN response to invading pathogens, and thus adequate numbers of 
peroxisome-associated MAVS are essential for type III IFN response. For examination of the 
peroxisomes in PEDV-infected cells, IPEC-DQ, LLC-PK1, and MARC-145 cells were infected 
with the virus, and the numbers and morphologies of peroxisomes were examined. The PMP70 
peroxisomal membrane protein is one of the major components of the peroxisomal membrane 
and indicates the proliferation of peroxisomes (Imanaka et al., 2000), thus is used as a 
peroxisomal marker. In mock-infected cells, peroxisomes were abundantly distributed 
throughout the cytoplasm (Fig. 4.8A). In contrast, much less number of peroxisomes was 
observed in PEDV-infected MARC-145, LLC-PK1, and IPEC-DQ cells. One hundred fifty 
PEDV-infected cells were randomly chosen, and the average number of peroxisomes per cell 
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was calculated. The results showed 30-50% reduction of peroxisomes in PEDV-infected cells 
(Fig. 4.8B). This study indicates that PEDV reduces the peroxisomes in number in PEDV-
infected cells. 
 
4.4.9 Conserved residues of nsp1 are crucial for reduction of peroxisomes and IRF1-
mediated IFN-λ suppression 
Since PEDV nsp1 inhibited IRF1 by activated MAVS (Fig. 4.6I), nsp1 might be the 
protein reducing the number of peroxisomes. To investigate this, IPEC-DQ cells were transfected 
with nsp1 gene or its mutants and stained for PMP70. The peroxisomes were abundant and 
normally distributed throughout the cytoplasm in control cells (Fig. 4.9A, top panel), whereas in 
nsp1-expressing cells, the number of peroxisomes decreased (Fig. 4.9A, second panel). 
Previously, we determined the predicted tertiary structure of nsp1 and reported that the 
conserved residues were critical for NF-κB regulation (Zhang et al., 2017b). The cellular 
distribution of nsp1 mutants in IPEC-DQ cells was consistent in HeLa cells (Fig. 4.9A). The 
mutant K70A was normally distributed and retained its ability to reduce the peroxisomes in 
number (Fig. 4.9A, third panel). The deletion mutant Δ37-51 was localized in the cytoplasm and 
also reduced the peroxisomes in number (Fig. 4.9A, fifth panel). The perinuclear mutant 
N93A/N95A (Fig. 4.9A, fourth panel) and other mutants G38A/F39A, F44A, G87A, 
L98A/E99A/E100A, and Δ37-75 showed punctate patterns in the nucleus and did not interfere 
the peroxisomes in number (Fig. 4.9A, sixth-tenth panel). The numbers of peroxisomes were 
quantified in nsp1- and mutant nsp1-expressing cells and the data indicate that the conserved 
residues of nsp1 were crucial for the reduction of peroxisomes in number (Fig. 4.9B).  
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To further identify the residues for	   nsp1-mediated IFN-λ suppression, reporter assays 
were conducted using the IFN-λ1 and IRF1 luciferase constructs. Cells were co-transfected with 
individual nsp1 constructs along with p-55λ1-(-225/-36)-Luc or pIRF1-Luc and then stimulated 
with poly(I:C) for reporter assays. The nsp1 and its mutants exhibited comparable expression 
levels (Fig. 4.9C). Among the nsp1 mutants, T68A, K70A, T68A/K70A, and L101A appeared to 
inhibit the IFN-λ1 expression (Fig. 4.9D). The deletion mutant Δ37-51 localized in the 
cytoplasm but retained the IFN-λ1 suppression activity, which confirms that the suppression of 
type III IFNs by nsp1 is a cytosolic event. The cellular distribution of N93A/N95A was mostly 
perinuclear and reverted the suppression of type III IFNs. The cellular distributions of 
G38A/F39A, F44A, G87A, L98A/E99A/E100A, and Δ37-75 were punctate in the nucleus and 
their activity for suppression of type III IFNs was significantly reverted (Fig. 4.9D), suggesting 
that the highly conserved residues of nsp1 were crucial for IFN-λ suppression. Furthermore, 
G38A/F39A, F44A, G87A, N93A/N95A, L98A/E99A/E100A, and Δ37-75 reverted their IRF1 
suppression activities (Fig. 4.9E), suggesting that the mutated amino acid residues were crucial 
for the IRF1-mediated suppression of type III IFN production.  
 
4.5 DISCUSSION 
Antiviral responses are primarily mediated by type I IFNs (IFN-α/β), leading to 
expression of hundreds of ISGs for the establishment of an antiviral state. Recent evidence, 
however, shows that type III IFNs play a critical role in innate antiviral immunity in the 
intestinal epithelial cells in the gut. Peroxisomes are the signaling platforms for innate antiviral 
activity, and the peroxisomal MAVS triggers type III IFN production for rapid ISG expression 
independent of type I IFNs (Dixit et al., 2010). The peroxisomal MAVS is essential for IRF1-
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mediated type III IFN response (Odendall et al., 2014), which plays a pivotal role in restricting 
viral infections in the epithelial cells at the mucosal surfaces (Lazear et al., 2015). PEDV is an 
enteric virus causing severe diarrhea in pigs, but virtually no information is available as to 
whether and how the virus modulates the type III IFN response in the intestinal epithelial cells. 
In the present study, we have first developed a subline of porcine intestinal epithelial cells 
(IPEC-DQ). These cells confer the productive infection of PEDV and serve as an excellent cell 
model for porcine enteric viruses. The IFN-λ proteins can inhibit PEDV replication in a dose-
dependent manner, and thus they are potent antiviral cytokines. In turn, PEDV inhibits type III 
IFN production, and the inhibition is mediated by interfering IRF and NF-κB. PEDV reduces the 
number of peroxisomes for suppression of IRF1-mediated type III IFN production. The 
conserved residues of PEDV nsp1 appear to be crucial for the reduction of peroxisomes in 
number and thus the suppression of IRF1-mediated type III IFNs. 
For humans, type III IFNs constitute four subtypes: IFN-λ1 (interleukin 29 [IL-29]), IFN-
λ2 (IL-28A), IFN-λ3 (IL-28B), and IFN-λ4 (Hermant and Michiels, 2014; Kotenko et al., 2003; 
Prokunina-Olsson et al., 2013; Sheppard et al., 2003). For swine, IFN-λ1 and IFN-λ3 have 
previously been described (Sang et al., 2010), and in the present study, we have identified the 
IFN-λ4 gene expression in porcine intestinal cells by RT-qPCR (Fig. 4.3C), implicating the 
importance of the type III IFN system for swine as well. We have not been able to identify IFN-
λ2 in IPEC-DQ cells. The antiviral function of type III IFNs was initially thought to be 
analogous to that of type I IFNs when they were discovered. It appears, however, that type III 
IFNs mainly exerts the antiviral activity in the epithelial cells at the mucosal surfaces via 
induction of ISGs by activating JAK-STAT signaling pathway (Lazear et al., 2015). To activate 
the JAK-STAT pathway, type I IFNs signal through a heterodimeric IFNAR receptor consisting 
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of IFNAR1 and IFNAR2, whereas type III IFNs signal through a distinct heterodimer of IFNLR 
receptor of IFNLR1 and IL10R2. The IL-10R2 is widely distributed in different cell types, 
whereas IFNRL1 is mostly restricted to epithelial cells (Sommereyns et al., 2008), which renders 
type III IFNs selectively exert their antiviral functions to epithelial cells. The receptors for type I 
IFNs are expressed in all nucleated cells. However, their expressions are minimal in IECs and 
thus type I IFNs fail to protect these cells from enteric viral infections (Mahlakoiv et al., 2015). 
The gut mucosa is equipped with the compartmentalized IFN system in which the intestinal 
epithelial cells mainly respond to type III IFNs that are produced after viral infection, whereas 
other cells mostly rely on type I IFNs for antiviral defense (Mahlakoiv et al., 2015). The cell 
tropism of enteric viruses determines the potency of antiviral activity of the different type of 
IFNs in the gut. Rotavirus mainly infects IECs (Lopez and Arias, 2006), and thus the infection is 
controlled exclusively by type III IFNs (Angel et al., 1999; Pott et al., 2011). Reovirus replicates 
in both epithelial and non-epithelial cells (Forrest and Dermody, 2003), and thus type I and type 
III IFNs cooperatively control the reovirus infection such that type III IFNs restrict the infection 
in epithelial cells whereas type I IFNs exert the antiviral activity in non-epithelial cells 
(Mahlakoiv et al., 2015). The recombinant swine type III IFNs have been shown to restrict the 
PEDV infection in both Vero and IPEC-J2 cells (Li et al., 2017a; Shen et al., 2016). We have 
also shown that type III IFNs restrict the PEDV infection in a dose-dependent manner (Fig. 
4.2B), which further confirms the strong anti-PEDV activities of type III IFNs. The swine type 
III IFNs also have greater antiviral activities against PEDV than IFN-α, which is probably since 
type III IFNs can induce differential and more potent ISG expressions than IFN-α in intestinal 
epithelial cells (Li et al., 2017a). In our study, IFN-λ3 restricts PEDV infection more efficiently 
than IFN-λ1 (Fig. 4.2A), which is consistent with the previous finding that IFN-λ3 exhibits a 
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more potent antiviral activity than IFN-λ1 (Li et al., 2017a; Palma-Ocampo et al., 2015). The 
potent antiviral activities of type III IFNs indicate therapeutic applications of these cytokines to 
enteric viral infections.   
Type III IFNs exhibit potent antiviral activities against many viruses, in particular for 
viruses infecting the epithelial cells of the respiratory, blood brain barrier, liver, urogenital tracts, 
and gastrointestinal tracts (Lazear et al., 2015). Given the potent antiviral activity of type III 
IFNs, viruses have evolved to encode viral antagonists for evasion from type III IFN responses. 
The treatment with recombinant IFN-λ1 inhibits the replication of foot and mouth disease virus 
(FMDV), and in turn, FMDV has evolved to interrupt the antiviral function of IFN-λ1 (Wang et 
al., 2011). FMDV infection does not induce type III IFNs, and several viral antagonists have 
been identified to inhibit the IFN-λ1 expression (Wang et al., 2011). Among them, the leader 
proteinase Lpro is the most potent viral antagonist and disrupts the activation of IRF and NF-κB. 
The catalytic activity of the proteinase and the SAP (SAF-A/B, Acinus, and PIAS) domain are 
crucial for the Lpro-mediated IFN-λ1 suppression (Wang et al., 2011). The Yaba-like disease 
virus (YLDV) is a primate pox virus that exclusively infects the skin. The secreted glycoprotein 
Y136 of YLDV binds to IFN-α/β for inhibition of IFNAR signaling and also binds to type III 
IFNs to inhibit the antiviral response (Bandi et al., 2010; Huang et al., 2007). Similarly, we have 
described that PEDV suppresses the type III IFN response, suggesting a potential therapeutic 
application of type III IFNs to treatment and prevention of PED. PEDV codes for many 
antagonists for type I IFN antagonists (Zhang et al., 2016). Due to the similar induction and 
signaling pathways between the type I and type III IFNs, PEDV may take similar evasion 
strategies. Indeed, many of the type III IFN antagonists also suppress the type I IFN production 
(Fig. 4.4B-C), suggesting the common mechanisms between IFN-α/β and IFN-λs. The type I IFN 
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antagonists of PEDV inhibit the IRF3-mediated and the NF-κB-mediated pathways (Ding et al., 
2014; Xing et al., 2013; Zhang et al., 2016), and we have shown here that PEDV also inhibits the 
IFN-λ expression by interfering IRF1 and NF-κB (Fig. 4.5A). PEDV nsp1 suppresses the IRF3-
mediated type I IFN production by degrading CREB-binding protein in the nucleus (Zhang et al., 
2016), and also inhibits IRF3-mediated IFN-λ1 activation (Fig. 4.6A-F). These findings suggest 
that the nsp1-mediated CBP degradation in the nucleus may also result in the suppression of type 
III IFN response. 
Similar to type I IFNs, type III IFNs also require IRF3, IRF7, and NF-κB for induction 
(Onoguchi et al., 2007; Sommereyns et al., 2008). However, the induction of type III IFNs does 
not need all the components of enhanceosome (Thomson et al., 2009). Epithelial cells 
preferentially induce the production of IFN-λ to IFN-α/β. Viruses thus may selectively cause the 
type III IFN production. Hepatitis B virus (HBV) infection of hepatocytes induces the production 
of IFN-λ, but not IFN-α/β (Sato et al., 2015). Hepatitis C virus (HCV) infection also 
preferentially induces the production of IFN-λ to IFN-α/β (Park et al., 2012). We have found that 
the induction of type III IFNs in IPEC-DQ cells is much more potent than that of type I IFNs 
(Fig. 4.1D), which confirms that intestinal epithelial cells abundantly induce type III IFNs upon 
stimulation. It may be due to the relative abundance of peroxisomes in the intestinal epithelial 
cells. The activation of mitochondrial MAVS induces the type I IFN production, whereas the 
activation of peroxisomal MAVS predominantly induces the IFN-λ production (Odendall et al., 
2014). IRF1 is the first identified IRF but does not induce the production of type I IFNs (Reis et 
al., 1994). IRF1 is also an ISG which is a prominent antiviral effector against many viruses 
(Schoggins and Rice, 2011). IRF1 can be induced by viral infections and translocates to the 
nucleus to activate the antiviral response (Li et al., 2015). The porcine IRF1 does not induce type 
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I IFN production but inhibits the replication of swine viruses, including swine influenza virus, 
pseudorabies virus, and transmissible gastroenteritis virus (Li et al., 2015). IRF1 is dispensable 
for type I IFN production but plays a crucial role in regulating MAVS-dependent signaling of 
peroxisomes for type III IFNs (Dixit et al., 2010; Odendall et al., 2014). Peroxisomes are the 
signaling platforms for the IRF1-dependent IFN-λ production. The differentiation process of 
IECs upregulates the biogenesis of peroxisomes for the robust response of type III IFNs 
(Odendall et al., 2014), which highlights the importance of type III IFNs for the innate antiviral 
state in the intestinal epithelial cells. Viruses may target the IRF1 activation, peroxisomal MAVS 
activation, or peroxisomal biogenesis for suppression of type III IFNs. Hepatitis C virus (HCV) 
NS3-4A can traffic and localize in the peroxisomes and specifically cleaves the peroxisomal 
MAVS and releases it into the cytosol (Ferreira et al., 2016). This action is intense to inhibit the 
peroxisome-dependent antiviral response and dampens the type III IFN responses. In flavivirus-
infected cells, the peroxisomes are reduced in number and redistributed, resulting in the 
suppression of type III IFNs (You et al., 2015). Capsid proteins of West Nile virus (WNV) and 
Dengue virus (DENV) bind to the Pex19 peroxisome biogenesis factor and impair the biogenesis 
of peroxisomes. The level of the peroxisomal matrix enzyme is also reduced in infected cells 
(You et al., 2015). PEDV also decreases the number of peroxisomes for evasion of IRF1-
mediated type III IFN response in intestinal epithelial cells (Fig. 4.8). This finding suggests that 
the targeting of peroxisomes is likely a key strategy for viral evasion from type III IFN responses. 
PEDV nsp1 blocks the IRF1 nuclear localization (Fig. 4.7C) and impairs the biogenesis of 
peroxisomes (Fig. 4.9A), indicating that targeting the peroxisome biogenesis is crucial for nsp1-
mediated type III IFN response. The conserved residues are essential for nsp1-mediated 
suppression of NF-κB (Zhang et al., 2017b), IFN-λ (Fig. 4.9D), and IRF (Fig. 4.9E), which 
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suggests that the conserved structures are crucial for nsp1-mediated innate immune evasion for 
PEDV.  
Peroxisomes are intracellular organelles that play a central role in regulating various 
metabolic activities in mammalian cells. They act in concert with mitochondria to control the 
metabolism of lipids and reactive oxygen species. Most RNA viruses replicate in the cellular 
membrane organelles or rely on them for entry and assembly. Coronaviruses and arteriviruses 
replicate in the double membrane vesicles (DMVs) and are assembled and released through the 
membrane trafficking, which is associated with the endoplasmic reticulum (ER) and Golgi 
complex. Despite the absence of evidence indicating that mammalian viruses replicate in the 
peroxisomes, some viruses interact with the peroxisomes. The influenza virus NS1 protein has 
been shown to bind to the peroxisomal enzyme 17-β-hydroxysteroid dehydrogenase (Wolff et al., 
1996), which may alter the peroxisome-specific lipid metabolism for viral replication (Tanner et 
al., 2014). The rotavirus spike protein VP4 contains peroxisome-targeting sequences, which may 
also associate with lipid metabolism or cholesterol formation for viral infectivity (Lazarow, 
2011). The HIV Nef protein interacts with thioesterase, which is the peroxisomal matrix protein 
(Liu et al., 1997; Watanabe et al., 1997). This interaction is associated with the downregulating 
of CD4 in HIV-infected cells (Cohen et al., 2000; Liu et al., 2000). The interactions between 
viruses and peroxisomes may dampen the innate antiviral signaling of the peroxisomes. In our 
study, PEDV and nsp1 reduce the number of peroxisomes for suppression of type III IFN 
production. PEDV replication and the nsp1 protein may impair the biogenesis of peroxisomes by 
direct interaction with essential peroxisome biogenesis factors, such as Pex19. It is also possible 
that PEDV and nsp1 protein trigger the disassembly of peroxisomes by disrupting the 
peroxisomal structure. The disassembly can be visualized by electron microscopy, and it will be 
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of interest to examine the structural disassembly. Identification of cellular proteins interacting 
with nsp1 in the peroxisomes and other viral factors affecting the antiviral signaling from 
peroxisomes will also be interesting. 
Coronavirus nsp1 is the first N-terminal cleavage product of pp1a and pp1a/b 
polyproteins (Ziebuhr, 2005). It is one of the most divergent viral proteins in four different 
genera and does not harbor any known cellular functional motifs (Connor et al., 2007). Only 
Alphacoronavirus and Betacoronavirus code for nsp1, whereas Gammacoronavirus and 
Deltacoronavirus do not contain the nsp1 gene (Woo et al., 2010; Woo et al., 2012; Ziebuhr et 
al., 2005; Ziebuhr et al., 2007). For Betacoronavirus nsp1, the regulation of host cell and viral 
gene expressions has been documented, and nsp1 is also a potent IFN antagonist. SARS-CoV 
nsp1 inhibits the reporter gene expression under the constitutive and IFN-β promoters (Kamitani 
et al., 2006), and employs a two-pronged strategy to inhibit host gene expression. It tightly 
associates with the 40S ribosomal subunit for inhibition of mRNA translation and induction of an 
endonucleolytic RNA cleavage of cellular mRNAs (Huang et al., 2011b; Kamitani et al., 2009). 
Murine hepatitis coronavirus (MHV) nsp1 affects the cellular gene expression by suppressing 
IFN-β, IFN-stimulated response element (ISRE), and SV40 promoter (Zust et al., 2007). MERS-
CoV nsp1 inhibits host gene expression by selectively targeting mRNAs transcribed in the 
nucleus for translation inhibition and mRNA degradation, but spares exogenous mRNAs 
introduced directly into the cytoplasm or virus-like mRNAs that originate in the cytoplasm 
(Lokugamage et al., 2015). However, nsp1 in Alphacoronavirus and Betacoronavirus lack an 
overall sequence similarity, and neither conserved motifs nor domains are found in viruses of 
Alphacoronavirus. Interestingly, the domains in SARS-CoV nsp1 responsible for suppression of 
host gene expression and type I IFN production are absent in PEDV nsp1 (Huang et al., 2011b; 
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Narayanan et al., 2008). Thus, it is plausible that nsp1 of Alphacoronavirus may have distinct 
functions regulating host innate immune response and gene expression. Transmissible 
gastroenteritis virus (TGEV), a porcine Alphacoronavirus, strongly inhibits host protein 
synthesis without binding to 40S ribosomal subunit in a cell-free in vitro translation system 
(Huang et al., 2011a). However, this translational suppression does not contribute to IFN 
suppression because TGEV induces a rapid and massive production of type I IFN both in vitro 
and in vivo (Charley and Laude, 1988; La Bonnardiere and Laude, 1981). SARS-CoV nsp1 
potently inhibits host gene expression universally, including the endogenous protein β-actin 
(Narayanan et al., 2008). For PEDV however, the suppression of protein translation by nsp1 may 
not be a universal event since the expression level of endogenous β-actin is unchanged after virus 
infection and nsp1-gene transfection (Zhang et al., 2016; Zhang et al., 2017b). Thus, it remains 
to be examined whether PEDV nsp1 also has similar functions as other coronaviruses for 
shutting off host gene translation and whether these biological activities contribute to the 
regulation of IFN response. 
In summary, we show that PEDV suppresses the IRF1-mediated type III IFN production 
and this suppression is correlated to decreased numbers of peroxisomes in the swine intestinal 
epithelial cells. PEDV codes for many antagonists for type III IFNs and IRF1. PEDV nsp1 
inhibits the RIG-I/MDA5-mediated activation of type III IFNs and IRF1 activities. Our data 
provide novel information on the innate immune evasion of PEDV in the intestinal epithelial 
cells, which may form the foundation for future development of effective therapies and control 
of PED.   
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4.6 FIGURES AND TABLES 
 
 
 
 
 
 
Fig. 4.1: Efficient replication of PEDV in porcine intestinal epithelial cells IPEC-DQ. (A), IPEC-DQ 
cells retained the intestinal epithelial phenotype. LLC-PK1, IPEC-J2, and IPEC-DQ cells were grown on 
coverslips and fixed with 4% paraformaldehyde in PBS at 4 °C overnight. The cells were then 
permeabilized with cold methanol for 15 min at -20 °C. Immunostaining was conducted to detect the 
presence of pan cytokeratin (epithelial cell marker) and Sucrase-Isomaltase (intestinal cell differentiation 
marker). (B), Expression of the viral nucleocapsid (N) protein in PEDV-infected IPEC-DQ cells. IPEC-J2 
and IPEC-DQ cells were infected with PEDV at MOI of 5 and 1, respectively. Cells were then fixed at 24 
h postinfection (hpi) with 4% paraformaldehyde and were stained with mouse anti-N mAb. (C), 
Expression of N protein in PEDV-infected IPEC-DQ cells by Western blot. IPEC-J2 and IPEC-DQ cells 
were infected with PEDV at MOI of 5 and 1, respectively, and Western blot was conducted using anti-N 
mAb at 24 hpi. (D), Induction of IFN in IPEC-DQ cells. Cells were stimulated with poly(I:C) for 12 h and 
were harvested to determine activation of the type I and type III IFNs by RT-qPCR. The relative IFN 
induction levels were normalized to those of IFN-α.  
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Fig. 4.2: Type III IFNs exert an antiviral role against PEDV. (A), Suppression of type III IFNs during 
PEDV infection. MARC-145 cells were seeded in 12-well plates and were treated with 100 ng/ml of IFN-
λ1 or IFN-λ3 for 12 h. The cells were then infected with PEDV at 1 MOI for 1 h, washed, and replenished 
with fresh infection medium containing indicated subtypes of IFN-λ. Cell culture supernatants were 
collected at 12, 18, 24, 36, and 48 h postinfection and were titrated for TCID50. (B)-(C), Restriction of 
PEDV infection by type III IFNs is dose-dependent. MARC-145 cells were seeded in 12-well plates and 
were treated with different amounts of IFN-λ1 or IFN-λ3 for 12 h. The cells were then infected with 
PEDV at 1 MOI for 1 h, washed, and replenished with fresh infection medium containing the indicated 
IFN. Cell culture supernatants were collected at 24 h post-infection and were titrated for TCID50 (panel B). 
The cells were fixed for immunostaining with anti-N mAb and visualized under a fluorescence 
microscope (panel C). (D), Inhibition of PEDV infection by type III IFNs under three different treatment 
conditions. MARC-145 cells were pretreated with IFN-λ1 or IFN-λ3 (100 ng/ml) for 12 h and then 
inoculated with PEDV at an MOI of 1, washed, and replenished with fresh infection medium without IFN 
(Before). MARC-145 cells were coincubated PEDV with IFN-λ1 or IFN-λ3 (100 ng/ml) for 1 h, washed, 
and replenished with fresh infection medium without IFN (During). Alternatively, cells were inoculated 
first with PEDV for 1 h, and were treated with IFN-λ1 or IFN-λ3 (100 ng/ml) during incubation for 12 h 
(After). (E)-(F), Relative expression of the nucleocapsid (N) mRNA in PEDV-infected cells determined 
by RT-qPCR. The experiments for panel B and panel D form a pair, and the cells were harvested for RT-
qPCR for PEDV N mRNA transcript. β-actin was used as an internal control for normalization.  
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Fig. 4.3: Inhibition of type III IFN production by PEDV. (A)-(C), PEDV does not induce type III IFN 
production in intestinal epithelial cells. IPEC-DQ cells were infected with PEDV at an MOI of 5, and 
total cellular RNA was prepared at indicated times post-infection to determine the type III IFN mRNA by 
RT-qPCR. (D), PEDV does not activate IFN-λ1 promoter. MARC-145 cells were grown in 12-well plates 
and cotransfected with p-55λ1-(-225/-36)-Luc and pRL-TK for 6 h followed by PEDV infection at an 
MOI of 1. Cells were harvested at 3, 6, 9, and 12 h postinfection for dual-luciferase reporter assays. 
Mock-infected cells transfected with poly(I:C) for 12 h were used as a positive control. (E), PEDV 
inhibits IFN-λ1 promoter. MARC-145 cells were grown in 12-well plates and transfected with p-55λ1-(-
225/-36)-Luc for 6 h followed by infection. The gene-transfected and PEDV-inoculated cells were then 
stimulated with poly(I:C) for 12 h, and cell lysates were prepared for dual-luciferase reporter assays. (F)-
(H), PEDV suppresses the induction of type III IFN mRNA as determined by RT-qPCR. LLC-PK1 cells 
were grown in 12-well plates for infection for 12 h and then stimulated with poly(I:C) for 12 h. Total 
cellular RNA was prepared for RT-qPCR. Results were obtained from three independent experiments in 
triplicate each and were presented as mean values with standard deviation. Asterisks indicate statistical 
significance. *, P<0.05; **, P<0.01; ***, P<0.001. 
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Fig. 4.4: Identification of PEDV nsp1 as a potent type III IFN antagonist. (A), Expression of 
individually cloned PEDV proteins in gene-transfected cells. Each gene was transfected to HeLa cells and 
the protein expression was determined by Western blot using anti-FLAG antibody. Transfection was 
conducted as described previously (Zhang et al., 2016). Numbers indicate respective nonstructural 
proteins representing nsp1 through nsp16. (B)-(C), Suppression of IFN-λ1 promoter activity by an 
individual PEDV protein. HeLa cells were grown in 24-well plates and cotransfected with p-55λ1-(-225/-
36)-Luc and different PEDV genes along with pRL-TK at the ratio of 1:1:0.1. At 12 h posttransfection, 
cells were stimulated with poly(I:C) (0.5 µg/ml) for 12 h and the luciferase activities were measured. (D), 
Dose-dependent inhibition of IFN-λ1 promoter activity by PEDV nsp1. HeLa cells were grown in 24-well 
plates and cotransfected with p-55λ1-(-225/-36)-Luc along with pRL-TK at the ratio of 1:0.1 with an 
increasing amount of PEDV nsp1 gene. At 12 h post-transfection, cells were stimulated with poly(I:C) 
(0.5 µg/ml) for 12 h and the luciferase activities were measured. The pXJ41 empty vector was used as a 
control. (E)-(G), Suppression of type III IFN production by PEDV nsp1. LLC-PK1 cells were grown in 
the 12-well plates and transfected with the pXJ41 empty vector or PEDV nsp1 gene for 12 h. Cells were 
then stimulated with poly(I:C) for 12 h. Total cellular RNA was prepared for RT-qPCR to determine 
mRNAs for IFN-λ1 (E), IFN-λ3 (F), IFN-λ4 (G). Results were normalized using β-actin mRNA and 
expressed as relative changes in mRNA levels to those in cells without stimulation. Data were obtained 
from three independent experiments, each in triplicate. 
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Fig. 4.5: Suppression of IFN-λ1 is mediated via IRF and NF-κB interference. (A), Suppression of 
IRF- and NF-κB-mediated IFN-λ1 activity by PEDV. MARC-145 cells were transfected with p-
55λ1mut.IRF-Luc, p-55λ1mut.NF-κB -Luc, or p-55λ1mut.IRF/mut.NF-κB-Luc for 6 h and infected with 
PEDV at an MOI of 1 for 12 h. Cells were then stimulated with poly(I:C) for 12 h, and cell lysates were 
prepared for dual-luciferase reporter assays. (B), PEDV blocks IRF1 activation. MARC-145 cells were 
transfected with pIRF1-Luc and infected with PEDV for dual-luciferase reporter assays. (C), 
Identification of IRF1 antagonists. HeLa cells were grown in 24-well plates and cotransfected with 
pIRF1-Luc, along with an individual PEDV gene and pRL-TK at the ratio of 1:1:0.1. At 12 h 
posttransfection, cells were stimulated with poly(I:C) and the luciferase activities were measured. (D), 
Inhibition of IFN-λ1 activity is mediated by IRF and NF-κB interference. HeLa cells were co-transfected 
with p-55λ1-(-225/-36)-Luc or its mutants along with PEDV nsp1 gene for dual luciferase assay. The 
reporter experiments were repeated three times, each time in triplicate. Asterisks indicate the statistical 
significance using the pXJ41 empty vector as a control. *, P<0.05; **, P<0.01; ***, P<0.001. 
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Fig. 4.6: Inhibition of RIG-I/MDA5-mediated IFN-λ1 and IRF1 activities by nsp1. (A)-(F), Inhibition 
of RIG-I/MDA5-mediated IFN-λ1 activation by nsp1. HeLa cells were cotransfected with an active form 
of RIG-I (A), MDA5 (B), MAVS (C), TBK1 (D), IKKε (E), or IRF3 (F), along with the nsp1 gene and 
the p-55λ1-(-225/-36)-Luc reporter.  Cell lysates were prepared to measure the luciferase activities. (G)-
(I), PEDV nsp1 inhibits RIG-I/MDA5-mediated IRF1 activation. HeLa cells were cotransfected with an 
active form of RIG-I (G), MDA5 (H), or MAVS (I), along with the nsp1 gene and IRF1-Luc reporter for 
luciferase assays.  
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Fig. 4.7: Inhibition of IRF1 nuclear translocation by PEDV and nsp1. (A), IPEC-DQ cells grown in 
12-well plates were infected with PEDV at 5 MOI, and lysed at indicated times for detection of IRF1 and 
PEDV N protein by Western blot. (B), PEDV blocks IRF1 nuclear translocation. IPEC-DQ cells were 
grown on coverslips and infected with PEDV for 12 h followed by stimulation with poly(I:C). Cells were 
then fixed and stained with anti-N antibody and anti-IRF1 antibody. Nuclei were stained with DAPI. 
Yellow arrows indicate IRF1 in the nucleus, and white arrows indicate IRF1 in the cytoplasm. (C), 
Inhibition of IRF1 nuclear translocation by PEDV nsp1. IPEC-DQ cells grown on coverslips were 
transfected with the PEDV nsp1 gene and then stimulated with poly(I:C). Cells were then fixed and 
stained with anti-Flag antibody and anti-IRF1 antibody. Yellow arrows indicate IRF1 in the nucleus after 
stimulation in the absence of nsp1 expression. White arrows indicate IRF1 in the cytoplasm in nsp1-
expressing cells.  
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Fig. 4.7 (cont.)  
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Fig. 4.8: Peroxisomes are decreased in number in PEDV-infected cells. (A), The reduction of 
peroxisomes in PEDV-infected cells. MARC-145, LLC-PK1, and IPEC-DQ cells grown on coverslips 
were infected with PEDV for 24 h and incubated with anti-PMP70 (peroxisome marker) antibody and 
anti-N antibody for immunostaining. (B), The relative numbers of peroxisomes in PEDV-infected cells. 
The number of peroxisomes in PEDV-infected cells was compared to that of non-infected cells. One 
hundred fifty PEDV-infected cells were randomly chosen, and the number of peroxisomes was quantified 
per cell. Asterisks indicate statistical significance. *, P<0.05; **, P<0.01; ***, P<0.001.   
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Fig. 4.9 (cont.)  
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Fig. 4.9 (conti.): Conserved residues of nsp1 are crucial for the reduction of peroxisomes and IFN-λ 
suppression. (A), Conserved residues of nsp1 are critical for the reduction of peroxisomes. IPEC-DQ 
cells were grown on coverslips and transfected with the PEDV nsp1 gene or one of its mutants for 24 h. 
Cells were then stained with anti-PMP70 (peroxisome marker) and anti-FLAG antibody for 1 h. Alexa 
Fluor 594-conjugated goat anti-rabbit antibody and 488-conjugated goat anti-mouse secondary antibody 
were used to visualize peroxisomes and nsp1, respectively. Nuclei were stained with DAPI. (B), The 
relative number percentages of peroxisomes in nsp1-expressing cells. The number of peroxisomes in 
nsp1-expressing cells was compared to that in pXJ41-transfected cells. One hundred fifty nsp1-expressing 
cells were randomly chosen, and numbers of peroxisomes were quantified. (C), Expression levels of 
PEDV wild-type nsp1 and its mutants in gene-transfected cells. HeLa cells were cotransfected with either 
p-55λ1-(-225/-36)-Luc or IRF1-Luc with each mutant of nsp1. After stimulation with poly(I:C), cell 
lysates were prepared for Western blot with anti-FLAG antibody to individual mutant of nsp1. Lanes 1 
through 13 represent empty vector pXJ41, wild-type nsp1, G38A/F39A, F44A, T68A, K70A, 
T68A/K70A, G87A, N93A/N95A, L98A/E99A/E100A, L101A, Δ37-75, and Δ37-51, respectively. β-
actin was as a loading control. (D)-(E), Conserved residues in nsp1 are crucial for IFN-λ suppression. 
HeLa cells were cotransfected with p-55λ1-(-225/-36)-Luc (panel D) or IRF1-Luc (panel E), along with a 
nsp1 mutant. Cells were then stimulated with poly(I:C), and cell lysates were prepared to measure the 
luciferase activities. Data were obtained from three independent experiments and are presented as the 
mean values with standard deviation. Asterisks indicate the statistical significance with relative luciferase 
value of nsp1. *, P<0.05; **, P<0.01; ***, P<0.001. 
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        Table 4.1: Real-time PCR primer sets for cytokine genes used in this study.  
Gene  Forward primer (5'-3') Reverse primer (5'-3') 
Accession 
no./References  
IFN-λ1 GGTGCTGGCGACTGTGATG GATTGGAACTGGCCCATGTG Wang et al., 2011 
IFN-λ3 ACTTGGCCCAGTTCAAGTCT CATCCTTGGCCCTCTTGA FJ853389.1 
IFN-λ4 GCTATGGGACTGTGGGTCTT AGGGAGCGGTAGTGAGAGAG NC_010456.4 
N GCAGCAAGTGTCCTAAAGAAGCA  GCTTGGGTTCTGCACAGATCT  KF272920 
β-actin ATCGTGCGTGACATTAAG ATTGCCAATGGTGATGAC Zhang et al., 2016 
 
 
	   154 
CHAPTER 5: GENERAL CONCLUSION 
 
Innate immunity forms the first line of host defense to restrict the viral infections. Among 
many cytokines, type I and type III IFNs carry the antiviral activities and are the major 
components of the antiviral innate immunity. In turn, viruses have evolved to modulate the 
cellular signaling processes and pathways to evade host innate immunity. PEDV appears to 
evade the type I IFN response in multiple ways for efficient replication. PLP2 (papain-like 
proteinase 2) of PEDV antagonizes the type I IFN response by deubiquitinating RIG-I and 
STING, and PEDV N protein suppresses the IRF3 and NF-κB activities and antagonizes the 
IFN-β production by disrupting the interaction between IRF3 and TBK1. PEDV nsp5 protein 
cleaves NEMO for suppression of NF-κB-mediated type I IFN production. It is unknown 
whether PEDV encodes additional IFN antagonists and their mechanism of action.  
In the present study, we first identified MARC-145 cells as susceptible cells for PEDV 
replication. These cells have an intact IFN signaling system, and during infection of these cells, 
PEDV suppresses IFN-β production. Of all PEDV proteins, ten viral proteins inhibit the IFN-β 
and IRF3 promoter activities. Coronavirus nsp1 is the N-terminal cleavage product of 
polyproteins and is one of the most divergent genes among four different genera. The nsp1 
protein of β-CoV is a potent IFN antagonist, and interestingly, PEDV nsp1 is also the potent IFN 
antagonist. PEDV nsp1 does not interfere the IRF3 phosphorylation and nuclear translocation, 
but interrupts the enhanceosome assembly of IRF3 and CREB-binding protein (CBP). PEDV 
induces the CBP degradation in virus-infected cells and PEDV nsp1 degrades CBP in the nucleus 
in a proteasome-dependent manner. The degradation of CBP is a novel mechanism for 
coronavirus and likely plays a key role for suppression of type I IFN production by PEDV.  
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Despite the importance of NF-κB during infection, regulation of NF-κB by PEDV is 
poorly understood. It is unclear whether it is time-dependent and TNFα-mediated. PEDV inhibits 
both NF-κB activities and early production of proinflammatory cytokines in the porcine 
epithelial cell model. PEDV does not induce the p65 activation in infected cells and but inhibits 
the p65 nuclear localization after TNFα stimulation. PEDV also blocks the PRD II-mediated NF-
κB activity. Among the PEDV proteins, nsp1, nsp3, nsp5, nsp7, nsp14, nsp15, nsp16, ORF3, and 
E have been identified as NF-κB antagonists, and nsp1 is the most potent suppressor of 
proinflammatory cytokines. Nsp1 interferes the phosphorylation and degradation of IκBα, and 
thus blocks the p65 activation. PEDV nsp1 does not interfere the IKKα/β phosphorylation. The 
expression of IKKα/β is stable, and the phosphorylation of IKKα/β normally occurs in nsp1-
expressing cells, which indicates that the antagonism occurs between IKKα/β and IκBα. 
Mutational studies demonstrate the essential requirements of the conserved residues of nsp1 for 
NF-κB suppression. The nsp1-mediated NF-κB modulation may facilitate the replication and 
pathogenesis of PEDV. 
Accumulating data show that type III interferons (IFN-λs) play a crucial role in the 
intestinal antiviral state, and in turn, enteric viruses may have evolved to evade the type III IFN 
response during infection. PEDV targets intestinal epithelial cells (IEC) in vivo, and IECs induce 
and selectively respond to type III IFNs. We have first developed a line of porcine intestinal 
epithelial cells (IPEC-DQ) as a cell model for PEDV replication. Both IFN-λ1 and IFN-λ3 
inhibit PEDV replication in a dose-dependent manner, indicating the anti-PEDV activity of type 
III IFNs. Eleven PEDV proteins suppress the type III IFN activities. PEDV specifically inhibits 
IRF1 nuclear translocation. Peroxisomes are the innate antiviral signaling platforms for 
activation of IRF1-mediated IFN-λ production, and PEDV reduces the peroxisomes in number in 
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PEDV-infected cells. PEDV nsp1 blocks the nuclear translocation of IRF1 and reduces the 
number of peroxisomes to suppress the IRF1-mediated type III IFN. The conserved residues of 
nsp1 are crucial for IRF1-mediated IFN-λ suppression.  
In summary, we have shown that PEDV inhibits the production of both type I and type III 
IFNs, and that their mechanisms of action differ. PEDV induces the degradation of CBP in the 
nucleus and inhibits the NF-κB activation for suppression of both type I IFNs and 
proinflammatory cytokines. PEDV reduces the number of peroxisomes for suppression of IRF1-
mediated type III IFN production in intestinal epithelial cells. PEDV nsp1 is a potent IFN 
antagonist for IRF1, IRF3, IRF7, and NF-κB, and conserved residues are crucial for this action. 
These studies are of great value to facilitate the design of new strategies for control of not only 
PED, but also other enteric viral infections.  
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